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Chapter 1 
 
Trifluoromethyl aldimines 
After the isolation of elemental fluorine in 1886 by Henri Moissan, the 
development of fluorination methodologies and synthesis of fluorinated 
compounds has been an ongoing topic of current interest to the chemical 
community.1 
Indeed, fluorinated compounds have opened new opportunities inherent to 
the physico-chemical properties of fluorine that could be defined a magic element 
because of strong electronegativity, low polarizability and a small size.  
Fluorinated compounds show advantages such as high thermal, light and 
chemical stability, oil and water repellency, low dielectric constants, and low 
flammability, as a result of all this they can be used in many different fields such as 
polymer science,2 pharmaceutical and molecular biology.3  
Since fluorine-containing compounds are almost completely absent in nature, 
an increasing number of synthetic bioactive pharmaceuticals4 and agrochemicals 
contain fluorine, in particular, as many as 35% of agrochemicals and 20% of 
pharmaceuticals.5 This popularity of organofluorine compounds has been attributed 
to the influence that the fluorine substituents could have on several properties, such 
as the acidity or basicity of neighboring groups, dipole moment, and biological 
                                                                 
1 Yang, X.; Wu, T.; Phipps, R. J.; Toste, F. D. Chem. Rev. 2015, 115, 826–870. 
2 a) Vitale, A.; Bongiovanni, R.; Ameduri, B. Chem. Rev. 2015, 115, 8835–8866. b) Cametti, M.; Crousse, B.; 
Metrangolo, P.; Milani, R.; Resnati, G. Chem. Soc. Rev. 2012, 41, 31–42. 
3 Tirotta, I.; Dichiarante, V.; Pigliacelli, C.; Cavallo, G.; Terraneo,G.; Bombelli, F. B.; Metrangolo, P.; Resnati, 
G. Chem. Rev. 2015, 115, 1106–1129. 
4 a) Müller, K.; Faeh C.; Diederich, F. Science 2007, 317, 1881–1886; b) Hagmann, W. K. J. Med. Chem. 
2008, 51, 4359–4369; c) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320–
330; d) Böhm, H. J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst -Sander, U.; Stahl, M. 
ChemBioChem 2004, 5, 637–643 
5 Wang, J.;Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; 
Liu, H. Chem. Rev. 2013, 114, 2432. 
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characteristics such as lipophilicity, metabolic stability, and bioavailability6 in 
potentially active molecules. 
Thus, for example, a fluorine atom has been used as a replacement for a 
hydrogen atom or a hydroxyl group, and a CF2 or CF3 moiety has been used as a 
mimic for an oxygen atom; in addition, in many such compounds, a trifluoromethyl 
group can be considered also as a good mimicry of methyl, isopropyl and phenyl 
residues.7 In addition, the presence of the fluorine atoms can confer unusual 
chemical reactivity and influence the stereochemical transformations of organic 
compounds compared to their analogous unfluorinated.8 
Finally, considering the properties of 19F nucleus,9 the organofluorine 
compound structural characterization is supported by the use of 19F NMR, coupled 
with the most usual 1H and 13C NMR spectra.10 
For these reasons, the synthesis of fluorinated compounds, especially 
trifluoromethylated, is a topic of considerable interest into the mainstream organic 
synthesis community. The synthesis of these compounds can occur either through 
trifluoromethylation techniques11 or choosing a suitable CF3-containing precursor 
that can be subsequently converted into a range of different compounds.  
The second approach is considered more efficient, easier and versatile 
method, obviously the basic issue is that the trifluoromethylated precursor has to be 
inexpensive, available on large scale, non-toxic, environmentally compatible, and 
potentially multifunctional for use in various reactions.12  
                                                                 
6 a) Banks, R. E.; Tatlow, J. C.; Smart, B. E. Organofluorine Chemistry Principles and Commercial 
Applications, Plenum Press: New York, 1994.; b) Crowley, P. J. Chemistry of Organic Fluorine Compounds II, 
Hudlicky, M.; Pavlath A. E. Eds., American Chemical Society: Washington, 1995. 
7 Mikami, K.; Itoh, Y.; Yamanaka, M. Chem. Rev. 2004, 104, 1–16. 
8 a) Catalan, S.; Munoz, S. B.; Fustero, S. Chimia 2014, 68, 382–409; (b) Zimmer, L. E.; Sparr, C.; Gilmour, R. 
Angew. Chem., Int. Ed. 2011, 50, 11860–11871; (c) Hunter, L. Beilstein J. Org. Chem. 2010, 6, No. 38; (d) 
Resnati, G.; Soloshonok, V. A. Fluoroorganic chemistry: synthetic challenges and biomedical rewards, In 
Proceedings of the Tetrahedron Symposia; Tetrahedron 1996, 58, 1–330. 
9 Saielli, G.; Bini, R.; Bagno, A. RSC Adv. 2014, 4, 41605–41611. 
10 a) Keita, M.; Kaffy, J.; Troufflard, C.; Morvan, E.; Crousse, B.; Ongeri, S. Org. Biomol. Chem. 2014, 12, 
4576–4581; b) Curtis-Marof, R.; Doko, D., Rowe, M. L.; Richards, K. L.; Williamson, R. A.; Howard, M. J. 
Org. Biomol. Chem. 2014, 12, 3808–3812. 
11 Langlois, B. R.; Billard,T. Synthesis 2003, 185−194. 
12 Bégué, J. P.; Bonnet-Delpon, D.; Crousse, B.; Legros, J. Chem. Soc. Rev. 2005, 34, 562–572. 
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The main trifluoromethylated intermediate used in the industrial field is 
trifluoroacetic acid (TFA), as well as its derivates: trifluoroacetic anhydride, esters, 
amides;5 unfortunately the corresponding aldehyde, fluoral (CF3CHO), is an 
unstable gas, therefore difficult to prepare and use.  
Compared to fluoral, its hydrate or hemiacetal derivatives (Figure 1) are 
however widely used in the synthetic field, because of their stability and 
commercial availability at low cost. 
 
Figure 1. Hydrate or hemiacetal derivatives from fluoral. 
Considering that in nature the most biologically active compounds contain 
nitrogen, the development of efficient synthetic methods for preparing nitrogenated 
fluorine-containing analogues of natural compounds has received increasing 
attention in recent years: in particular, 1,2- and 1,3-difunctionalized compounds, 
including β-amino alcohols and α- and β-amino acids, as well as nitrogen 
heterocycles, important building blocks for more complex structures. 
Hydrate or hemiacetal derivatives of fluoral react with primary amines, in the 
presence of p-toluenesulfonic acid (PTSA) as catalyst at toluene reflux and with a 
Dean–Stark apparatus, giving the corresponding trifluoromethyl aldimines,13 as 
important scaffolds characterized by the presence of both a nitrogenous residue and 
a CF3 group (Scheme 1).14  
 
                                                                 
13 For a very recent review, see: Fioravanti, S. Tetrahedron 2016, 72, 4449−4489. 
14 Pirkle, W. H.; Hauske, J. R. J. Org. Chem. 1977;42, 2436–2439. 
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Scheme 1. Synthesis of trifluoromethyl aldimines under classical conditions. 
However, this methodology does not afford the product in good yields, 
because of the presence of −CF3 which can stabilize the hemiaminal intermediate 
and destabilize the carbocationic intermediate. Consequently, different synthetic 
strategies have been often required, such as the use of ultrasound or microwave,15 
high reaction temperatures or different activation methods.16 
In this field, an efficient solvent-free methodology for the synthesis of 
trifluoromethylated aldimines, ketimines, and hydrazones has been developed in 
the laboratory where I did my PhD thesis (Scheme 2).17  
 
Scheme 2. Solvent-free synthesis of trifluoromethyl aldimines. 
Starting from an equimolar solution of α,α,α-trifluoroacetophenone or 
trifluoroacetaldehyde ethyl hemiacetal with different aliphatic amines or 
hydrazines, and heating, the desired products were obtained with excellent yields. 
In addition, the reaction occurred with complete stereoselectivity, giving only the E 
isomer, as determined by NOE experiments. 
                                                                 
15 Abid, M.; Savolainen, M.; Landge, S.; Hu, J.; Prakash, G.K. S.; Olah, G. A.; Török B. J. Fluorine Chem. 
2007, 128, 587–594 
16 a) Barney, C. L.; Huber, E. W.; McCarthy, J. R. Tetrahedron Lett. 1990, 31, 5547−5550; b) Gulevich, A. V.; 
Shevchenko, N. E.; Balenkova, E. S.; Röschenthaler, G-V.; Nenajdenko, V. G. Tetrahedron 2008, 64, 11706–
11712 and refs therein. 
17 Carroccia, L.; Fioravanti, S.; Pellacani, L.; Tardella, P. A. Synthesis 2010, 4096–4100. 
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The presence in these compounds of the C=N function allows to use them as 
interesting electrophiles in several reactions (Scheme 3); in addition the presence 
of electron-withdrawing trifluoromethyl group increases the electrophilicity of the 
carbon–nitrogen double bond compared with that of nonfluorinated imines.9  
 
Scheme 3. Families of compounds after nucleophilic addition on trifluoromethyl aldimines.  
Alkylation and arylation reactions, using organometallic and related reagents, 
have been widely developed, also in the asymmetric versions. Funabiki and Enders 
using the SAMP/RAMP-methodology reported a highly diastereoselective 
alkylation (> 96% de) of hydrazones with alkyllithium reagents, especially with 
those derived from primary halides (Scheme 4).18 
                                                                 
18 Enders, D.; Funabiki, K. Org. Lett. 2001, 3, 1575−1577. 
12 
 
 
Scheme 4. Organometallic addition to trifluoromethyl hydrazones. 
As well as trifluoromethyl aldimines undergo arylation reaction when treated 
with a broad array of aryllithium reagents (Scheme 5), as reported by Gosselin et 
al.19 
 
Scheme 5. Organometallic addition to trifluoromethyl aldimines. 
Through a Strecker-type reaction, Brigaud and co-workers obtained 
diastereomerically pure trifluoromethyl amino nitriles (Scheme 6) starting from 
chiral −CF3 aldimines.20 
 
Scheme 6. Strecker-type reactions of chiral fluorinated aldimines. 
In all cases, these reactions required the presence of catalytic amount of 
ytterbium(III) trifluoromethanesulfonate [Yb(OTf)3] or MgBr2.  
The reaction of aromatic compounds with trifluoromethyl aldimines by a 
Friedel–Crafts type reaction can provide an interesting entry to benzylamine 
                                                                 
19 Gosselin, F.; Roy, A.; O’Shea, P. D.; Chen, C.-y.; Volante, R. D. Org. Lett. 2004, 6, 641−644. 
20 Huguenot, F.; Brigaud, T. J. Org. Chem. 2006, 71, 7075−7078. 
13 
 
analogues; in this field Kato reported the synthesis of α-CF3 α-aryl methylamines in 
the presence of BF3•Et2O (Scheme 7).21 
 
Scheme 7. Friedel−Crafts type reactions on trifluoromethyl aldimines. 
More recently, Soloshonok and co-workers reported Lewis acid catalyzed 
Friedel−Crafts-type additions on chiral trifluoromethyl N-tert-butylsulfinylimine 
with various indoles (Scheme 8).22 
 
Scheme 8. Friedel−Crafts type reactions on substituted N-methyl indoles. 
Aza-Diels–Alder reactions have also been investigated with Danishefsky’s 
diene in order to afford the corresponding dihydropyridinone (Scheme 9).23 
 
Scheme 9. Aza-Diels–Alder reactions on trifluoromethyl aldimines. 
Given that the large majority of modern drugs and agrochemicals contain one 
or more heterocyclic rings, it is not surprising that the synthesis of trifluoromethyl 
heterocycles is a topic of current interest to the chemical community. Small CF3-
                                                                 
21 Gong, Y.; Kato, K.; Kimoto, H. Bull. Chem. Soc. Jpn. 2002, 75, 2637–2645. 
22 Wua, L.; Xie, C.; Mei, H.; Soloshonok, V. A.; Han, J.; Pan, Y. J. Org. Chem. 2014, 79, 7677−7681. 
23 Crousse, B.; Narizuka, S.; Bégué, J.-P.; Bonnet-Delpon, D. J. Org. Chem. 2000, 65, 5009–5013. 
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containing nitrogen heterocycles, including aziridines, can be integrated in the 
elaboration of amino acids to create modified peptides with special features.24 
Bégué and co-workers highlighted a straightforward synthesis of aziridine-2-
carboxylates, as potential precursors of non-proteogenic α- and β-amino acids, 
using ethyl diazacetate as nuchelophile and BF3•Et2O as catalyst at low temperature 
(Scheme 10).25  
 
Scheme 10. Synthesis of trifluoromethyl aziridines. 
In the laboratory in which I am attending my PhD, trifluoromethyl aldimines 
were used to obtain interesting optically active fluorinated diaziridines and 
oxaziridines.26 The amination reaction has been developed without any added base 
and using, as aminating agents, aza-anions formed in situ from different alkyl 
nosyloxycarbamates (NsONHCO2R, Ns=4-NO2C6H4SO2).  
 
Scheme 11. Synthesis of trifluoromethyl diaziridines. 
As reported in Scheme 11, the reaction proceeds through an aza-anion 
nucleophilic attack followed by a ring closure reaction, affording the corresponding 
trifluoromethyl diaziridines in good yields. It was demonstrated that the 
stereoselective induction was controlled by steric or electronic effects present on  
                                                                 
24 Salwiczek, M.; Nyakatura, E. K.; Gerling, U. I. M.; Ye, S.; Koksch, B. Chem. Soc. Rev. 2012, 41, 2135–
2171. 
25 Crousse, B.; Narizuka, S.; Bonnet-Delpon D.; Bégué, J.-P. Synlett 2001, 679–681. 
26 Carroccia, L.; Fioravanti, S.; Pellacani, L.; Sadun, C.; Tardella, P. A. Tetrahedron 2011, 67, 5375−5381 
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or carbonof the aminic residue. In fact, when the phenyl group is present in the 
α position a very good diastereomeric induction (99:1) was observed, but if this last 
group is present in the β position a reversal of induction was observed leading to a 
1:1.7 mixture of diastereomers  
Starting from trifluoromethyl aldimines also trifluoromethyl oxaziridines26 
can be obtained through epoxidation reactions using m-CPBA (m-
chloroperoxybenzoic acid) as oxidant (Scheme 12).  
 
Scheme 12. Synthesis of trifluoromethyl oxaziridines. 
The reactivity of trifluoromethyl aldimines has been also studied in the aza-
Henry reactions to successfully synthesize trifluoromethyl β-nitro amines in the 
presence of catalytic amounts of zirconium tetrachloride (ZrCl4) (Scheme 13).27 
 
Scheme 13. ZrCl4-catalyzed aza-Henry addition to trifluoromethyl aldimines. 
The pathway proposed (Scheme 14) for the aza-Henry reaction involves a 
previous coordination between the imine and Zr(IV), which can coordinate even 
the nitro compound28 and this coordination increases the acidity of its hydrogens 
which can be deprotonated by another imine molecule, thus forming the key 
intermediate of the reaction (II). A final intramolecular attack followed by 
protonation gave the desired product and restored both the catalyst and the imine.  
                                                                 
27 Fioravanti, S.; Pellacani, L.; Vergari M. C. Org. Biomol. Chem. 2012, 10, 8207–8210. 
28 a) Johannsen, M.; Jørgensen, K. A. J. Chem. Soc., Perkin Trans. 2 1997, 1183–1185; b) Nishiwaki, N.; 
Knudsen, K. R.; Gothelf K. V.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 2992–2995. 
16 
 
 
Scheme 14. Possible pathway of ZrCl4-catalyzed aza-Henry addition. 
The β-nitro amines were subsequently considered in a selective reduction of 
nitro group (Scheme 15), 
 
Scheme 15. Synthesis of ψ[CH(CF3)NH]-peptidomimetics. 
followed by a coupling reaction with suitable N-Boc-protected L-α-amino acids,29 
to obtain interesting ψ[CH(CF3)NH]-peptidomimetics.30,31
                                                                 
29 Fioravanti, S.; Pelagalli, A.; Pellacani, L.; Sciubba, F.; Vergari M. C. Amino Acids 2014, 46, 1961–1970. 
30 Molteni, M.; Bellucci, M. C.; Bigotti, S.; Mazzini, S; Volonterio, A.; Zanda, M. Org. Biomol. Chem. 2009, 7, 
2286–2296. 
31 Sani, M.; Volonterio, A.; Zanda, M. Med. Chem. 2007, 2, 1693–1700. 
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Chapter 2 
 
Mannich-type reaction 
In 1912, Carl Mannich reported his systematic studies of the three-
component reaction (M-3CR) between an enolizable substrate, a primary or 
secondary amine and a nonenolizable aldehyde, classically formaldehyde, to form 
β-amino carbonyl compounds, known as Mannich bases.1 
The classical M-3CR is, however, characterized by a number of serious 
disadvantages,2 therefore numerous methods have been developed for the indirect 
reaction, namely the Mannich-type reaction, through the use of preformed 
electrophiles (e.g., iminium salts or imines) or nucleophiles (enolates, enol ethers, 
and enamines) (Scheme 1).  
 
Scheme 1. Direct and indirect Mannich reactions. 
The nucleophilic species is usually an aromatic or aliphatic aldehyde or 
ketone, but even derivatives of carboxylic acids, β-dicarbonyl compounds, nitro 
alkanes, nitriles, or isocyano acetates, showing to be a versatile reaction. Moreover, 
the obtained products are useful synthetic intermediates, that can be converted into 
                                                                 
1 Mannich, C.; Krosche, W. Arch. Pharm. 1912, 250, 647. 
2a) Tramontini, M.; Angiolini, L. Mannich Bases–Chemistry and Uses; New Directions in Organic and 
Biological Chemistry Series; CRC Press, Boca Raton, FL, 1994. b) Tramontini, M.; Angiolini, L. Tetrahedron 
1990, 46, 1791–1837. c) Traxler, P.; Trinks, U.; Buchdunger, E.; Mett, H.; Meyer, T.; Müller, M.; Regenass, 
U.; Rösel, J.; Lydon, N. J. Med. Chem. 1995, 38, 2441–2448. d) Dimmock, J. R.; Sidhu, K. K.; Chen, M.; Reid, 
R. S.; Allen, T. M.; Kao, G. Y.; Truitt, G. A. Eur. J. Med. Chem. 1993, 28, 313–322. 
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a great number of derivatives which possess valuable applications in several fields, 
especially in medicinal chemistry.28  
The development of the asymmetric Mannich-type reaction has attracted 
considerable attention and various methods for conducting highly 
diastereoselective and/or enantioselective Mannich reactions have been developed 
in the past.3 
2.1 Chiral organometallic catalysts 
Traditionally, asymmetric Mannich-type reactions are catalyzed by chiral 
transition‐metal complexes.4  
The first enantioselective Mannich-type reaction on benzaldehyde imine 
derivatives has been reported by Kobayashi’s group; the reaction was catalyzed by 
a chiral Lewis acid [Zr(IV)-BINOL], able to coordinate the imine towards the 
addition of silicon enolates and the silyl transfer, facilitating the catalyst recovery. 
The syn- and anti-selectivity was controlled by simply choosing the protective 
groups of the R-alkoxy and the ester moieties of silyl enolates (Scheme 2).5 
                                                                 
3 a) Friestad, G. K.; Mathies, A. K. Tetrahedron 2007, 63, 2541–2569; b) Córdova, A. Acc. Chem. Res. 2004, 
37, 102–112; c) Kobayashi, S.; Ishitani, H. Chem. Rev. 1999, 99, 1069–1094; d) List, B. Tetrahedron 2002, 58, 
5573-5590; e) Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B. Chem. Rev. 2007, 107, 5471–5569. 
4 a) Asymmetric Catalysis in Organic Synthesis; Noyori, R. Wiley, New York, 1994; b) Catalytic Asymmetric 
Synthesis  Ojima I., Wiley, New York, 2000; c) Transition Metals for Organic Synthesis, 2nd ed. Beller, M.; 
Bolm, C. Wiley-VCH, Weinheim, 2004; d) GrMger, H.; Wilken, J. Angew. Chem., Int. Ed. 2001, 40, 529–532; 
5 a) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. Soc. 1997, 119, 7153–7154. b) Kobayashi, S.; Ishitani, 
H.; Ueno, M. J. Am. Chem. Soc. 1998, 120, 431–432. c) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. 
Soc. 2000, 122, 8180–8186. 
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Scheme 2. Mannich-type reaction catalyzed by a chiral Lewis acid [Zr(IV)-BINOL]. 
Subsequently, other BINOL- and BINAP-derived catalysts have been used 
for the asymmetric Mannich-type reactions.6 In 1998, Sodeoka’s group developed a 
new binuclear palladium complex prepared from chiral Tol-BINAP for the 
Mannich reactions of imines derived from glyoxylate (Scheme 3).7  
 
Scheme 3. Mannich type reaction catalyzed by binuclear palladium complex. 
One disadvantage of these stereoselective Mannich reactions is the 
preparation and stability of the preformed enolate, and a major step for this 
                                                                 
6 a) Ihori, Y.; Yamashita, Y.; Ishitani, H.; Kobayashi, S. J. Am. Chem. Soc. 2005, 127, 15528–15535; b) 
Yamashita, Y.; Ueno, M.; Kuriyama, Y.; Kobayashi, S. Adv. Synth. Catal. 2002, 344, 929–931. 
7 a) Hagiwara, E.; Fujii, A.; Sodeoka, M. J. Am. Chem. Soc. 1998, 120, 2474–2475; b) Fujii, A.; Hagiwara, E.; 
Sodeoka, M. J. Am. Chem. Soc. 1999, 121, 5450–5458. 
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important class of reactions has been to develop catalytic enantioselective version 
that uses carbonyl compounds, especially aldehydes, as nucleophile precursors. 
Subsequently, good results in the asymmetric Mannich-type reactions on α-
carbonyl esters were obtained using copper(II) complexes. Jørgensen’s group 
disclosed an approach to asymmetric Mannich reactions that utilizes 
copper(II)/bisoxazoline complexes. These catalysts are very effective for the 
addition of α-carbonyl esters to N-tosyl α-aldimino ethyl ester which make this 
method a simple synthetic procedure in order to obtain functionalized α-amino acid 
derivatives using readily available carbonyl compounds rather than the silyl enol 
ethers or silyl ketene acetals (Scheme 4).8 
 
Scheme 4. Mannich type reaction catalyzed by Cu(OTf)2/(R)-Ph-BOX. 
These same authors disclosed the first asymmetric Mannich-type reaction 
catalyzed by chiral tert-butyl-bisoxazoline/Cu(OTf)2 using malonic esters as pro-
nucleophiles or β-keto esters as nucleophiles (Scheme 5).9 
 
Scheme 5. Mannich type reaction catalyzed by Cu(OTf)2/t-Bu-BOX. 
                                                                 
8 Juhl, K.; Gathergood, N.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 2995–2997. 
9 Marigo, M.; Kjærsgaard, A.; Juhl, K.; Gathergood, N.; Jørgensen, K. A. Chem. Eur. J. 2003, 9, 2359–2367.  
21 
 
It was found that the best results in terms of yield, diastereo- and 
enantioselectivity were obtained when β-keto esters bearing the tert-butyl group on 
the ester function were used as the substrate. 
Chiral Ni(II) complexes, derived from glycine Schiff bases, were used as 
Mannich donors in the addition reactions to N-tert-butylsulfinyl-3,3,3-
trifluoroacetaldimine (Scheme 6).10 In that case the chiral transition‐metal complex 
is used as a chiral auxiliary, and a perfectly matched between the two reactants 
provided satisfactory diastereoselectivity. 
 
Scheme 6. Chiral Ni(II) complexes as Mannich donors.  
Chiral complex are also used in the asymmetric vinylogous Mannich (AVM)-type 
reactions that can be regarded as a self-class of Mannich-type additions. In this 
context, Shi and co-workers11 reported the silver(I)-catalyzed asymmetric Mannich 
reaction of fluorinated aldimines with trimethylsiloxyfuran, using chiral 
phosphine–oxazoline ligands (Scheme 7). 
 
Scheme 7. AVM-type reaction of trifluoromethyl aldimine and 2 trimethylsiloxyfuran. 
                                                                 
10 Kawamura, A.; Moriwaki, H.; Röschenthaler, G.-V.; Kawada, K.; Aceña, J. L.; Soloshonok, V. A. J. 
Fluorine Chem. 2015, 171, 67–72 
11 Zhao, Q.-Y.; Yuan, Z.-L.; Shi, M. Tetrahedron: Asymmetry 2010, 21, 943–951. 
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The corresponding adducts were obtained in good to excellent yields and 
good diastereoselectivities along with moderate to good enantioselectivities. 
2.2 Chiral organocatalysts 
Organocatalytic methods, which generally involves small organic molecules 
in sub-stoichiometric quantities to promote organic reactions, have emerged as a 
potent instrument to build chiral intermediates and products. The term 
“organocatalysis” was coined up by David MacMillan12 in 2000 to summarize and 
to describe several classes of organic catalysts that had been used during the last 
fifty years. 
Organocatalysts such as amino acid derivatives, especially those derived 
from proline,13 cinchona-type alkaloids,14 chiral amine thioureas and chiral 
Brønsted acids15 have been widely used in the Mannich type reaction. 
2.2.1 syn-anti Selective chiral organocatalysts 
Enamine catalysis using amino acid derivatives has been widely developed39 
since List and co-workers reported the first example of a proline-catalyzed 
Mannich reaction,16 to obtain enantiopure syn-γ-amino alcohols starting from 
different aldehydes (Scheme 8).  
                                                                 
12 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4224. 
13 a) Cordova, A.; Notz, W.; Zhong, G.; Betancort, J. M.; Barbas, C. F., III. J. Am. Chem. Soc. 2002, 124, 
1842–1843; b) Cordova, A.; Watanabe, S. I.; Tanaka, F.; Notz, W.; Barbas, C. F., III. J. Am. Chem. Soc. 2002, 
124, 1866–1867; c) Carlone, A.; Cabrera, S.; Marigo, M.; Jørgensen, K. A. Angew. Chem., Int. Ed. 2007, 46, 
1101–1104.  
14 a) McCooey, S. H.; Connon, S. J. Angew. Chem., Int. Ed. 2005, 44, 6367–6370; b) Han, X.; Kwiatkowski, J.; 
Xue, F.; Huang, K.-W.; Lu, Y. Angew. Chem., Int. Ed. 2011, 50, 2653–2664. 
15 a) Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 128, 1086–1087; b) Yamanaka, M.; Itoh, J.; 
Fuchibe, K.; Akiyama, T. J. Am. Chem. Soc. 2007, 129, 6756–6764; c) Sickert, M.; Schneider, C. Angew. 
Chem., Int. Ed. 2008, 47, 3631–3634; d) Tillman, A. L.; Dixon, D. J. Org. Biomol. Chem. 2007, 5, 606–609; e) 
Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem., Int. Ed. 2004, 43, 1566–1568. 
16 a) List, B. J. Am. Chem. Soc. 2000, 122, 9336–9337; b) List, B.; Pojarliev, P.; Biller, W. T.; Martin, H. J. J. 
Am. Chem. Soc. 2002, 124, 827–833. 
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Scheme 8. Mannich reaction catalyzed by L-proline. 
Subsequently Barbas III and co-workers reported results similar to those 
obtained by List’s group concerning the proline-catalyzed Mannich reaction, 
starting from several ketones and involving preformed imines (Scheme 9).17 
 
Scheme 9. Mannich type reaction catalyzed by L-proline. 
The proline approach has been applied in the Mannich reactions with several 
nucleophiles and electrophiles.18 In these transformation the syn configuration of 
the final product is generally controlled by a hydrogen-bond interaction between 
the imine nitrogen and the hydroxyl hydrogen of proline (Figure 2).  
 
                                                                 
17 a) Notz, W.; Watanabe, S.; Chowdari, N. S.; Zhong, G.; Betancort, J. M.; Tanaka, F.; Barbas, C. F., III. Adv. 
Synth. Catal. 2004, 346, 1131–1140; b) Notz, W.; Tanaka, F.; Watanabe, S. I.; Chowdari, N. S.; Turner, J. M.; 
Thayumanavan, R.; Barbas, C. F. J. Org. Chem. 2003, 68, 9624–9634.  
18 a) Marques, M. M. B. Angew. Chem. 2006, 118, 356–360; Angew. Chem., Int. Ed. 2006, 45, 348–352; b) 
Còrdova, A. Acc. Chem. Res. 2004, 37, 102–112. 
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Figure 1. Proposed transition states. 
In order to synthetize all possible stereoisomers, recently, other proline 
derivatives, namely diarylprolinol ethers (Figure 2), have been developed.19  
 
Figure 2. Diarylprolinol ethers . 
With these catalysts the relative configuration of the product is controlled by 
the steric hindrance of the α substituent to the nitrogen (Figure 3), in the transition 
state the only anti-type attack being thus favored. 
 
Figure 3. Proposed transition states. 
Fustero et al.20 have described the asymmetric Mannich reaction between 
fluoroalkyl aldimines and propanal catalyzed by proline that, after reduction, gave 
                                                                 
19 a) Córdova, A.; Barbas, C. F., III. Tetrahedron Lett. 2002, 43, 7749–7752; b) Zhang, H.; Mifsud, M.; 
Tanaka, F.; Barbas, C. F., III. J. Am. Chem. Soc. 2006, 128, 9630–9631; c) Mitsumori, S.; Zhang, H.; Cheong, 
P. H.-Y.; Houk, K. N.; Tanaka, F.; Barbas, C. F., III. J. Am. Chem. Soc. 2006, 128, 1040–1041; d) Franzén, J.; 
Marigo, M.; Fielenbach, D.; Wabnitz, T. C.; Kjaersgaerd, A.; Jørgensen, K. A. J. Am. Chem. Soc. 2005, 127, 
18296–18304; e) Galzerano, P.; Agostino, D.; Bencivenni, G.; Sambri, L.; Bartoli, G.; Melchiorre, P. Chem.-
Eur. J. 2010, 16, 6069–6076.  
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syn-3-fluoroalkyl-1,3-amino alcohols. Later the same authors described a highly 
diastereo- and enantioselective synthesis of anti-γ‐amino alcohols using (S)-
α,α‐diarylprolinol trimethylsilyl ether as catalyst (Scheme 10).21  
 
Scheme 10. Organocatalyzed Mannich type reaction on fluoroalkyl aldimines. 
Recently, in the laboratory in which I am attending my PhD 
diastereomerically pure fluorinated syn- or anti-γ-amino alcohols (Scheme 26) 
were obtained by an eco-friendly one-pot solvent free L-proline catalyzed 
Mannich-type reaction only by changing the reaction temperature (complete 
selectivity syn or anti at 40 °C or 0 °C, respectively).22  
 
Scheme 11. One-pot solvent-free L-proline-catalyzed Mannich-type reaction on chiral aldimines. 
                                                                                                                                                                                    
20 Fustero, S.; Jiménez, D.; Sanz-Cervera, J. F.; Sánchez-Roselló, M.; Esteban, E.; Simón-Fuentes, A. Org. 
Lett. 2005, 7, 3433–3436.  
21 Fustero, S.; Mojarrad, F.; Carrion, M. D. P .; Sanz-Cervera, J. F.; Aceña, J. L. Eur. J. Org. Chem. 2009, 
5208-5214. 
22 Fioravanti S, Parise L, Pelagalli A, Pellacani L, Trulli L. RSC Adv. 2015, 5, 29312–29318. 
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We decided to extend this work to chiral aldimines functionalized with L-α-
amino ester moieties. 
 
Scheme 12. Synthesis of functionalized N-α-amino ester trifluoromethyl aldimines. 
A new methodology, starting from the commercial fluoral ethyl hemiacetal 
and different L-α-amino esters, has been developed for the synthesis of the 
aldimines (Scheme 12) that subsequently were considered in a proline-catalyzed 
Mannich-type reaction: again a complete syn or anti selectivity simply by changing 
the reaction temperature was observed. (Scheme 13).23 
 
Scheme 13. Synthesis of L-α-amino ester functionalized trifluoromethyl (S,S,R)-anti-γ-amino 
alcohols.  
 
 
 
                                                                 
23 Fioravanti S, Parise L, Pelagalli A, Pellacani L, Trulli L.; Vergari M. C. Chirality 2015, 27, 571-575. 
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2.2.2 Chiral Brønsted Bases 
Readily available and inexpensive chincona alkaloids are among the most 
useful organocatalysts to date. The family of cinchona alkaloids consists of two 
pseudoenantiomeric pairs, including cinchonine, cinchonidine, quinine and 
quinidine (Figure 4). The presence of 1,2-amino alcohol moiety, containing the 
basic and bulky quinuclidine, is responsible for the catalytic activity. 
 
Figure 4. Chincona alkaloids organocatalysts. 
They are widely used in the asymmetric Mannich-type reaction, especially 
with active methylene compounds that, after deprotonation, provide a chiral ionic 
pair whose anion reacts with the imine in a stereoselective way. 
In this context, Schaus et al. were the first to describe the cinchona alkaloid-
catalyzed Mannich reaction of 1,3-dicarbonyl compounds with N-carbamoyl aryl 
imines. They were able to obtain the desired product, characterized by an α-
quaternary carbon, in good yield and high diastereo- and enantioselectivities, using 
several cinchona alkaloid (Scheme 14).24  
                                                                 
24 Ting, A.; Lou, S.; Schaus, S. E. Org. Lett. 2006, 8, 2003–2006. 
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Scheme 14. Mannich type reaction catalyzed by chincona alkaloids. 
Subsequently, numerous organocatalysts derived from cinchona and 
structurally simpler thiourea organocatalysts25 were developed and investigated in 
several Mannich-type reactions, with a variety of nucleophiles, including isocyano 
acetates,26 nitro compounds,27 phenyl acetates and thioesters.28 
Recently, the efficiency of bifunctional thiourea catalyst was also studied in 
the Mannich-type reaction between N-PMP trifluoromethyl aldimine and different 
βketo esters; the products, characterized by vicinal chiral centers, were obtained 
in good diastereo- and enantioselectivity (Scheme 15).29 
 
Scheme 15. Asymmetric organocatalyzed Mannich-type reaction by bifunctional thiourea. 
                                                                 
25 a) Yamaoka, Y.; Miyabe, H.; Yasui, Y.; Takemoto, Y. Synthesis 2007, 2571–2577; b) Wenzel, A. G.; 
Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964–12965. 
26 Zhang, Z.-W.; Lu, G.; Chen, M.-M.; Lin, N.; Li, Y.-B.; Hayashi, T.; Chan, A. S. C. Tetrahedron: Asymmetry 
2010, 21, 1715–1721. 
27 Wei, Y.; He, W.; Liu, Y.; Liu, P.; Zhang S. Org. Lett. 2012, 14, 704–707. 
28 Kohler, M. C.; Yost, J. M.; Garnsey, M. R.; Coltart, D. M. Org. Lett. 2010, 12, 3376–3379. 
29 Ji, S.; Alkhalil, A. E.; Su, Y.; Xia, X.; Chong, S.; Wang, K.-H.; Huang, D.; Fu, Y.; Hu, Y. Synlett 2015, 26, 
1725–1731. 
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Chapter 3 
 
Reformatsky reaction 
The Reformatsky reaction, introduced for the first time in 1887,30 is among 
the most useful methods for the C−C formation; its classical form involves zinc 
enolates derived from α-bromo ester and aldehydes or ketones as suitable 
electrophiles, affording the corresponding β-hydroxy esters.  
Nowadays, we can define Reformastky reaction all the transformations 
resulting from metal (zinc or other metals in low oxidation state) insertion into a 
carbon-halogen bond, activated by a carbonyl or carbonyl-related groups, followed 
by addition to the electrophile species (Scheme 1). 
 
Scheme 1. Reformatsky-type reaction. 
The main advantage of these transformations is that the enolate is formed 
under mild and neutral reaction conditions; in fact, no activation by strong acids or 
bases is needed, it follows its excellent functional group tolerance.  
In addition, the enolate formation is highly regioselective, in fact, the position 
of the halogen atom determines unambiguously the site of metal insertion.  
There seems to be no definitive experimental studies defining the mechanism 
precisely, probably it involves cyclic transition states, for which semiempirical 
                                                                 
30 Reformatsky, S. Ber. Dtsch. Chem. Ges. 1887, 20, 1210–1211. 
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calculations MO (PM3) suggest that the boat like transition state is favored, 
compared to the chair like transition state, using zinc as a metal.31 
3.1 Aza-Reformatsky reaction 
A major extension of the Reformatsky reaction has been achieved by the use 
of imines as suitable electrophiles. Aza-Reformatsky reaction affords β-amino 
esters and/or β-lactams, useful and valuable synthetic intermediates in organic 
synthesis and pharmacologically important compounds (Scheme 2).  
 
Scheme 2. Aza-Reformatsky-type reaction. 
The first zinc enolate-imine condensation reaction was originally reported by 
Gilman and Speeter32 in 1943 who employed a Reformatsky-type reaction between 
α-bromo esters with an imine for the production of an N-aryl-β-lactam (Scheme 3).  
 
Scheme 3. Gilman-Speeter reaction. 
Subsequently, a great attention has been paid to the study of the aza-
Reformatsky reaction,33 starting from several bromo esters and a variety of imines, 
with β-amino esters being preferred product especially when an ortho-substituent is 
present in an arylamine-derived imine.  
                                                                 
31 Maiz, J.; Arrieta, A.; Lopez, X.; Ugalde, J. M., Cossio, F. P.; Lecea, B. Tetrahedron Lett. 1993, 34, 6111–
6114. 
32 Gilman, H.; Speeter, M. J. Am. Chem. Soc., 1943, 65, 2255−2256. 
33 a) Honda, T.; Wakabayashi, H.; Kanai, K. Chem. Pharm. Bull. 2002, 50, 307–308; b) Adrian, J. C.; Barkin, 
J. L.; Hassib, L. Tetrahedron Lett. 1999, 34, 2457–2460; c) Mecozzi, T.; Petrini, M. Tetrahedron Lett. 2000, 
41, 2709–2712: d) Shankar, B. B.; Kirkup, M. P.; McCombie, S. W.; Clader, J. W.; Ganguly, A. K. 
Tetrahedron Lett. 1996, 37, 4095–4098; e) Robinson, A. J.; Wyatt, P. B. Tetrahedron 1993, 49, 11329–11340. 
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In 2001 Gong et al.34 reported a typical aza-Reformatsky reaction starting 
from trifluoromethyl aldimines: the corresponding β-lactam was the favored 
product starting from N-p-methoxyphenyl (PMP) protected aldimine. On the other 
hand, using N-phenyl protected trifluoromethyl aldimine, the Reformatsky reaction 
gave the corresponding β-amino esters as major products (Scheme 4).  
 
Scheme 4. Aza-Reformatsky-type reaction on trifluoromethyl aldimines. 
Later, Bonnet-Delpon reported a modified Reformatsky reaction, between 
ethyl bromoacetate and trifluoromethyl aldimines, performed under Barbier 
conditions. The authors were able to obtain the corresponding β-amino β-
trifluoromethyl esters in satisfactory yields, using a polar solvent (DMF) (Scheme 
5).  
 
Scheme 5. Aza-Reformatsky-type reaction on trifluoromethyl aldimine. 
However, it is necessary to underline that, even if the aza-Reformatsky 
reaction has a great potential, the corresponding products are often isolated as a 
mixture of β-amino esters and β-lactams.  
 
 
 
                                                                 
34 Gong, Y.; Kato, K. J. Fluorine Chem. 2001, 111, 77–80. 
32 
 
3.2 Stereoselectivity in Reformatsky reactions 
The main limitation of the Reformatsky transformations is due to observed 
low yields and diastereoselectivities, probably because it is classically performed 
under heterogeneous conditions that made the development of stereoselective 
variants quite difficult. 
To date, a few examples of highly diastereo and enantioselective 
Reformatsky reactions have been reported.35 
3.2.1 Heterogeneous conditions 
In recent years several ligands, such as carbohydrates,36 amino alcohols 
(ephedrines and N-alkyl ephedrines),37 α-amino acid esters,38 were considered as 
additives in the Reformatsky reactions performed between benzaldehyde and α-
bromo esters in the presence of metallic zinc (Scheme 6).   
 
Scheme 6. Enantioselective Reformatsky reactions. 
                                                                 
35 Choppin, S.; Ferreiro-Medeiros, L.; Barbarotto, M.; Colobert F. Chem. Soc. Rev. 2013, 42, 937–949. 
36 Ribeiro, C. M. R.; Santos, E. S.; Jardim, A. H. O.; Maia, M. P.; da Silva, F. C.; Moreira, A. P. D.; Ferreira, 
V. F. Tetrahedron: Asymmetry 2002, 13, 1703–1706. 
37 a) Mi, A.; Wang, Z.; Zhang, J.; Jiang, Y. Synth. Commun. 1997, 27, 1469–1473; b) Mi, A.; Wang, Z.; Chen, 
Z.; Jiang, Y. Tetrahedron: Asymmetry 1995, 6, 2641–2642; c) Andrés, J. M.; Martin, Y.; Pedrosa, R.; Perez-
Encabo, A.Tetrahedron 1997, 53, 3787–3794; d) Soai, K.; Kawase, Y. Tetrahedron: Asymmetry 1991, 2, 781–
784; e) Pini, D.; Uccello-Barretta, G.; Mastantuono, A.; Salvadori, P. Tetrahedron 1997, 53, 6065–6072; f) 
Fujiwara, Y.; Katagiri, T.; Uneyama, K. Tetrahedron Lett. 2003, 44, 6161−6163; g) Andrés, J. M.; Martinez, 
M. A.; Pedrosa, R.; Pèrez-Encabo, A. Synthesis 1996, 1070−1072. 
38 Wang, Z. Y.; Shen, J.; Jiang, C. S.; You, T. P. Chin. Chem. Lett. 2000, 11, 659–662. 
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In some specific cases, good enantiomeric excesses have been obtained. 
Yamano and co-workers reported a highly enantioselective Reformatsky reaction 
with ketones using cinchona alkaloids as chiral ligands (Scheme 7).39 
 
Scheme 7. Enantioselective Reformatsky reaction performed with cinchonine. 
In this transformation the high enantioselectivity is due to the chelation of the 
sp2-nitrogen with the cinchonine catalyst.  
However, in all the above shown examples most of the ligands were used in 
more than stoichiometric amounts. 
In recent years improvements to perform highly diastereoselective 
Reformastky reactions have been obtained using chiral auxiliaries, either on the 
electrophile or on the nucleophile.66  
Awasthi et al. reported the synthesis of β-amino esters by a Zn-mediated 
Reformatsky-type reaction, starting from chiral imines derived from (S)-
phenylglycinol. The desired products were obtained with good yields and 
stereoselectivities up to 98% (Scheme 8).40 
 
Scheme 8. Diastereoselective Reformatsky reactions. 
                                                                 
39 Ojida, A.; Yamano, T.; Taya, N.; Tasaka, A. Org. Lett. 2002, 4, 3051–3054. 
40 Awasthi, A. K.; Boys, M. L.; Cain-Janicki, K. J.; Colson, P.-J.; Doubleday, W. W.; Duran, J. E.; . Farid, P. 
N. J. Org. Chem. 2005, 70, 5387–5397. 
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Chiral trifluoromethyl aldimine, derived from the methyl ether of (R)-
phenylglycinol, was also studied in the Reformatsky reaction by Bonnet-Delpon’s 
group;41 using THF at reflux, affordthe corresponding β-amino ester in good yield 
(80%) and selectivity (81% dr) (Scheme 9).  
 
Scheme 9. Diastereoselective Reformatsky reaction on trifluoromethyl aldimine. 
In this context, the reactivity of chiral N-tert-butyl-sulfinylimines with 
several nucleophiles in the aza Reformatsky reaction also has been widely 
studied.42 Poon, Brinner et al.43 explain the observed diastereoselectivity with a 
chiral N-tert-butylsulfinylimine by a Zimmerman–Traxler six-membered transition 
state (Scheme 10).  
 
Scheme 10. Diastereoselective Reformatsky reaction on chiral N-tert-butylsulfinylimine. 
The tert-butylsulfinyl group on the nucleophile has also been successfully 
used as chiral auxiliary in SmI2-mediated Reformatsky-type reactions. The addition 
                                                                 
41 Dos Santos, M.; Crousse, B.; Bonnet-Delpon, D. Synlett 2008, 399–401. 
42 a) Jing, Z. T.; Huang, Y. G.; Qing, F. L. Chin. Chem. Lett. 2011, 22, 919–922; b) Concellon, J. M.; 
Rodriguez-Solla, H.; Simala, C. Adv. Synth. Catal. 2009, 351, 1238–1242; c) Wang, L.; Shen, C.; Xu, M.-H. 
Sci. China Chem. 2011, 54, 61–65.  
43 Brinner, K.; Doughan, B.; Poon, D. J. Synlett 2009, 991–993. 
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of an α-bromo α-sulfinyl ketone to linear aldehydes44 or aryl aldimines45 proceeded 
with complete syn selectivity (Scheme 11).  
 
Scheme 11. Diastereoselective Reformatsky reaction on α-bromo α-sulfinyl ketone. 
3.2.2 Homogenous conditions 
In order to simplify the design of a catalytic asymmetric version of the 
Reformatsky reaction, homogenous reaction conditions have been considered, 
using Me2Zn or Et2Zn, as zinc sources.46  
In 2006 Cozzi47 reported the first example of catalytic asymmetric 
Reformatsky reaction, between ketones and ethyl α-iodoacetate, in the presence of 
Me2Zn, using a chloromanganese–Salen complex (20 mol %) as catalyst and 4-
phenylpyridine N-oxide (25 mol %) as additive (Scheme 12). 
 
Scheme 12. Dimethylzinc-mediated Reformatsky reactions promoted by manganese salen 
complex. 
The reaction shows broad scope and the corresponding products were 
obtained with moderate to good stereoselection.  
                                                                 
44 a) Obringer, M.; Colobert, F.; Neugnot B.; Solladié, G. Org. Lett. 2003, 5, 629–632. b) Obringer, M.; 
Colobert, F.; Solladié, G. Eur. J. Org. Chem. 2006, 1455–1467. 
45 Barbarotto, M.; Choppin S.; Colobert, F. Tetrahedron: Asymmetry 2009, 20, 2780–2787. 
46 Cozzi, P. G. Angew. Chem., Int. Ed. 2007, 46, 2568–2571. 
47 a) Cozzi, P. G. Angew. Chem., Int. Ed. 2006, 45, 2951–2954; b) Cozzi, P. G.; Mignogna, A.; Zoli, L. 
Synthesis 2007, 17, 2746–2750. 
36 
 
In the same year Cozzi reported the first catalytic asymmetric aza-
Reformatsky reaction using inexpensive and commercially available N-
methylephedrine as chiral ligand. In addition, in order to obtain reproducible results 
and initiate the radical process, admission of air into the reaction mixture was 
necessary (Scheme 13).48 
 
Scheme 13. One-pot three-component Reformatsky reactions. 
Two years later Feringa’s group49 reported a catalytic enantioselective 
Reformatsky reaction for aldehydes, using BINOL derivative as chiral catalyst 
(Scheme 14); the protocol of these transformations also required air to have a good 
conversion and good enantiomeric excess. 
 
Scheme 14. Reformatsky reactions with aldehydes in the presence of BINOL derivative ligand. 
                                                                 
48 Cozzi, P. G. Adv. Synth. Catal. 2006, 348, 2075−2079. 
49 Fernández-Ibáñez, M. A.; Maciá, B.; Minnaard, A. J.; Feringa, B. L. Angew. Chem., Int. Ed. 2008, 47, 1317–
1319. 
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After the pioneering work of Feringa and Cozzi, different catalytic systems 
based on the formation of radicals from Me2Zn have been developed, using Schiff 
base, bisoxazolidine, or amino alcohol as chiral catalysts.50 
Recently, given the importance of fluorinated organic compounds, great 
attention has been paid to the study of  fluorinated α-fluoro halogenated esters as 
reactants in the Reformatsky reactions, especially in the development of 
asymmetric versions.51 Knochel et al.82a described the enantioselective addition of 
ethyl bromodifluoroacetate to aromatic and aliphatic aldehydes, using (−)-N,N-
dimethylaminoisoborneol [(−)-DAIB] as chiral ligand (Scheme 15). 
 
Scheme 15. Reformatsky Reaction in the presence of chiral amino alcohol. 
The authors were able to obtain the desired products with good yields and 
satisfactory enantioselectivities. 
Good enantiocontrol was also found through the reaction of ethyl 
iodofluoroacetate with alkyl and aryl ketones in the presence of (1R,2S)-1-phenyl-
2-(1-pyrrolidinyl)propan-1-ol that unfortunately must be used in stoichiometric 
amount (Scheme 16).82b 
                                                                 
50 a) Tanaka, T.; Hayashi, M. Chem. Lett. 2008, 37, 1298–1299. b) Wolf, C.; Moskowitz, M. J. Org. Chem. 
2011, 76, 6372–6376; c) Cozzi, P. G.; Benfatti, F.; Capdevila, M. G.; Mignogna, A. Chem. Commun. 2008, 
3317−3318; d) Cozzi, P. G.; Mignogna, A.; Vicennati, P. Adv. Synth. Catal. 2008, 350, 975−978. 
51 a)Knochel, P.; Kloetzing, R. J.; Thaler, T. Org. Lett. 2006, 8, 1125−1128; b) Fornalczyk, M.; Singh, K.; 
Stuart, A. M. Chem. Commun. 2012, 48, 3500−3502; c) Fornalczyk, M.; Singh, K.; Stuart, A. M. Org. Biomol. 
Chem. 2012, 10, 3332−3342  
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Scheme 16. Reformatsky Reaction in the presence of chiral amino alcohol. 
In 2014, the same chiral amino alcohol was reported by Tarui et al.52 in the 
first asymmetric aza-Reformastky reaction (Scheme 17). 
 
Scheme 17. Aza-Reformatsky Reaction in the presence of chiral amino alcohol. 
Starting from different aldimines, ethyl dibromofluoroacetate led to enantio-
enriched α-bromo-α-fluoro-β-lactams  
                                                                 
52 Tarui, A.; Nishimura, H.; Ikebata, T.; Tahira, A.; Sato, K.; Omote, M.; Minami, H.; Miwa,Y.; Ando, A. Org. 
Lett. 2014, 16, 2080−2083. 
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Chapter 4 
 
Purpose and aims 
1,2- and 1,3-Difunctionalized compounds, including β-amino esters or more 
generally β-amino carbonyl compounds as well as nitrogen heterocycles, have all 
been found to possess a variety of biological properties, making them valuable and 
useful synthetic intermediates in organic synthesis and in medicinal chemistry. 
Considering the relevance of the presence of fluorine in bioactive molecules, the 
synthesis of fluorine-containing analogues of before mentioned compounds was the 
prevalent scope of this PhD thesis. 
The studies focused on the reactivity of different active methylene 
compounds towards different N-protected trifluoromethyl aldimines, optimal 
scaffolds for the construction of fluorinated molecules, in order to obtain 
interesting potentially bioactive highly functionalized molecules, suitable for 
further chemoselective transformations.  
Among the various methods involving nucleophilic additions on 
trifluoromethyl imines, Mannich-type and aza-Reformatsky reactions have been 
considered as powerful approaches to obtain interesting trifluoromethyl 
compounds. 
To the best of our knowledge, few examples of Mannich-type additions of 
active methylene compounds on trifluoromethyl imines are reported in the 
literature1 and so the reactivity of C-CF3 substituted N-protected aldimines with 
malonate or β-keto esters has been here studied (Scheme 1).  
                                                                 
1 a) Ji, S.; Alkhalil, A. E.; Su, Y.; Xia, X.; Chong, S.; Wang, K.-H.; Huang, D.; Fu, Y.; Hu, Y. Synlett 2015, 26, 
1725–1731; b) Shibata, N.; Nishimine, T.; Shibata, N.; Tokunaga, E.; Kawada, K.; Kagawa, T.; Aceña, J. L.; 
Sorochinsky, A. E.; Soloshonok, V. A. Org. Biomol. Chem. 2014, 12, 1454–1462; c) Shibata, N.; Nishimine, 
T.; Shibata, N.; Tokunaga, E.; Kawada, K.; Kagawa, T.; Sorochinsky, A. E.; Soloshonok, V. A. Chem. 
Commun. 2012, 4124−4126. 
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Scheme 1. Mannich-type reactions on malonate or β-keto esters.  
The aim was to find an efficient methodology to obtain interesting 
compounds, characterized by different sites that can allow a further molecular 
growth. In addition, the usefulness of these Mannich-type reactions may be 
enhanced by a decarboxylation reaction of the newly obtained β-keto esters. 
Indeed, it is well-known that the direct addition reaction of enolizable ketones to 
imines suffers from low yields and/or low selectivity.2  
Just as interesting is the synthesis of heterocycles that constitute a major 
family of pharmaceuticals and agrochemicals.3 Therefore, trifluoromethyl-
functionalized heterocyclic compounds are becoming modern attractive targets in 
medicinal chemistry.4 Thus, the attention has been directed towards the synthesis of 
2-imidazoline derivatives which have attracted considerable interest because of 
their wide applications in the synthesis of biologically active compounds such as 
α,β-diamino acids and also their presence in some biologically active natural 
products.5 
                                                                 
2 Funabiki, K.; Nagamori, M.; Goushi, S.; Matsui, M. Chem. Commun. 2004, 1928−1929. 
3 a) Eguchi, S. Bioactive Heterocycles I, Springer, Heidelberg, 2006; b) Joule J. A.; Mills, K. Heterocyclic 
Chemistry at a Glance, Blackwell, Oxford, 2007. 
4 a) Petrov, V. A. Fluorinated Heterocyclic Compounds: Synthesis, Chemistry, and Applications, Wiley, 
Hoboken, New Jersey, 2009; b) Kirsch, P. Modern Fluoroorganic Chemistry,  Wiley-VCH, Weinheim, 2004; 
c) Muzalevskiy,V. M.; Shastin, A. V.; Balenkova, E. S.; Haufe, G.; Nenajdenko, V. G. Synthesis 2009, 
3905−3929; d) Erian, A. W. J. Heterocycl. Chem. 2001, 38, 793−808; e) Lin, P.; Jiang, J. Tetrahedron 2000, 
56, 3635−3638; f) Silvester, M. J. Adv. Heterocycl. Chem. 1994, 59, 1−38; g) Welch, J. T. Tetrahedron, 1987, 
43, 3123−3198. 
5 a) Viso, A.; Pradilla, R. F.; García, A.; Flores, A. Chem. Rev. 2005, 105, 3167−3196. b) Liu, H.; Du, D. M. 
Adv. Synth. Catal. 2009, 351, 489−519.  
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One of the most efficient methods for the synthesis of imidazolines is the 
Mannich-type addition/cyclization cascade reaction between imines and suitable α-
isocyano acetates. With the aim to obtain trifluoromethyl functionalized 
imidazolines, this reaction was then studied during my thesis for the first time 
starting from trifluoromethyl aldimines and several substituted α-isocyano acetates 
(Scheme 2). 
 
Scheme 2. Mannich-type reactions on isocyano acetates. 
Trifluoromethyl aldimines were also considered in the aza-Reformatsky 
reaction with different α-bromo esters, hoping to find also an efficient methodology 
to obtain univocally β-lactam or β-amino ester (Scheme 3).  
 
Scheme 3. Aza-Reformatsky reactions on trifluoromethyl aldimines . 
The β-amino esters, β-amino keto esters, and β-amino malonates obtained 
through aza-Reformatsky and Mannich type-reactions respectively, are 
characterized by the [CH(CF3)] group. 
The [CH(CF3)] group can be introduced into a peptidic structure to obtain a 
fluorinated ψ[CH(CF3)NH]-peptidomimetic.6 Indeed, this group is a known isoster 
of the carbonyl group and can mimic his behavior. The term of “isoster” was 
                                                                 
6 See ref.30 and 31 in the Chapter 1. 
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coined by Langmuir, indicating a group of similar steric and electronic profile to 
the original functional group. This definition has been also extended to the 
compounds with similar biological properties or compounds eliciting a similar 
biological effect, the terms used in this case is “bioisoster”.  
And it is precisely the synthesis of molecules characterized by an acetyl 
lysine bioisoster portion, the aim of the project carried out at the University of 
Oxford (UK) under the supervision of Professor Darren J. Dixon and in 
collaboration with the SGC (Structural Genomics Consortium). 
The project was focused on the development of epigenetic probes against 
PCAF (p300/CBP-associated factor). Starting from the lead compound reported in 
Figure 1, 
 
Figure 1. Lead compound. 
compound that showed a weak affinity for the bromodomain module of PCAF, a 
library of compounds was developed in order to clarify the key binding elements 
and therefore increase the affinity for the abovementioned site.  
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Results and Discussion 
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Chapter 5 
 
Mannich type reactions of 1,3-dicarbonyl compounds with 
trifluoromethyl aldimines 
The reactivity of 1,3-dicarbonyl compounds in the Mannich type reaction is 
well established, especially in the asymmetric version. Nowadays, there are few 
data reported in literature about the reactivity of trifluoromethyl aldimines towards 
1,3-dicarbonyl compounds.1 
However, these nitrogen containing organofluorine are extremely attractive 
synthetic targets. 
5.1 Preliminary studies 
The entire trifluoromethyl (E)-aldimines tested in the subsequent Mannich-
type reactions were synthesized followed the reported solvent-free protocol 
between the trifluoroacetaldehyde ethyl hemiacetal and amines2 and used without 
further purification.  
The investigation of Mannich-type reaction with 1,3-dicarbonyl compounds 
started with the reaction of trifluoromethyl aldimines 1a,b and diethyl malonate 2 
in equimolar ratio. As reported in Table 1, different reaction conditions were 
considered.  
 
 
 
 
                                                                 
1 See ref.13 in the Chapter 1. 
2 See ref.17 in the Chapter 1. 
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Table 1. Optimization of the reaction conditions on diethyl malonate 2.  
 
Entry Pg Catalyst 
Molar 
(%) 
Time 
(min) 
T (°C) 
Yield 
(%)a 
1 
Bn 
CuCl2 
25 5 25 50 
2 25 30 0 35 
3 25 60 20 40 
4 
AlCl3 
50 30 25  
5 25 30 25  
6 10 30 25  
7 ZrCl4 10 10 25 75 
8 
PMP 
CuCl2 
50 30 25  
9 25 30 25  
10 10 30 25  
11 
AlCl3 
50 30 25  
12 25 30 25  
13 10 30 25  
14 ZrCl4 10 30 25 79 
aAfter flash chromatography on silica gel (eluent hexane/ethyl acetate 
= 8:2). 
To promote the Mannich-type reaction, the Lewis acid catalysis was 
considered hoping to increase, through the coordination with the carbonyl groups, 
the acidity of methylene protons. These latter could be deprotonated by 
trifluoromethyl aldimines 1, giving the nucleophilic species and activating 
themselves through self-protonation at the same time. Three Lewis acids were 
considered as catalysts, CuCl2,3 widely used to promote different addition 
                                                                 
3 a) Li, J.-L.; Liu, L.; Pei, Y.-N.; Zhu, H.-J. Tetrahedron 2014, 70, 9077−9083; b) Liu, Y.; Wan, J.-P. Org. 
Biomol. Chem. 2011, 9, 6873−6894; c) Le Engers, J.; Pagenkopf, B. L. Eur. J. Org. Chem. 2009, 2009, 
6109−6111, d) Shintani, R.; Hayashi, T. In New Frontiers in Asymmetric Catalysis; Mikami, K.; Lautens, M., 
Eds.; Wiley: New York, 2007; Ch 3, pp 59−100. 
e) Gonzalez, A. S.; Arrayas, R. G.; Carretero, J. C. Org. Lett. 2006, 8, 2977−2980. 
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reactions, AlCl3, and ZrCl4,4as easily disposable, eco-friendly, and efficient Lewis 
acid.5 
All the reactions were performed under solvent-free condition; in the 
presence of AlCl3 no reaction occurs starting from either 1a or 1b (entries 4-6 and 
11-13). On the other hand, the use of ZrCl4 (entries 7 and 14) as catalyst gave the 
corresponding Mannich adducts 3a,b in higher yields and shorter times than when 
the reactions were performed with CuCl2 (entries 1-3 and 8-10). 
Thus, in order to study the stereofacial induction of reaction, a 
diastereoselective ZrCl4-catalyzed Mannich-type reaction was performed, under the 
fixed optimal reaction conditions, starting from optically pure trifluoromethyl 
aldimine (R)-1c (Scheme 1). 
The desired products 4,5c were obtained in satisfactory yield, but no 
induction was observed. The reaction was repeated by varying the temperature (0 
and –20 °C), but no significant changes in the diastereomeric ratio (dr) were 
determined by the 19F NMR analysis performed on the crude mixtures. 
 
Scheme 1. ZrCl4-Catalyzed Mannich-type reaction on optically pure 1c. 
Therefore, the interest has been directed towards the reactivity of β-keto 
esters. 
In order to find the optimal reaction conditions for direct catalytic Mannich-
type additions of β-keto esters to trifluoromethyl aldimines, the trifluoromethyl 
                                                                 
4 a) See ref. 27 and ref 28 in the Chapter 1; b) Morandi, B.; Carreira, E. M. Angew. Chem. 2011, 123, 
9251−9254; Angew. Chem., Int. Ed. 2011, 50, 9085−9088. 
5 a) Zhang, Z.-H.; Li, T.-S. Curr. Org. Chem. 2009, 13, 1−30; b) Smitha, G.; Chandrasekhar, S.; Reddy, C. S. 
Synthesis 2008, 2008, 829−855. 
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aldimine 1a and the simplest β-keto ester, methyl acetoacetate (6), were considered 
as reactants in equimolar ratio under different reaction conditions (Table 2). 
Table 2. Optimization of the reaction conditions of β-keto ester 6. 
 
Entry Catalyst 
Molar 
(%) 
Solvent Time T (°C) 
Yield 
(%)a 
1    2 d 25  
2 Et3N 100 THF 4 h 25  
3 KF 100 THF 4 h 25  
4 Cinchonidine 10 CH2Cl2 1 d 25  
5 
L-proline 
10  24 h 25  
6 30  2 h 25  
7 10 DMSO 24 h 25  
8 10 NPM 3 h 25 <5c 
9 10 THF 2 d 25 <5c 
10 
b 
10  1 d 25  
11 10 NPM 3 d 25 <5c 
aAfter flash chromatography on silica gel (eluent hexane/ethyl acetate = 
8:2). b(S)-α,α-diphenylprolinol (Hayashi’s catalyst).cConversion determined 
by 19F NMR. 
Considering the higher acidity of the β-keto esters compared to the 
malonates, at first, the Mannich-type reaction was performed without catalyst 
(entry 1), to test if the same imine could generate in situ the nucleophile, acting as 
both base and substrate.6 Unfortunately,the reaction did not give the expected 
product, and both reagents were quantitatively recovered (entry 1). 
Subsequently, the most common organic or inorganic bases (entries 2 and 3) 
were considered to promote the formation of nucleophilic species, but once again, 
both aldimine 1a and methyl acetoacetate 6 were quantitatively recovered in every 
cases.  
                                                                 
6In the aziridination reactions with ethyl nosyloxycarbamate the same fluorinated imines were able to 
deprotonate in situ the aminating agent, acting as both base and substrate: see ref. 26 in the Chapter 1 and 
Barani, M.; Fioravanti, S.; Loreto, M. A.; Pellacani, L.; Tardella, P. A. Tetrahedron 1994, 50, 3829−3834. 
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It is possible to suppose that, once obtained the nucleophile, it is necessary 
also an activation of the imine in order that the Mannich addition could occur. Then 
bifunctional catalysts (entry 4-11), able to activate both the imine and the β-keto 
ester, were considered. 
As shown in Table 2, while no reaction occurs with cinchonidine, using L-
proline (entries 8 and 9) or (S)-α,α-diphenylprolinol (entry 11) in the presence of a 
suitable solvent the formation of expected Mannich adducts was observed, but only 
in traces (<5%) by NMR. On the contrary, working under solvent-free conditions, 
the β-enamino ester 8 (Scheme 2), was obtained as major product, resulting from a 
L-proline-catalyzed nucleophilic addition of benzylamine, in situ formed by 
hydrolysis of 1a, to the ketone moiety of 6.7 
 
Scheme 2. Synthesis of β-enamino ester 8. 
Finally, based on previous results, a Lewis acid catalysis was considered 
(Table 3). 
 
 
 
 
 
 
 
 
 
                                                                 
7 Kundu, D.; Majee, A.; Hajra, A. Chin. J. Chem. 2008, 26, 15451548. 
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Table 3. Lewis acid catalyzed Mannich-type reactions. 
 
Entry Catalyst Molar (%) Time T (°C) Yield (%)a 
1 
CuCl2 
25 5 min 25 50 
2 25 30 min 0 35 
3 25 1 h 20 40 
4 
AlCl3 
25 15 min 25 40 
5 25 25 min 0 36 
6 25 45 min 20 30 
7 
ZrCl4 
10 10 min 25 75 
8 10 1 h 0 35 
9 10 3 h 20 30 
10 10 6 h 70  
11 25 6 h 70  
aAfter flash chromatography on silica gel (eluent hexane/ethyl 
acetate = 8:2). 
The reactions, performed under solvent-free conditions, gave the expected 
products 7,7'a. The best reaction conditions, reported in entry 7, involve the ZrCl4 
as catalyst allowing to obtain the desired products in only 10 min and in good 
yield. No diastereoselectivity was observed; in fact, the two syn/anti diastereomers 
were obtained in equimolar ratio even by changing the reaction temperature, in 
lower yields and longer reaction time (entries 8-9). 
Fixed the best conditions and in order to investigate the scope of addition, 
ZrCl4-catalyzed Mannich-type reactions were performed starting from different β-
keto esters 9-11 and N-protected trifluoromethyl aldimines 1a,b (Table 4). 
In all cases the reactions took successfully place in a short time, and the 
expected Mannich adducts were obtained in satisfactory yields after flash 
chromatography on silica gel. In addition very high stereoselectivity was achieved, 
especially when six-membered cyclic β-keto ester 11 was used (entries 3 and 6). 
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Table 4. Solvent-free ZrCl4-catalyzed Mannich-type reaction of different β-keto esters. 
 
Entry Pg n Product 
Time 
(min) 
major/minora 
Yield 
(%)b 
1 
Bn 
0 
12a/12'
a 
30 7:3c 65 
2 1 
13a/13'
a 
10 7:3c 75 
3 2 14a 10 9.9:0.1 78 
4 
PMP 
0 
12b/12'
b 
30 7:3c 68 
5 1 
13b/13'
b 
10 7:3c 73 
6 2 14b 10 9.9:0.1 85 
aDetermined by 19F NMR spectra performed on the crude 
mixtures. bAfter flash chromatography on silica gel. cThe ratio 
did not change by working at lower temperatures. 
In order to explain the ZrCl4-catalyzed Mannich-type reaction pathway 
performed on trifluoromethyl (E)-aldimines a catalytic cycle can be proposed 
(Scheme 3).  
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Scheme 3. Proposed pathway for ZrCl4-catalyzed Mannich-type addition of 6. 
As shown in the Scheme 3, Zr (IV) could coordinate both β-dicarbonyl 
oxygen atoms (I) so determining an increase in acidity of methylene protons, which 
can then be deprotonated by trifluoromethyl aldimine. Finally, an intermolecular 
nucleophilic attack to form II brings to the formation of the expected fluorinated β-
amino β-dicarbonyl compounds and restores the catalytic cycle. 
Subsequently, in order to develop a catalytic asymmetric Mannich-type 
reaction, the use of chiral ligand was considered. As reported in the introduction of 
this thesis, Zr(IV)-BINOL is an efficient organometallic catalyst widely used in the 
Mannich-type reactions of silyl enol ethers with aldimines.8 Thus, on the basis of 
the collected data, the same chiral catalyst was considered for the reaction between 
the aldimine 1a and the methyl acetoacetate 6 (Scheme 4). 
                                                                 
8a) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. Soc. 1997, 119, 7153–7154. b) Kobayashi, S.; Ishitani, 
H.; Ueno, M. J. Am. Chem. Soc. 1998, 120, 431–432; c) Ishitani, H.; Ueno, M.; Kobayashi, S. J. Am. Chem. 
Soc. 2000, 122, 8180–8186. 
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Scheme 4. Mannich-type reaction catalyzed by Zr(IV)-BINOL. 
The catalyst was prepared in situ starting from zirconium-(IV) tert-butoxide 
[Zr(Ot-Bu)4] and (R)-(+)-1,1′-bi(2-naphthol) as ligand. Unfortunately, the desired 
product was obtained in low yield and neither diastereo- or enantioselectivities 
were observed even by changing the reaction temperature.  
Therefore, considering the proposed reaction pathway (Scheme 3), the 
optically pure trifluoromethyl aldimine (R)-1c was considered as suitable chiral 
auxiliary in the Mannich type reaction with β-keto esters, hoping that the chiral 
centre on the aldimine could give diastereoselective addition.  
The Mannich type reactions were performed with different β-keto esters, 
ZrCl4 as catalyst and under solvent free conditions. The results are reported in 
Table 5.  
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Table 5. ZrCl4-catalyzed Mannich-type reaction on optically pure 1c. 
 
Entry β-Keto ester 
Time 
(min) 
Product dra 
anti/syn
a 
Yield 
(%)b 
1 6 30 
anti-
17,18 
syn-
17',18' 
5:5 5:5 72 
2 9 10 19 ≥ 9.9 9.9:0.1 68 
3 10 10 20 ≥ 9.9 9.9:0.1 78 
4 11 20 21 ≥ 9.9 9.9:0.1 78 
5 15 30 
anti-
22,23 
syn-
22',23' 
5:5 5:5 65 
6 169 30 24 ≥ 9.9 9.9:0.1 64 
aDetermined by 19F NMR spectra performed on the crude mixtures. bAfter 
flash chromatography on silica gel. 
Starting from (R)-1c and methyl acetoacetate (6), the reaction was successful 
leading to syn-17/18'anti-17/18' addition products in good yield, but the 
stereoselective control failed; in fact all the four possible diastereomers were 
obtained (entry 1).  
As shown in the entry 5, also the presence of a bulky group in the ester 
residue did not influence the reaction stereochemistry,10 in fact with tert-butyl ester 
15 (entry 5), dr and anti/syn ratio did not change compared with methyl ester 6 
(entry 1). On the contrary, the presence of the ever-increasing steric hindrance on 
the nucleophilic site led to highly stereocontrol (entry 16). 
                                                                 
9 Hashimoto, T.; Naganawa, Y.; Maruoka, K. J. Am. Chem. Soc. 2011, 133, 8834−8837. 
10 See ref.40 in the Chapter 2. The authors reported that the absolute configuration of Mannich adducts was 
reversed when going from a β-keto ester with an ester group derived from a secondary to a tertiary alcohol.  
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High diastereomeric and anti/syn ratios were obtained starting from methyl 
substituted or cyclic methylene active compounds 9-11 and 16 (entries 2-4, 6): in 
all cases only one of the four possible diastereomers, characterized by the presence 
of a quaternary chiral center, was obtained.  
In order to unequivocally assign the absolute configuration of the quaternary 
chiral center, as well as the relative configuration syn or anti of the obtained 
diastereomers, the diastereoselective decarboxylation of compound 24 was 
performed (Scheme 5), following the procedure reported in the literature.10 
 
Scheme 5. Decarboxylation reaction of 24. 
Treatment of the Mannich adduct 24 with 
trimethylsilyltrifluoromethanesulfonate and saturated aqueous NaHCO3 gave the 
corresponding ketone 25 and a high diastereoselectivity was maintened in this 
transformation. 
Following an already reported methodology,11 2D NOESY 1H NMR analysis 
(Figure 1).were acquired on 24 and 25 that, coupled with computational studies, 
permits to assign the relative and the absolute configurations to the Cβ and to the 
Cα, respectively.  
                                                                 
11 a) Fioravanti, S.; Parise, L.; Pellacani, L., Sciubba, F.; Trulli, L. J. Org. Chem. 2015, 80, 8300−8306 and see 
ref.29, 54 in the Chapter 1 and 2. 
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Figure 1. NOESY 1H NMR spectra of 24 and 25. 
The 2D NOESY 1H NMR analysis permitted to determinate the relative 
interproton distances and thus molecular geometry, by the following equation:  
VR
VX
dX
dR
6
=
 
in which VR is the volume of the reference cross peak, dR is the corresponding 
interproton distance and VX is the volume relative to the unknown distance dX. 
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Therefore, starting from a reference cross peak whose interproton distance is 
known, it is possible to calculate the distances between other protons.  
Since the chiral center on the amine residue has R configuration, the 
interproton distance between Hb and the protons Hc in both 24 and 25 can be 
considered as a fixed value and used to determine the distance between Ha and Hb 
in 24 and the distance between Hd and He in 25 through the previous equation. 
Subsequently, the comparison between the values measured by NOESY 
spectra with those determined by minimization structure permitted to assign the R 
absolute configuration to Cβ for 24, and the R absolute configuration to Cα for syn-
25. As a consequence, the (R,R,S) absolute configuration and the anti relative 
configuration can be assigned to the starting β'-amino β-keto ester 24. The same 
(R,R,S) absolute configuration can be assigned to all obtained β'-amino β-keto ester 
anti-isomer 19, 20, and 21(Figure 2), for which 2D NOESY 1H NMR spectra were 
also performed on the purified compounds. 
All optimized geometries were located using hybrid functional theory 
(B3LYP)12 and the 6-31G(d, p)13 basis set using the continuum solvation model14 
with chloroform (ε = 4.71) as the solvent conforming to the experimental 
conditions. All calculations were carried out using the Gaussian 09 program.15 
                                                                 
12Becke, A. D. J. Chem. Phys. 1993, 98, 1372–1377. 
13a) Ditchfield, R.; Hehre, W. J.; Pople, J. A. J. Chem. Phys. 1971, 54, 724–728; b) Hehre, W. J.; Ditchfield, 
R.; Pople, J. A. J. Chem. Phys.1972, 56, 2257–2261; c) Hariharan, P. C.; Pople, J. A. Theor. Chim. Acta 1973, 
28, 213–223. 
14 Barone, V.; Cossi, M.; Tomasi, J. J. Comp. Chem. 1998,19, 404–17. 
15Gaussian 09, Revision D.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; 
Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, 
X.; Hratchian, H. P.; Izmaylov, A. F.;Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, 
K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; 
Montgomery Jr., J. A. J.; Peralta, E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; 
Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J.C.; Iyengar, 
S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, 
C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, 
J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; 
Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian, Inc., 
Wallingford CT, 2013.  
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Figure 2. Assigned absolute configurations. 
Considering the previously supposed mechanism (Scheme 3), it is possible to 
rationalize the stereochemical outcome of these Zr-catalyzed Mannich-type 
reactions. 
The enolate, coordinated in an octahedral-like intermediate around the 
zirconium center, is constrained in a planar geometric disposition, which allows the 
nucleophilic attack take place only on the sterically less hindered prochiral Re face 
of optically pure aldimine (R)-1c (Figure 3).  
 
Figure 3. Proposed transition state. 
Considering the stereochemical results reported in Table 5, a steric hindrance 
on the E double bond of zirconium complex III was required to obtain complete 
stereoselective control. 
In fact, starting from unsubstituted acyclic β-keto esters 6 or 16 low dr values 
and no syn/anti selectivity was observed.  
Therefore, in order to study the importance of zirconium on the high 
diastereoselectivity observed, the Mannich-type addition reaction between (R)-1c 
and 8 was repeated but using AlCl3 as catalyst (Scheme 6). 
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Scheme 6. AlCl3-catalyzed Mannich-type reaction. 
As shown by the 19F NMR analysis performed on the crude mixture, AlCl3-
catalyzed Mannich-type reaction led to all the four possible diastereomers in equimolar 
ratios (Figure 4). 
 
Figure 4. 19F NMR spectra of a mixture of anti-19, 26 and syn-19′,26′ obtained in the presence of 
AlCl3; only anti-19 isomer obtained in the presence of ZrCl4. 
In order to explain the obtained results, a reaction pathway is proposed, in 
which Al coordinates only the carbonyl oxygen (IV) giving, consequently, the 
acyclic anionic intermediate V (Scheme 7). 
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Scheme 7. Proposed pathway for AlCl3-catalyzed Mannich-type addition of 9. 
Finally, the solvent effect on the stereoselective reaction outcome was 
investigated. Thus, the ZrCl4-catalyzed Mannich-type reaction of 9 with chiral 
aldimine (R)-1c (Scheme 8)was performed by using some different organic 
solvents (DMSO, THF, CHCl3, and PhCH3). 
 
Scheme 8. ZrCl4-catalyzed Mannich-type reaction on optically pure 1c in the presence of the 
solvent. 
The reaction did not occur using DMSO as solvent, probably because ZrCl4 is 
coordinated to the solvent and no longer available to promote the catalytic cycle. 
On the other hand, performing the reaction in almost non polar toluene, the 
Mannich addition takes place in satisfactory yields (68%), but all the four possible 
diastereomers anti-19,26 and syn-19',26' are formed in equimolar ratios. Indeed, 
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the use of less polar THF or CHCl3 gave only the diastereomerically pure 19, 
although in yields lower than those obtained in reactions performed under solvent-
free conditions (32 and 43%, respectively). 
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Chapter 6 
 
Synthesis of trifluoromethyl 2-imidazolines through Mannich-
type reactions with isocyano acetates 
The reaction of α-isocyano acetates with imines represents a convenient 
method for the synthesis of 2-imidazolines, an interesting class of five-membered 
ring,1 which can be found in natural product chemistry, in medicinal chemistry, in 
organic synthesis, in coordination chemistry, and even in homogeneous catalysis.2 
Therefore, the broad utility of these heterocyclic compounds have prompted 
considerable interest to develop an efficient method for the preparation of 
trifluoromethyl 2-imidazolines, considering even the general relevance of CF3 
group. 
A traditional synthetic approach towards 2-imidazolines usually involves the 
use of BuLi to generate the nucleophile.3 Other synthetic methods concerning the 
use of metal catalyst complexes (Cu, Ag, Au, Pd, Ni),4 or of weaker bases,5 or the 
simultaneous use of both6 have also been developed. 
An alternative strategy involves a direct reaction between primary amines, α-
isocyano acetates, and carbonyl compounds performed in the presence of a metal 
catalyst or even without catalyst,7 the same imine being able to act as a base. 
                                                                 
1 Grimmett, M. R. Comprehensive Heterocyclic Chemistry, Eds.: A. R. Katrizky, C. W. Rees, E. F. V. Scriven, 
Pergamon, Oxford, 1996, 3, 77–120. 
2 a) Betschart, C.; Hegedus, L. S. J. Am. Chem. Soc. 1992, 114, 5010–5017; b) Rondu, F.; Bihan, G. L.; 
Godfroid, J. J. J. Med. Chem. 1997, 40, 3793–3803, c) Haiao, Y.; Hegedus, L. S. J. Org. Chem. 1997, 62, 
3586–3591; d) Liu, H.; Du, D.-M. Adv. Synth. Catal. 2009, 351, 489–519 and references therein; e) Dalko, P. 
I.; Langlois, Y. Chem. Commun. 1998, 331–332. 
3 Both activated and unactivated isocyanides can successfully be deprotonated because of the high basicity of 
BuLi. a) Meyer, R.; Schöllkopf, U.; Böhme, P. Liebigs Ann. Chem. 1977, 1183−1193, b) van Leusen, D.; van 
Leusen, A. M. Org. React. 2001, 57, 417−666. 
4 Hayashi, T.; Kishi, E.; Soloshonok, V. A.; Uozumi, Y. Tetrahedron Lett. 1996, 37, 4969−4972. 
5 Zhang, Z.; Lu, G.; Chen, M.; Lin, N.; Li, Y.; Hayashi, T.; Chan, A. S. C.  Tetrahedron:Asymmetry 2010, 21, 
1715–1721. 
6 Qi, X.; Xiang, H.; Yang, C. Org. Lett. 2015, 17, 5590–5593. 
7 a) Bon, R. S.; Hong, C.; Bouma, M. J.; Schmitz, R. F.; de Kanter, F. J. J.; Lutz, M.; Spek, A. L. Org. Lett. 
2003, 5, 3759-3762. b) Bon, R. S.; van Vliet, B.; Sprenkels, N. E.; Schmitz, R. F.; de Kanter, F. J. J.; Stevens, 
C. V.; Swart, M.; Bickelhaupt, F. M.; Groen, M. B.; Orru, R. V. A. J. Org. Chem. 2005, 70, 3542–3553. c) 
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Recently also catalytic asymmetric Mannich-type/cyclization cascade reactions 
between α-isocyano acetates and imines has received much attention.8  
6.1 Preliminary studies  
At first an equimolar ratio of (E)-1-phenyl-N-(2,2,2-
trifluoroethylidene)methanamine (1a) and methyl 2-isocyanoacetate (2) was 
reacted without catalyst but no reaction occurred, not even changing the reaction 
conditions (solvent, temperature, molar ratio), and both reagents were 
quantitatively recovered.  
Therefore, starting from data reported in the literature,5 different inorganic or 
organic bases were considered to promote the nucleophile formation: the expected 
product was obtained only by using Et3N as added base and THF as solvent in very 
low yield (Scheme 1) but high diastereoselectivity, only trans isomers being 
detected.9  
 
Scheme 1. Base catalyzed Mannich-type reaction.  
Therefore, to increase the reaction yield, a Lewis acid catalysis was 
attempted, hoping that the coordination of a metal at the terminal isocyano acetate 
carbon allows for an easier α-deprotonation. 
                                                                                                                                                                                    
Elders, N.; Schmitz, R. F.; de Kanter, F.J. J.; Ruijter, E.; Groen, M. B.; Orru, R. V. A. J. Org. Chem. 2007, 72, 
6135–6142. 
8 a) Zhou, X.-T.; Lin, Y.-R.; Dai, L.-X. Tetrahedron: Asymmetry 1999, 10, 855−862. b) Shao, P.-L.; Liao, J.-
Y.; Ho, Y. A.; Zhao, Y. Angew. Chem., Int. Ed. 2014, 53, 5435−5439. c) Nakamura, S.; Maeno, Y.; Ohara, M.; 
Yamamura, A.; Funahashi, 
Y.; Shibata, N. Org. Lett. 2012, 14, 2960−2963. d) Ortín, I.; Dixon, D. J. Angew. Chem., Int. Ed. 2014, 53, 
3462−3465. e) de la Campa, R.; Ortín, I.; Dixon, D. J. Angew. Chem., Int. Ed. 2015, 54, 4895–4898.   
9 The trans relative configuration was assigned by comparing H/H coupling constant values (3Jtrans = 5.0−6.0 
Hz) reported in the literature for similar compounds. a) Xie, H., Zhu, J.; Chen, Z.; Li, S.; Wu, Y. J. Org. Chem. 
2010, 75, 7468–7471. b) Aydin, J.; Kumar, K. S.; Eriksson, L.; Szabò, K. J. Adv. Synth. Catal. 2007, 349, 
2585–2594 
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Considering the successful use of ZrCl4 as catalyst in the Mannich-type 
reactions of 1,3-dicarbonyl compounds (see Chap. 5), this Lewis acid was added in 
catalytic amounts in the reaction between 1a and 2, but only a complex reaction 
mixture was formed. Thus, to promote the Mannich-type/cyclization cascade 
reaction of isocyano acetate 2 with N-protected trifluoromethyl aldimine 1a some 
classic silver derivatives were considered (Table 1). 
Table 1. Optimization of the reaction conditions of 2. 
 
Entry Pg Product Catalyst Solvent 
Time 
(h) 
Yield 
(%)a 
1 
Bn 3a 
AgOAc THF 22 46 
2 AgNO3 THF 24 52 
3 Ag2O THF 18 60 
4 Ag2O CH2Cl2 20 62 
5 Ag2O DMSO 15 66 
6 Ag2O NMP 15 63 
7 Ag2O DMF 15 65 
8 Ag2O EtOH 16 45 
9 Ag2O iPrOH 15 40 
10 Ag2O - 5 85 
11 PMP 3b Ag2O - 5 88 
aAfter flash chromatography on silica gel. 
As shown in Table 1, Ag2O turned out to be the best catalyst compared to 
AgOAc and AgNO3 (entries 1-3); in fact the desired product trans-3a was obtained 
in higher yield and in shorter time. Then, the Ag2O-catalyzed Mannich-type 
reaction was repeated by changing the solvent, ranging from polar aprotic and 
protic (entries 3−9), but the performance of addition does not seem to be influenced 
by the solvent nature. On the contrary, working under solvent-free condition (entry 
10), trans-3a was obtained in shorter time and in very high yield and purity. 
Working under the same solvent-free conditions, imidazoline trans-3b (entry 11) 
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was successfully obtained starting from N-protected trifluoromethyl aldimine 1b. 
On the basis of collected data, a possible reaction mechanism is proposed in 
Scheme 2.  
 
Scheme 2. Possible reaction mechanism.   
The silver-isocyano acetate complex I, generated according to the literature,10 
is deprotonated by a molecule of trifluoromethyl aldimine and, then, the attack of a 
second molecule of aldimine, leads to II. The ring closure reaction followed by the 
exchange silver(I) cation/proton provides the 2-imidazoline. 
 
 
 
 
                                                                 
10 a) Gulevich, A. V.; Zhdanko, A. G.; Orru, R. V. A.; Nenajdenko, V. G. Chem. Rev. 2010, 110, 5235–5331; 
b) Bon, R. S.; van Vliet, B.; Sprenkels, N. E.; Schmitz, R. F.; Kanter, F. J. J.; Stevens, C. V.; Swart, M.; 
Bickelhaupt, F. M.; Groen, M. B.; Orru, R. V. A. J. Org. Chem. 2005, 70, 3542–3553 
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6.2 Reaction scope 
In order to explore the reaction scope, additional α-isocyano esters (4-6), 
prepared by α-amino acid methyl ester hydrochlorides were obtained in high purity 
and yield (Scheme 3), through slight modifications of standard protocols,11 
 
Scheme 3 Synthesis of different α-isocyano esters. 
and then considered in the Mannich-type reactions with aldimines 1a-b. The results 
are reported in Table 2. 
Table 2. Mannich-type reactions of α-isocyano esters 4-6. 
 
Entry R Pg  Product Solvent 
Time 
(h) 
Yield 
(%)a 
1 Bn 
Me 
7/7'a  4 60 
2 PMP 7/7'b  4 48 
3 Bn 
iBu 
8/8'a CH2Cl2 16 45 
4 PMP 8/8'b CH2Cl2 16 55 
5 Bn 
Bn 
9/9'a CH2Cl2 12 38 
6 PMP 9/9'b CH2Cl2 10 40 
aAfter flash chromatography on silica gel.  
While in all cases the stereoselectivity was completely lost,12 the reactions 
involving 4 proceeded as expected under solvent-free conditions (entries 1-2). On 
                                                                 
11 Elders, N.; Schmitz, R. F.; Kanter, F. J. J.; Ruijter, E.; Groen, M. B.; Orru, R. V. A. J. Org. Chem. 2007, 72, 
6135-6142. 
12 Even by changing the reaction conditions (molar ratios, silver catalysts, and temperature) no improvements 
of stereoselectivity were observed. 
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the contrary, starting from 5 or 6 the use of CH2Cl2 as solvent was required to 
afford the desired products albeit in moderate yields (entries 3-6), showing that 
these reactions suffer from the steric hindrance on the  carbon, that can determine 
the decrease of yields and the increase of reaction time. Moreover, the substituent 
on the nucleophile carbon could be responsible also for the similar energy between 
the E and Z enolates, resulting in a total loss of geometric selectivity, which instead 
is controlled by the formation of the only E enolate isomer of -isocyano acetate 2. 
6.3 Control of stereofacial induction 
Turning the interest towards the possible stereofacial attack, the Mannich-
type additions were performed starting from the optically pure aldimine 1c. The 
presence of an -alkyl substituent on the imine nitrogen coupled with an R group 
of isocyano acetates 4-6 seems to approach the limits for these Mannich-type 
reactions, the expected products being obtained only in traces. On the contrary, the 
Mannich-type reaction between methyl 2-isocyanoacetate (2) and the imine 1c, 
performed under solvent-free conditions, afforded the expected trans 2-
imidazolines (Scheme 4) but in very low diastereomeric ratio (dr = 6:4), even when 
the reactions were attempted at lower temperatures (from −20 to 0 °C). Anyway, 
the diastereomers could be separated between them by flash chromatography on 
silica gel, and diastereomerically pure compounds 10 (major isomer) and 10′ 
(minor isomer) were obtained.13  
 
Scheme 4. Mannich-type reactions on optically pure aldimine 1c. 
                                                                 
13 For these latter, the absolute configurations were determinate using the same previously described 
methodology (see Chap 5, pp. 59−60) involving computational studies coupled with the data obtained from 2D 
NOESY NMR spectra.   
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With the hope to increase the stereofacial induction, very interesting optically 
active trifluoromethyl aldimines deriving from L-α-amino esters14 were considered. 
The additions of 2 to aldimines 1d-f occurred with very high 
diastereoselectivity, leading in all cases only to (S,R,R) diastereomers. The results 
are reported in Table 3.  
Table 3. Mannich-type reactions on aldimines 1d-f.  
 
Entry 1 R Product Yield (%)
a 
1 d iPr 18 39 
2 e iBu 19 30 
3 f Bn 20 28 
 aAfter flash chromatography on silica gel. 
To explain the high diastereoselectivity and the absolute configurations 
obtained, a possible transition state could be suggested (Figure 1). 
 
Figure 1. Proposed transition state. 
The imine ester group could be coordinate by silver of the activated methyl 
2-isocyanoacetate (2). This interaction could create a well-defined chiral pocket 
that can readily differentiate the enantiotopic faces of aldimine, favoring the attack 
of the enolate preferentially to the Re imine face and the formation of enantiopure 
valuable trifluoromethyl imidazolidines, enriched by an -amino acid residue. 
                                                                 
14 See ref. 54 in the Chapter 2. 
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Chapter 7 
 
Aza-Reformatsky reactions on trifluoromethyl aldimines 
Fluorinated 1,2- and 1,3-difunctionalized compounds, including β-amino 
esters as well as nitrogen heterocycles like β-lactams, could have a variety of 
interesting biological properties, making them useful and versatile synthetic 
intermediates in organic synthesis. β-Amino esters and β-lactams could be obtained 
through the aza-Reformatsky reaction. Thus, the aim of this chapter is the study of 
the reactivity of trifluoromethyl aldimines in the aza-Reformastky reaction.  
7.1 Heterogeneous conditions 
7.1.1 Preliminary studies  
The preliminary aza-Reformatsky reaction was performed between methyl-2-
bromoacetate (2a) and trifluoromethyl aldimine 1a. A two-step procedure was 
used: in the first step the Reformatsky reagent (I) was synthesized by refluxing 2a 
with freshly-activated zinc dust; after 5 min at 60 °C, 0.5 equiv of aldimine 1a1 
were added.  
Different reaction conditions were screened in order to find an efficient 
methodology: in all cases the reaction lead to the formation of only β-lactams 
(Table 1). 
 
 
 
 
 
 
 
 
 
                                                                 
1 See ref.17 in the Chapter 1. 
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Table 1. Optimization of the reaction conditions on methyl-2-bromoacetate (2a). 
 
Entry Solvent Tb(°C) 
Time  
(h)b 
Yield 3 
(%)c 
1 THF 25 36  
2 THF 40 18 79 
3a THF 40 20 35 
4 CH2Cl2 40 36 20 
5 PhCH3 40 36 36 
aReaction performed by using the following molar 
ratios 1a/Zn/2a = 3:3:0.5. bRelative to the second step. 
cAfter flash chromatography on silica gel. 
Initially, using THF as solvent, the addition of 1a was carried out at room 
temperature (entry 1), but after 36 h only the same aldimine was recovered. 
Increasing the addition step temperature (40 °C, entry 2), the expected product was 
obtained in very good yields. Decreasing the amount of metal Zn (entry 3), β-
lactam 3 was obtained in lower yield as well as changing the reaction solvent 
(entries 4 and 5). Interestingly, following the reactions by 1H NMR spectroscopy, 
in all cases only the simultaneous disappearance/appearance of the aldimine 1a 
signals and those of β-lactam 3, respectively, was observed. It is important to 
underline that the signals relating to a possible β-amino ester intermediate were not 
detected. 
With the optimal two-step reaction conditions in hand, the heterogeneous aza-
Reformatsky reaction was investigated starting also from α-bromo esters 2b,c 
(Scheme 1). 
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Scheme 1. Aza-Reformatsky reactions on α-bromo esters 2b,c. 
Unexpectedly, while the reaction with α-bromo ester 2b proceeded smoothly 
leading to trans-4,2 although in very low yield, the reaction did not occur by using 
2c, even by chancing some reaction conditions (solvent, temperature and/or molar 
ratios). Hoping to get better results, a one-pot procedure was tested, following a 
procedure reported in the literature (Table 2).3 
Table 2. One-pot Aza-Reformatsky reactions on α-bromo esters 2b,c. 
 
Entry R 
Time 
(h) 
Product trans:cisa 
Yield 
(%)b 
1 Me 18 trans-4 >99:1 70 
2 Ph 10 trans-5 >99:1 83 
aDetermined by 19F NMR spectra of the crude reaction 
mixture. bAfter flash chromatography on silica gel. 
As shown in Table 2, aldimine 1a was converted into the products trans-4,5 
in good yield by a convenient one-pot protocol. Once again, only β-lactams in trans 
configuration were achieved, showing that reactions proceeded also with high 
diastereoselectivity.  
                                                                 
2 The trans relative configuration was assigned by comparing the H/H coupling constant values (3Jtrans = 
1.5−2.5 Hz; 3Jcis = 4.5−6.0 Hz) of ring protons and the δ values of CF3 group on the 
19F NMR spectra 
recorded by us with those reported in the literature for similar compounds: Bevilacqua P. F.; Keith D. D.; 
Roberts J. L. J. Org. Chem. 1984, 49, 14301434. 
3 Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Miwa, Y.; Minami, H.; Ando, A. Tetrahedron Lett. 2010, 51, 
2000−2003. 
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To explain this, two possible reaction pathways can be suggested: a via 
ketene-imine mechanism4 or an addition-cyclization mechanism5 (Scheme 2).6 The 
former hypothesized that the reaction was occurring via a ketene Staudinger-type 
mechanism (A). The ketene, formed by α-bromo ester due to the presence of Zn,7 
could add to imine through a formal [2+2] cycloaddition, leading to trans β-lactam 
via the favored transition state II. 
 
Scheme 2. Proposed reaction pathways. 
Alternatively, the zinc enolate addition to the (E)-aldimine could lead to the 
anti-β-amino ester (V), never detected during these reactions, which quickly 
cyclize giving the corresponding trans β-lactam (Scheme 2, B).  
                                                                 
4 Jian, S.-Z.; Ma, C.; Wan, Y.-G. Synthesis 2005, 5, 725–730.  
5 Hart, D. J.; Ha, D. C. Chem. Rev. 1989, 89, 1447-1465. 
6 For brevity only the synthesis of one enantiomer has been reported. 
7 Hafner, A.; Ley, S. V. Synlett 2015, 26, 1470–1474 
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In the last hypothesis, the stereochemical data could be rationalized through a 
rigid cyclic chair- and/or a boat-type transition states, depending by the E or Z 
enolate configuration. Whereas the E isomer should be the most stable, only the 
boat-like transition state III could be invoked to explain the observed trans 
diastereoselectivity of the addition,8 because the chair Zimmerman-Traxler 
transition state would give cis β-lactam. However, such as reported in the 
literature,9 it cannot be excluded that both isomers are in fast equilibrium between 
them and that the minor Z isomer reacts, through a chair-type transition state (IV), 
much faster than the E enolate, leading to the anti-β-amino ester (V). 
7.1.2 Enantio- and diastereoselective studies  
In order to achieve optically pure trans β-lactams, a suitable chiral ligand was 
considered, namely the inexpensive and commercially available amino alcohol 
(1R,2S)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol (6, Figure 1), already used in the 
asymmetric Reformatsky reaction.10  
 
Figure 1. (1R,2S)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol. 
To test the enantioselective addition, methyl 2-bromoacetate (2a) and imine 
1a were reacted both under two-step (A) and one-pot (B) conditions (Scheme 3). 
                                                                 
8 a) Georg, G. I.; Harriman, G. C. B.; Hepperle, M.; Clowers, J. S.; Vander Velde, D. G.; Himes, R. H. J. Org. 
Chem 1996, 61, 2664−2676. b) Annunziata, R.; Benaglia, M.; Cinquini, M.; Cozzi, F.; Martini, O.; Molteni, V. 
Tetrahedron. 1996, 52, 2583−2590. c) lshihara, T.; Ichihara, K.; Yamanaka, H. Tetrahedron, 1996, 52, 
255−262. d) Cainelli, G.; Panunzio, M.; Bandini, E.; Martelli, G.; Spunta, G. Tetrahedron. 1996, 52, 
1685−1698. e) Evans, D. A.; Nelson, J. V.; Taber, T. R. Topics in Stereochemistry, Stereoselective Aldol 
Condensations, ed. by N.L. Allinger, E. L, Eliel and S. H. Wilen, Wiley, New York (1982). 
9 a) Maanen, H.; Kleijn, H.; Jastrzebski, J. T. B. H.; Van Koten, G. Bull Soc Chim Pr 1995, 132, 86−94. b) Van 
der Steen, F.H.; Kleijn, H.; Jastrzebski, J. T. B. H.; Van Koten, G. J. Org. Chem. 1991, 56, 5147−5158. c) Van 
der Steen, F.H.; Kleijn, H.; Britovsek, G. J.P.; Jastrzebski, J. T. B. H.; Van Koten, G. J. Org. Chem. 1992, 57, 
3906−3916. 
10 a) Andrés, J. M.; Martinez, M. A.; Pedrosa, R.; Pèrez-Encabo, A. Synthesis 1996, 1070−1072. b) Kloetzing, 
R. J.; Thaler, T.; Knochel, P. Org. Lett. 2006, 8, 1125−1128 
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Scheme 3. Enantioselective Reformatsky reactions. 
The classical two-step reaction was attempted at high temperature (the 
second step was performed at a range between 40−60 °C) also by using a large 
excess (12 equiv) of Zn metal, but 3 was still obtained in very low yield (10 and 18 
% respectively) and as a racemic mixture, as determined by chiral HPLC analyses. 
On the contrary, working at lower temperature (0 and 25 °C) no reaction occurred 
and both aldimine 1a and α-bromo ester 2a were recovered in all cases.  
Consequently, a one-pot procedure was considered, but again the β-lactam 
was obtained only in trace and as a racemic mixture.  
Failed the enantioselective control, we attempted to obtain chiral β-lactams 
starting from optically pure trifluoromethyl aldimine (R)-1c,1 still bearing a benzyl 
residue on the nitrogen atom easily removable under mild hydrogenolytic 
conditions (Scheme 4). 
 
Scheme 4. Aza-Reformatsky reactions on optically pure 1c. 
The reaction successfully gave the expected β-lactams 7/7′ in satisfactory 
yield, but once again no selectivity was observed. However, hoping that an 
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increasead steric hindrance on the pre-nucleophile species could give better results, 
the one-pot aza-Reformatky reactions were performed even by using α-bromo 
esters 2b-c (Table 3).  
Table 3. Aza-Reformatsky reactions on optically pure 1c. 
 
Entry R Time (h) Product dra trans:cisa 
Yield 
(%)b 
1 Me 12 8/8′ 1:1 >99:1 65 
2 Ph 15 9/9′ 1:1 >99:1 61 
aDetermined by 19F NMR spectra of the crude reaction mixture. 
bAfter flash chromatography on silica gel. 
Once again, high yields and high geometric selectivity were obtained, the 
only diastereomers trans-7/7′ and 8/8′ being obtained, but no stereoinduction was 
observed (dr = 1/1), probably due to the high required reaction temperature. 
All diastereomers were purified by flash chromatography on silica gel to 
obtain optically pure compounds; absolute configurations of the newly formed 
stereocenters (Figure 2) was assigned by 2D NOESY 1H NMR spectra coupled 
with geometric optimization processes through the reported methodology (see 
Chap 5, pp 58-59).11 
                                                                 
11 See ref.11 in the Chapter 5. 
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Figure 2. Assigned absolute configurations.  
7.2 Homogeneous conditions 
Then, the interest has been directed towards the aza-Reformatsky reactions 
on trifluoromethyl aldimines under homogeneous conditions, by using 
commercially available Et2Zn as source of metal. 
7.2.1 Preliminary studies  
The investigation begin by reacting methyl 2-bromoacetate (2a) and 
trifluoromethyl aldimine 1a in the presence of diethylzinc, changing some reaction 
parameters (Table 4). 
Table 4. Optimization of the homogeneous aza-Reformatsky reaction conditions on 1a.  
 
Entry Solvent T(°C) Time 
Yield of 
10 (%)a 
1 THF 40 12 h - 
2 THF 25 36 h 5 
3 THF 0 3 d - 
4 THF −10 3 d - 
5b THF 25 36 h - 
6 CH2Cl2 25 24 h 68 
aAfter flash chromatography on silica gel. bPerformed 
by using 1 equiv of 2a 
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Working in THF at 40 °C (entry 1), a very complex crude mixture was 
recovered after 12 h. At room temperature, only β-amino ester 10 was formed but 
in trace (entry 2). Furthermore, decreasing the reaction temperature (entries 3, 4), 
the major observed product was the adduct 11, resulting from the addition of 
diethylzinc to aldimine 1a, even working in equimolar ratios (entry 5). Finally by 
changing the reaction solvent (from THF to CH2Cl2, entry 6), only 10 was achieved 
in satisfactory yield. 
It must be emphasized that, working under homogeneous conditions, β-
lactam 3 was not observed in any case even in trace, on the contrary to what 
reported in the literature for analogous aza-Reformatsky reactions performed on 
unfluorinated aldimines.12 
Thanks to the more reactivity of diorganozinc reagents (R2Zn)13 obtained 
using Et2Zn, we are able to promote the reaction at room temperature and, since 
only β-amino esters were obtained, the enolate-imine mechanism is the only 
reasonable Then, the best homogeneous aza-Reformatsky reaction conditions has 
been extended to the α-bromo esters 2b-c. The results are reported in Table 5.  
Table 5. Homogeneous aza-Reformatsky reactions. 
 
Entry R 
Temp 
(°C) 
Time 
(d) 
Product syn:antia 
Yield 
(%)b 
1 
Me 
25 3  
syn-12 
>99:1 44 
2 0 3  >99:1 56 
3 −20 9  >99:1 60 
4 
Ph 
25 3   
anti-13 
>1:99 40 
5 0 5  >1:99 48 
6 −20 10  >1:99 57 
aDetermined by 19F NMR spectra of the crude reaction mixture. bAfter flash 
chromatography on silica gel.  
                                                                 
12 Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Miwa, Y.; Minami, H.; Ando, A. Tetrahedron Letters 2010, 
51, 2000–2003.  
13a) Knochel, P; Perea, J. J. A.; Jones, P. Tetrahedron, 1998, 54, 8275−8319; b) Knochel, P.; Jones, P. 
Organozinc Reagents: A Practical Approach, Oxford Press, 1999. 
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As shown in Table 5, the reactions proceeded smoothly to afford only β-
amino esters in satisfactory yields, which increase when temperatures decrease 
(entries 3 and 6). Concerning the diastereoselective reaction outcome, the syn or 
anti selectivity was observed depending from the different starting α-bromo esters 
2b-c, namely starting from 2b, only β-amino ester syn-12 was obtained and from 
2c only the isomer anti-13 was formed.14  
Assuming the enolate in the only E configuration, two possible transition 
states, chair-like transition state VI for syn-12 and boat-like transition state VII for 
anti-13, can be invoked in order to rationalize the different stereochemical results 
(Figure 3).8 This difference is probably due to the increased planarity of the (E)-
enolate resulting from 2c, by favouring the boat-like transition state VII.15  
 
Figure 3. Proposed transitions states.  
In order to confirm the relative configuration of both, the homogeneous aza-
Reformatsky reactions were repeated and the obtained β-amino ester crude 
mixtures were allowed to rise to 25 °C to promote the intramolecular cyclization 
(14 d, Scheme 5).  
                                                                 
14 The syn and anti relative configurations were assigned by comparing H/H coupling constant values (3Jsyn= 
6.5−7 Hz; 3Janti= 8.5−9 Hz) with the data reported in the literature. Stiles, M.; Winkler, R. R.; Chang, Y.-L.; 
Traynor, L. J. Am. Chem. Soc., 1964, 86, 3337–3342.  
15 The anti- stereochemistry could be also explained through a chelated six-membered chair 
transition involving the Z enolate (see p. 78, ref. 9). 
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Scheme 5. Homogeneous aza-Reformatsky reactions followed by intramolecular cyclization. 
As expected, β-lactams cis-14 and trans-5 were obtained starting from syn-
12 and anti-13, respectively.  
7.2.2 Enantio- and diastereoselective studies 
As reported in the introduction (see Chap. 3) homogeneous conditions could 
make the development of asymmetric aza-Reformatsky reaction easier. Therefore, 
in order to achieve enantioselective reaction control, the aza-Reformatsky 
additions of α-bromo ester 2a-c on 1a were performed in the presence of chiral 
amino alcohol (R,S)-6 by using a moderate excess of Et2Zn. The results are 
reported in Table 6. 
Table 6. Enantioselective homogeneous aza-Reformatsky reactions. 
 
Entry R 
Time 
(d) 
Product syn:antia Yield(%)b 
ee 
(%)c 
1 H 5 10′  50 98 
2 Me 6  syn-12′ >99:1 52 98 
3 Ph 9  anti-13′ >1:99 58 91 
aDetermined by 19F NMR spectra of the crude reaction mixture. 
bAfter flash chromatography on silica gel. cDetermined by chiral 
HPLC. 
The expected β-amino esters 10′, syn-12′ and anti-13′ were obtained in 
satisfactory yields and excellent enantioselectivity. 
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7.3 Synthetic elaboration of obtained compounds: synthesis of 
ψ[CH(CF3)NH]-peptidomimetic precursors 
In order to demonstrate the utility of optically pure β-amino β-trifluoromethyl 
ester syn-12′, the synthesis of small ψ[CH(CF3)NH]-peptidomimetic precursors 
was considered through appropriate chemical transformations. 
In fact, the obtained compounds can be considered as starting point for the 
synthesis of peptidomimetics precursors characterized by a chiral ψ[CH(CF3)NH]-
16 cores in which a carbonyl group is replaced by its isoster, the -CHCF3 group. 
Two are the possible molecular growth sites: the carboxylic group, that after 
methyl ester group removal permits a C-terminal molecular growing or to fix the 
trifluoromethylated core to solid matrix, and a free NH2 moiety obtainable by a 
benzyl group hydrogenolysis reaction (Scheme 6). 
 
Scheme 6. Molecular growth sites. 
The second chemical elaboration was considered, to obtain the primary amine 
group as molecular growing site. 
After removal of the benzylic residue, DCC coupling reaction with the N-
Boc-L-Val was performed on syn-14′ following the classical conditions (Scheme 
7).17 
Scheme 7. Synthesis of 15′. 
                                                                 
16 a) Aresu, E.; Fioravanti, S.; Gasbarri, S.; Pellacani, L.; Sciubba, F. RSC Adv. 2013, 3, 13470-13476; b) 
Aresu, E.; Fioravanti, S.; Gasbarri, S.; Pellacani, L.; Ramadori, F. Amino Acids 2013, 44, 977-982 and see 
ref.30 in the Chapter 1.  
17 Fioravanti, S.; Massari, D.; Morreale, A.; Pellacani, L.; Tardella, P. A. Tetrahedron 2008, 64, 3204−3211. 
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The coupling reaction gave in satisfactory yields the corresponding 15′ as a 
pure diastereomer compound. 
7.4 Determination of the absolute configuration 
In order to assign unequivocally the absolute configuration of the new chiral 
centers formed in the organocatalyzed aza-Reformatsky reactions and hence to the 
diastereomer 15′, the addition reactions was repeated starting from the chiral 
aldimine (R)-1c and further chemical modifications were required. 
To begin the study, trifluoromethyl aldimine (R)-1c and 12b were reacted, 
either in the presence or in the absence of the chiral ligand 6 (Table 7).  
Table 7. Homogeneous aza-Reformatsky reactions on optically pure 1c. 
 
Entry 
Time 
(d) 
6 
(equiv) 
Et2Zn 
(equiv) 
Product dra syn:antia 
Yield 
(%)b 
1 6 - 1 16/16′ 1:1 >99:1 68 
2 5 0.38 1.2 16′ >99:1 >99:1 49 
aDetermined by 19F NMR spectra of the crude reaction mixture. bAfter flash 
chromatography on silica gel.  
As shown in Table 7, performing the addition without chiral ligand only the 
geometric stereocontrol was achieved, being controlled by the nucleophilic species 
(entry 1). The result showed also that a resident chiral center of the imine cannot 
influenced the facial selectivity. On the contrary, adding to the reaction (R,S)-6, a 
complete stereofacial selectivity was obtained (entry 2), only one syn diastereomer 
having been formed. Then, the organocatalyzed homogenous aza-Reformatsky 
reactions was brought at room temperature (14 d) to form the corresponding cis-β-
lactam 17 (Scheme 8).  
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Scheme 8. Homogeneous aza-Reformatsky reactions followed by intramolecular cyclization. 
The same previously described methodology, based on the 2D NOESY 1H 
NMR spectra and geometric optimization processes, permitted to assign the (S,S) 
absolute configuration to the newly chiral centers of 17, and as a consequence even 
to those of starting β-amino ester 16'. 
After removal of chiral benzyl group of (R,S,S)-16', chiral HPLC analysis 
showed that the obtained primary amine (S,S)-14′ is the same isomer formed by 
hydrogenolysis reaction carried out from syn-12′ to which, therefore, the same 
configuration can be attributed (Scheme 9). 
Scheme 9. Hydrogenolysis  reactions on 16′ and 12′. 
In order to confirm this, DCC coupling reaction with the N-Boc-L-Val was 
also performed on the β-amino ester obtained by hydrogenolysis of (R,S,S)-16' 
(Scheme 10). 
 
Scheme 10. Synthesis of 15′.  
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The coupling reaction gave, as expected, the same diastereomer 15′, already 
obtained starting from (S,S)-12′, thus confirming the matching between the 
absolute configurations. 
Extending these studies even to the other enantioriched β-amino esters 
(Table 6, entry 1 and 3), the absolute configurations of the new synthesized chiral 
trifluoromethyl compounds are reported below (Figure 4). 
 
Figure 4. Assigned absolute configurations.  
Considering the found absolute configuration, the chiral ligand 6 promotes 
the nucleophilic attack preferentially on the Si face of the starting imine and 
Noyori’s representative transition model can be used to explain the 
stereoselectivity of this Reformatsky reaction (Figure 5).18  
 
Figure 5. Proposed transitions states. 
Transition model VIII and IX provide the products with the observed 
stereochemistry. The proposed stereochemical models are based on the formation 
                                                                 
18 Kitamura, M.; Suga, S.; Niwa, M.; Noyori, R. J. Am. Chem. Soc. 1995, 117, 4832−4842. 
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of a coordination network involving the imine nitrogen, zinc ion, ligand, and 
Reformatsky reagent, which would allow for the successful formation of multiple 
chiral inductions. 
In order to investigate how the presence of a further ester group could 
influence the chemical outcome, the trifluoromethyl aldimine 1g19 derived from β-
alanine was reacted under one-pot heterogeneous aza-Reformatsky conditions with 
α-bromo esters 2a-c to give, as expected, only β-lactams. The results are showed in 
Table 8. 
Table 8. Aza-Reformatsky reactions on 1g. 
 
Entry R 
Time 
(h) 
Product trans:cisb 
Yield 
(%)c 
1a H  18 - 34 
2 Me 18 trans-19 >99:1 40 
3 Ph 10 trans-20 >99:1 42 
aHigher yields in the one-procedure compared to the two-
step protocol. bDetermined by 19F NMR spectra of the 
crude reaction mixture. cAfter flash chromatography on 
silica gel. 
While lower yields compared to those obtained starting from imine 1g (Table 
1 and 2) were observed, the same high trans diastereoselectivity (entry 2-3) and 
chemoselectivity were found. One again the compounds can be derived by the two 
different pathways before reported: via ketene-imine mechanism and a 
condensation-cyclization mechanism (see Chap. 7, pp 76-77). It is noteworthy to 
stress that, if the second suggested mechanism was the one involved, no trace of a 
possible β-lactam resulting by cyclization of aza-Reformastky adduct on the imine 
                                                                 
19 See ref.54 in the Chapter 2. 
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ester group was observed, consistent with a high reaction chemoselectivity.20 Next, 
the homogeneous Et2Zn-promoted aza-Reformatsky reactions, were performed, 
even in the asymmetric version (Table 9).   
Table 9. Homogeneous aza-Reformatsky reactions on 1g. 
 
Entry R 
Time 
(h) 
Et2Zn 
(equiv) 
6 
(equiv) 
Product syn/antia 
Yield  
(%)b 
1d H 18 
1.0 - 
21 - 40 
2d Me 18 syn-22 >99:1 45 
3d Ph 12 anti-23 >1:99 56 
4 H 72 
1.2 0.38 
21' 
(74% ee) 
- 50 
5  Me 72 syn-22' >99:1 48 
6 Ph 72 anti-23' >1:99 51 
aDetermined by 19F NMR spectra of the crude reaction mixture bAfter flash 
chromatography on silica gel. cDetermined by chiral HPLC. d Reaction 
performed at room temperature. 
As shown in Table 9, the expected β-amino esters 21-23 were obtained in 
satisfactory yields; however, a change of the solvent was required (PhCH3 instead 
of CH2Cl2). In addition, while a high syn/anti stereochemical outcome was 
observed, a lower enantiocontrol was found (see Table 6). 
A reasonable explanation, taking into account the ester group on the N-chain 
of the aldimine, may be given. On the basis of the stereochemical model proposed 
before, another transition state could be suggested (Figure 6). In this latter the 
network of coordination involves the ester moiety of the β-alanine chain, instead of 
the imine nitrogen, thereby giving lower stereoselectivity of attack.  
                                                                 
20 The presence of the strong electron-withdrawing –CF3 group increases the electrophilicity of the ester moiety 
in the β-position of β-amino ester intermediate, so directing the nucleophilic attack 
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Figure 6. Proposed transitions state 
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Chapter 8 
 
Work towards the discovery of selective and potent PCAF 
inhibitors 
During my PhD, I spent a period of six months at the University of Oxford (UK) 
under the supervision of Professor Darren J. Dixon and in collaboration with the 
SGC (Structural Genomics Consortium). 
During this period the attention was focused on the development of different 
phthalazine-based derivatives in order to obtain epigenetic probes able to clarify 
key binding elements for the good affinity with the bromodomain module of PCAF 
(p300/CBP-associated factor).   
The chemical probes are selective small-molecules that specifically bind and 
potently control the activity of a cellular target in order to deciphering biochemical 
pathways.1,2,3 They can rapidly and reversibly inhibit a protein or a protein domain 
in cells or animals, modulate individual functions of multifuctional proteins and 
they can be used in almost any cell type and disclose temporal features of target 
inhibition;4 in addition a probe that shows a positive effect can serve as a chemical 
starting point for drug discovery and in this way they can be quite useful at 
invalidating drug targets.5 Target discovery currently uses a number of tools to 
associate a protein target with a disease, including the use of chemical probes in 
cellular or animal disease models.   
                                                                 
1 Knapp, S.; Arruda, P.; Blagg, J.; Burley, S.; Drewry, D. H.; Edwards, A.; Fabbro, D.; Gillespie, P.; Gray, N. 
S.; Kuster, B.; Lackey, K. E.; Mazzafera, P.; Tomkinson, N. C.; Willson, T. M.; Workman, P.; Zuercher, W. J. 
Nat. Chem. Biol 2013, 9, 3-6. 
2 Kroeze, W. K.; Sassano, M. F.; Huang, X. P.; Lansu, K.; McCorvy, J. D.; Giguère, P. M.; Sciaky, N.; Roth, 
B. L. Nat. Struct. Mol. Biol. 2015, 22,362–369.  
3 King, R.; Finley, D.  Nat. Chem. Biol. 2014, 10, 870-874. 
4 Arrowsmith, C.; Audia, J.; Austin, C.; Baell, J.; Bennett, J.; Blagg, J.; Bountra, C.; Brennan, P. et al. Nat. 
Chem. Biol 2015, 11, 536-541. 
5 Sweis, R. F. ACS Med. Chem. Lett. 2015, 6, 618–621. 
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In fact, in order to find new medicines for diseases, like Alzheimer’s disease, 
cancer and chronic inflammation, we first need to discover a new disease-
associated protein target. 
Epigenetic is an exciting new area for target discovery: especially epigenetic 
chemical probes, allowing the investigation of the epigenome, are having a strong 
impact in biological discovery and target validation for several classes of 
chromatin- interacting proteins.6 
We can consider three classes of epigenetic proteins, discovered through the 
study of post-translational modification (PTM) of lysine and/or arginine residues in 
histones and other proteins through methylation and acetylation: a) those which add 
a methyl or acetyl group (writers) using S-adenosylmethionine (methylation) and 
acetyl-CoA (acetylation) as co-factors, b) those which remove a methyl or acetyl 
group (erasers) and c) those which bind histones/proteins containing a particular 
PTM (readers).   
Therefore, as long as it is recognized that these proteins contribute to the 
control of various genes and they represent a rich source of potential therapeutic 
targets, it is important to unravel the biology of these proteins by developing small-
molecule inhibitors and antagonists with the following properties:4 
 IC50 or Kd < 100 nM 
 Selectivity > 30-fold over proteins in the same family 
 Significant cellular activity below 1 μM. 
8.1 Bromodomain 
The interest has been directed towards the development of chemical probes 
against the bromodomain proteins family in recent years. The bromodomain, 
named for the Drosophilia gene brahma from which it was first identified,7 is a 
conserved module that has been found in a number of proteins involved in 
                                                                 
6 Huston, A.; Arrowsmith, C. H.; Knapp, S.; Schapira, M. Nat. Chem. Biol 2015, 11, 542-545. 
7 Haynes, S. R.; Dollard, C.; Winston, F.; Beck, S.; Trowsdale, J.; Dawid, I. B. Nucleic Acids Res. 1992, 20, 
2603 
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transcription regulation that selectively recognize ɛ-N-acetylated lysine residues,8,9 
acting as “readers” of the histone code. The bromodomain family shall consist of 
61 diverse domains in humans that have been described in 41 nuclear proteins,10,11 
(Figure 1)  
 
 
Figure 1. Human bromodomain family. 
 
all of these characterized by 110 amino acids arranged in a characteristic structure 
made up of four α-helices (αZ, αA, αB, αC) connected by interhelical loops, termed 
the BRD fold (Figure 2).  
                                                                 
8 Müller, S.; Knapp, S. Med. Chem. Commun. 2014, 5, 288–296. 
9 Mujtaba, S.; Zeng, L.; Zhou, M. Oncogene 2007, 26, 5521–5527. 
10 Filippakopoulos, P.; Picaud, S.; M angos, M.; Keates, T; Lambert, J. P.; Barsyte-Lovejoy, D.; Felletar, I.; 
Volkmer, R.;. Muller, S.; Pawson, T.; Gingras, A. C.; Arrowsmith, C. H.; Knapp, S. Cell 2012, 149, 214–231. 
11 Filippakopoulos, P.; Knapp, S. FEBS Lett. 2012, 586, 2692–2704. 
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Figure 2. General structure of a bromodomain module. 
 
The interaction with the acetylated lysine residue occurs via a hydrogen bond 
with a conserved asparagine. In addition the water molecules in the binding pocket 
can mediate further interaction between the anchored acetylated lysine and the 
hydroxyl of a conserved tyrosine residue.12 Bromodomains have recently been 
implicated in the development of cancer and have been shown to contain a 
"druggable" binding pocket, however their precise biological role is still poorly 
understood. 
Hence development of selective chemical probes targeting the bromodomain-
histone interaction is highly desirable for our understanding of the biological roles 
of these proteins within the human genome and to provide starting points for new 
molecular therapeutics against cancer. 
8.1.1 p300/CBP-associated factor, PCAF 
PCAF, also known as K(lysine) acetyltransferase 2B, KAT2B, is a 
transcriptional coactivator that works both as a histone lysine acetyltransferase, 
through its HAT domain which is highly homologous to the yeast GCN5 
                                                                 
12 Liu, Y.; Wang, X.; Zhang, J.; Huang, H.; Ding, B.; Wu, J.; Shi, Y. Biochemistry, 2008, 47, 6403–6417. 
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(yGCN5),13 and as an acetyl-lysine reader through its conserved bromodomain 
located directly C-terminal to the HAT domain.14,15  
The simultaneous presence of these two domains is a sign of the importance 
of PCAF and a direct link between transcriptional regulation and chromatin 
modification. Given the significant role in regulation of gene expression, PCAF has 
been implicated in numerous types of cancer.  
The Hedgehog signaling pathway, that plays an important role in embryonic 
patterning and development of many tissues and organs as well as in maintaining 
and repairing mature tissues in adults, has been implicated in developmental 
abnormalities as well as in several types of cancer, including brain tumors like 
medulloblastoma and glioblastoma, and PCAF is involved as a cofactor of the 
genes involved in this pathway.16  
In addition it has been found that PCAF can acetylate and stabilize 
overexpressed ATP-citrate lyase that promotes tumor growth of human lung 
cancers.17 PCAF has also been found to regulate the stability of β-catenin, which is 
involved in colorectal tumors.18 No probes against the bromodomain of PCAF have 
yet been described; on the contrary the HAT domain of PCAF has been targeted 
with a number of broad-activity HAT inhibitors. Therefore, given the number of 
diseases in which PCAF is involved, it is necessary to develop selective inhibitors 
to treat these pathologies.  
In the group where I spent a period of my PhD they are making progress 
toward the development of PCAF inhibitors, starting from different acetyl lysine 
bioisosters (Figure 3), 
                                                                 
13 Marcus, G.A.; Silverman, N.; Berger, S.L.; Horiuchi, J.; Guarente, L. EMBO J. 1994, 13, 48074815. 
14 Marmorstein, R. Cell Mol Life Sci, 2001, 58, 693703. 
15 Carrozza, M.J.; Utley, R.T.; Workman, J.L. Trends Genet, 2003, 19, 321327. 
16 Malatesta, M.; Steinhauer , C.; Mohamma, F.; Pandey, D. P.; Squatrito, M.; Helin, K. Cancer Res. 2013, 73, 
6323-6333.  
17 Lin, R.; Tao, R.; Gao, X.; Li, T.; Zhou, X.; Guan, K. L.; Xiong, Y.; Lei, Q. Y. Mol. Cell. 2013, 51, 506–518. 
18 Xinjian, G.; Qihuang, J.; Fang, Z.; Tingting, Y.; Qiwei, Z. Mol. Biol. Cell. 2009, 20, 419–427. 
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Figure 3. Families of compounds to be synthesized against PCAF, the acetyl lysine mimic motif 
of each structure is highlighted (red). 
and the best compound 1 in the different families is reported to have a KD of 1.0 
μM a significantly weak affinity.  
However all the molecular portions, the position of the phenyl ring, the 
length of the chain and the tertiary amine, that could be responsible binding 
elements, they were simultaneously changed.  
The aim of my project was to understand the key binding elements from 1, 
especially the phenyl residue position, the importance of terminal tertiary amine 
and the effect of chain; in addition my goal was to try to investigate a range of N-
substituents derivatives in order to explore new binding elements and to optimize 
the terminal H-bond 
The measuring of biological activity of potential probes, through biophysical 
assay [Differential Scanning Fluorimetry (DSF)], was used to guide the 
optimization process toward a future design of high-affinity PCAF probes.  
The synthetic approach of potential PCAF ligands was based on the 
condensation between different amines and an acetyl lysine mimic, namely the 6-
chloro-3-methyl-[1,2,4]triazolo[3,4-a]phthalazine (2), that can be obtained 
following the procedure reported in the literature19 (Scheme 1). 
 
                                                                 
19 Xue, D.; Zhang, Y.; Wang, C.; Zhu, N.; Shao, K.; Zhang, X.; Zhang, Z. Eur. J. Med. Chem. 2014, 85, 235-
244. 
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Scheme 1. Synthesis of 2. 
Starting from the lead compound 1, several amines were chosen in order to 
understand the important moieties (Figure 4).  
 
 
Figure 4 Amines chosen, the modified moieties of each structure are highlighted. 
The amines 4-7 were obtained by classical reactions of organic chemistry, 
because they are either expensive or not commercially available.  
The synthesis of amine 4 involved a Michael addition reaction of an 
opportune Grignard reagent to β-nitrostyrene,20 followed by nitro group 
reduction.21  
 
Scheme 2 Synthesis of 4. 
 
The gem-diamine 5, characterized by the presence of both a primary and 
secondary amine moiety, was obtained through a Strecker reaction, involving 
                                                                 
20 Yao, C.; Kao, K.; Liu, J.; Wang, Y.; Chen, W.; Lin, Y.; Yan, M.; Tetrahedron 1998, 54, 791−822. 
21 Martinelli, E.; Vicini, A. C.; Mancinelli, M.; Mazzanti, A.; Zania, P.; Bernardi, L.; Fochi, M. Chem. 
Commun. 2015, 51, 658-660.  
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benzaldeyde, methylamine solution and trimethylsilyl cyanide (TMSCN),22 
followed by a nitrile reduction with LiAlH4 (Scheme 3). 
 
 
Scheme 3 Synthesis of 5. 
A similar Strecker reaction,23 followed by alkylation with iodomethane and 
nitrile group reduction, leads to the amine 6 (Scheme 4). 
 
Scheme 4 Synthesis of 6. 
Finally, to synthesize amine 7 a procedure reported in the literature24 was 
followed (Scheme 5), but strangely the last step of reported synthetic pathway did 
not give the desired product.  
  
Scheme 5. Attempted synthesis of 7. 
                                                                 
22 Vongvilai, P.; Linder, M.; Sakulsombat, M.; Svedendahl Humble, M.; Berglund, P.; Brinck, T.; Ramstrm, O. 
Angew. Chem., Int. Ed. 2011, 50, 6592 –6595. 
23 Taylor, H. M.; Hauser, C. R. Organic Syntheses, Coll. Vol. 5, p.437 (1973). 
24 Gomtsyan, A.; Bayburt, E.; Keddy, R.; Turner, S.; Jinkerson, T.; Didomenico, S.; Perner, R.; Koenig, J.; 
Drizin, I.; McDonald, H.; Surowy, C.; Honore, P.; Mikusa, J.; Marsh, Wetter, J.; Faltynek C.; Lee C. Bioorg. 
Med. Chem. Lett. 2007, 17, 3894−3899. 
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Then, in order to obtain 7, a new synthetic approach, involving a reductive 
amination reaction with ammonium acetate, was developed starting from the 
ketone 8 (Scheme 6).  
 
 
Scheme 6 Synthesis of 7. 
The commercial piperazine 3 was the first tested amine and its reaction with 
2 was performed in the presence of NaOH, following a procedure reported in the 
literature19 (Table 1). 
 
Table 1 Optimization of the coupling reaction. 
 
 
Once again, the reaction, performed by following the literature conditions 
(entry 1), gave the undesired bifunctionalized 10 as major product in all cases, even 
by changing some parameters (entries 2‒3). Then, to obtain only 9, a methodology 
developed by the Dixon’s group was followed, using catalytic KI and HCl (entry 4) 
to form in situ a more reactive aryl iodide. Under these conditions, the substitution 
Entry 
2:3 
ratio 
Conditions 
9/10a  
(Yield of 9) 
1 1:1.2 NaOH (3 equiv), DMF 2/8 
2 1:1.2 NaOH (1.5 equiv), DMF 2/8 
3 1:3 NaOH (1.5 equiv), DMF 2/8 
4 1:2 
KI (0.1 equiv), HCl (0.2 equiv), 
EtOH 
>9.9/0.1 
(63)b 
aDetermined by 1H NMR performed on the crude mixture. 
bAfter flash chromatography on silica gel. 
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reaction lead to 9 as the only product from which 11 was obtained through the 
Eschweiler-Clarke reaction.25 
 
 
Scheme 7. Synthesis of 11. 
The same tandem procedure was repeated starting from synthesized amines 
4‒7 and the expected products 12-15 were obtained as the only products (Table 2). 
Table 2 SNAr coupling reaction with different amines. 
 
Entr
y 
R Time Product 
Yielda 
(%) 
1 
 
7d 12 35 
2 
 
4d 13 30 
3 
 
12h 14 21 
4 
 
12h 15 17 
aAfter flash chromatography on silica gel. 
                                                                 
25 Sahakitpichana, P.; Ruchirawat, S.; Tetrahedron Lett. 2003, 44, 5239–5241. 
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Unfortunately, the DSF26 analysis performed on all obtained compounds 
(Figure 4) suggested a general very low affinity of these compounds for PCAF, 
only the compound 13 resulting to be better than the lead compound 1, whose value 
to cause ΔTm is 1.7 °C.  
 
 
Figure 4. Thermal shifts of 11-15. 
 
Encouraged by the results, we decided to create a series of different 
homologous of 13 generating a library of compounds from which structure-activity 
relationships (SARs) can be readily explored.   
So, we thought that a nucleophilic substitution of a suitable leaving group, 
such as the methanesulfonate group, with different primary amines could be a 
simple and quick methodology to obtain different compounds (Schema 8).  
 
 
Schema 8. Synthesis of 17 followed by mesylation reaction.  
 
However during the mesylation of the hydroxylic group of 17, formed 
through SNAr coupling reaction between 2 and phenylethanolamine (16), the 
expected product undergoes a very fast nucleophilic intramolecular attack, giving 
18 as major compound. 
                                                                 
26 DSF is an inexpensive and rapid screening method to detect low-molecular-weight ligand interactions 
promoting protein stability: Niesen, F. H.; Berglund, H.; Vedadi, M. Nat. Protoc. 2007, 2, 2213. 
102 
 
Therefore, we attempted to convert the amino alcohol 16 in the 
corresponding cyclic sulfamidate, which, used in its asymmetric version,27 could 
moreover provide enantioenriched products after ring-opening reaction. 
But once again, following the classical mesylation procedure (Scheme 9),26 
the reaction did not occur and only a complete crude mixture was obtained. 
 
 
Scheme 9. Attempted synthesis of cyclic sulfamidate. 
 
Then, we decided to completely change the synthetic strategy and, after 
oxidation of 16, a reductive amination finally gave the synthetic targets in good 
yield (Scheme 10). 
 
 
Scheme 10. Synthesis of 20-27. 
 
Given the relevance of H-bond donors and acceptors in the pocket, the 
reductive amination was used to obtain the primary amine 28 allowing also the 
                                                                 
27Moss, T. A.; Alonso, B.; Fenwick, D. R.; Dixon, D. J. Angew. Chem. 2010, 122, 578–581; Angew. Chem., 
Int. Ed. 2010, 49, 568–571. 
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derivatization of the terminal position with alternative H-bond donors and 
acceptors (Scheme 11).  
 
Scheme 11. Synthesis of 28-32. 
In conclusion a series of potential epigenetic probe was generated and to date 
biophysical assay are currently underway to test the affinity with the 
bromodomanin module of PCAF.  
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Chapter 9 
 
Conclusions 
In this thesis the reactivity of N-protected trifluoromethyl (E)-aldimines 
towards different active methylene compounds in the Mannich-type and aza-
Reformatsky reactions was studied.  
At first, suitable trifluoromethyl aldimines were reacted with β-dicarbonyl 
compounds, including diethyl malonate and several β-keto esters. The presence of a 
trifluoromethyl group, lowering both nitrogen basicity and carbon electrophilicity 
of the imine C=N group, greatly affects the Mannich-type addition of β-dicarbonyl 
compounds. In fact, the most common organic or inorganic bases, such as some 
organocatalysts (cinchonidine, L-proline or their derivatives), frequently used to 
promote Mannich-type reactions between aromatic aldimines and β-dicarbonyl 
compounds,1 did not give the expected results. 
Excellent results were obtained only through a Lewis acid catalysis, indeed 
an efficient solvent-free Zr-catalyzed Mannich-type reaction has been developed 
for the synthesis of fluorinated β-amino β-dicarbonyl compounds starting from N-
protected trifluoromethyl aldimines and cyclic or acyclic β-keto esters bearing 
different ester residues.  
The presence of an alkyl substituent on the nucleophilic carbon and the use of 
Zr as coordinating metal lead to a high stereoselective control of reactions (Scheme 
1).  
                                                                 
1 a) Ting, A.; Lou, S.; Schaus, S. E. Org. Lett. 2006, 8, 2003−2006; b) Song, J.; Shih, H.-W.; Deng, L. Org. 
Lett. 2007, 9, 603−606, c) Fini, F.; Bernardi, L.; Herrera, R. P.; Pettersen, D.; Ricci, A.; Sgarzani, V. Adv. 
Synth. Catal. 2006, 348, 2043−2046. 
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Scheme 1. Solvent-free ZrCl4-catalyzed Mannich-type reaction of different β-keto esters. 
Instead, contrary to what reported in the literature for similar reaction,2 the 
ester residue did not affect the reaction outcome: in fact, no difference in reactivity 
was found by changing the ester moiety. 
Then, in order to develop a catalytic asymmetric Mannich-type reaction, 
failing all attempts using an added chiral catalyst, we successfully developed a new 
asymmetric Zr-catalyzed Mannich-type reaction at low cost starting from the 
optically pure aldimine derived by the inexpensive chiral (R)-α-
methylbenzylamine. A complete facial and geometric stereoselective induction 
with formation of a chiral quaternary center was so obtained, the same chiral 
substrate acting as chiral ligand (Figure 1).  
 
Figure 1. Proposed transition state. 
                                                                 
2See ref. 40 in the Chapter 2. 
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The nucleophilic attack takes place only on the sterically less hindered 
prochiral Re face of optically pure aldimine, giving R,R,S pure diastereomeric 
compounds bearing a quaternary chiral center. 
In addition, the diastereoselective catalytic Mannich-type reaction represents, 
thanks to a diastereoselective decarboxylation reaction of the new obtained β-keto 
esters, a valid approach to obtain optically active trifluoromethyl β-amino ketones.  
 
Scheme 2. Decarboxylation reaction. 
Extending my studies, the interest has been directed towards the possibility to 
synthesize attractive trifluoromethylated 2-imidazolines by Mannich-type 
addition/cyclization cascade reaction of -isocyano acetates on trifluoromethyl 
aldimines. Silver(I) oxide is turned out to be a very efficient catalyst for the 
reaction performed under solvent-free conditions between methyl 2-
isocyanoacetate (2) and trifluoromethyl aldimines 1a,b (Scheme 3).  
 
Scheme 3. Ag2O-catalyzed Mannich-type ractions. 
High cis/trans stereoselective control was obtained, the reaction affording 
only trans imidazolines 3a,b. 
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Subsequently, the study has been extended to the reactivity of α-isocyano 
esters bearing a tertiary carbon center. Though the silver(I) catalysis appeared once 
again to be a good reaction catalyst, the use of dichloromethane as solvent was 
required and the total loss of geometric selectivity was recorded because of the 
steric hindrance on the nucleophilic site (Scheme 4).  
 
Scheme 4. Ag2O-catalyzed Mannich-type reactions. 
 
Excellent stereoselectivity was obtained starting from the trifluoromethyl (E)-
aldimines 1d,f deriving from L-α-amino esters (Scheme 5). 
 
Scheme 5. Ag2O-catalyzed Mannich-type reactions on 1d-f. 
A complete stereoselective control was obtained and the reactions lead to the 
formation of the only optically pure trans isomers. To explain the high 
diastereoselectivity observed and the stereochemical outcome, a transition state can 
be proposed (Figure 2).  
 
Figure 2. Proposed transition state. 
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The coordination of the imine ester group to the silver promotes the enolate 
attack preferentially to the Re imine face, obtaining enantiopure valuable 
trifluoromethyl imidazolines enriched by an α-amino ester residue. 
As a further and last class of active methylene compounds, α-bromo esters have 
been considered in the aza-Reformatsky reactions, always with different 
trifluoromethyl aldimines.  
The reactions were studied under two different conditions: heterogeneous 
conditions, using activated metal zinc as catalyst, and homogenous conditions, 
using Et2Zn as source of the metal.  
Working under heterogeneous conditions, only β-lactams in good yields and 
high trans geometric selectivity were achieved when the reactions were performed 
starting from α-bromo esters (Scheme 6). 
 
Scheme 6. Aza-Reformatsky reaction under heterogeneous conditions. 
However, adding (1R,2S)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol as chiral 
ligand no enantioselective control was obtained. Even the presence of a chiral center 
on the aldimine does not seem able to control the facial attack selectivity. 
Then, we moved on to study the homogeneous reaction outcome.  
Under optimal conditions, the additions lead to the only β-amino esters, in 
good isolated yields and high geometric selectivity, the syn or anti isomer 
formation depending from the R substituent. In fact, while a complete syn 
selectivity was achieved starting from methyl substituted α-bromo ester 2b, the anti 
β-amino ester was obtained starting from phenyl substituted α-bromo ester 2c 
(Scheme 7). 
110 
 
 
Scheme 7. Aza-Reformatsky reaction under homogeneous conditions. 
Subsequently, the first example of a convenient enantioselective aza-
Reformatsky reaction on trifluoromethyl aldimines has been successfully 
developed. 
Using diethyl zinc and substoichiometric amount of (1R,2S)-1-phenyl-2-(1-
pyrrolidinyl)propan-1-ol as chiral ligand, trifluoromethyl enantioenriched β-amino 
esters in good yields and enantioselectivities (up to 91% ee) were synthesized 
(Scheme 8). 
 
Scheme 8. Enantioselective aza-Reformatsky reaction.  
The S absolute configuration assigned to C-CF3 substituted chiral center 
suggested that the Si-face of the coordinate imine was preferentially exposed, as 
shown in the proposed transition model reported below (Figure 3).  
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Figure 3. Proposed transition states in the presence of (1R,2S)-6. 
Finally, in order to investigate how the presence of a further ester group 
could influence the chemical outcome, the trifluoromethyl aldimine 1g3 derived 
from β-alanine was considered in the two different approaches (Scheme 9).  
 
Scheme 9. Aza-Reformatsky reactions performed on 1g under homogeneous and heterogeneous 
condition. 
Under heterogeneous conditions, the reactions lead to the expected β-lactams 
with high chemoselectivity and also high trans diastereoselectivity. In addition, 
corresponding expected β-amino esters were obtained under homogeneous 
conditions. Confirming our proposed transition states, the presence of an ester 
group on the β position of imine nitrogen, is responsible for the low or absent 
enantiocontrol found in the asymmetric aza-Reformatsky reactions.  
                                                                 
3 See ref. 54 in the Chapter 2. 
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β-Amino esters, keto esters, and malonates obtained through aza-
Reformatsky and Mannich type-reactions respectively, allow to approach, through 
appropriate chemical transformations, new ψ[CH(CF3)NH]-peptidomimetics. In 
fact, the [CH(CF3)] group is a known isoster of the carbonyl group.  
Similarly, the synthesis of bioisoster has been the aim of the project carried 
out at the University of Oxford (UK) under the supervision of Professor Darren J. 
Dixon and in collaboration with the SGC (Structural Genomics Consortium). 
I have turned the attention on the development of potential epigenetic probes, 
characterized by a portion of acetyl lysine bioisoster, in order to draw conclusions 
about the binding elements, which are important for affinity with the bromodomain 
module of PCAF. A library of 20 compounds was developed and improvements in 
terms of affinity, compared to the lead compound, were obtained.  
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General Experimental Methods 
IR spectra were recorded on a Perkin-Elmer 1600 Series FT/IR 
spectrophotometer in CHCl3 as the solvent, and reported in . 1H NMR, 13C NMR, 
and 19F NMR spectra were recorded on a Varian-Mercury 300 instrument and on a 
Bruker Avance III 400 instrument, and reported in δ units. CDCl3 was used as the 
solvent and CHCl3 as the internal standard. ESI MS analyses were performed using 
a quadrupole-time of flight (Q-TOF) mass spectrometer equipped with an ESI 
source and a syringe pump. The experiments were conducted in the positive ion 
mode.  
HPLC analyses were performed with a Varian 9001 instrument using an 
analytical column (3.9 × 300 mm, flow rate 1.3 mL/min; detector: 254 nm) 
equipped with a Varian RI-4 differential refractometer, or a Varian 9050 UV/VIS 
detector. Eluents were HPLC grade. Enantiomeric excess were determined using 
analytical high performance liquid chromatography (HPLC) performed on Varian 
9001 instrument (column and solvent conditions are given with the compound). 
Analytical thin-layer chromatography (TLC) was carried out on precoated (0.25 
mm) silica gel plates.  
Silica gel 230-400 mesh was used for column chromatography. 
Computational details 
All optimized geometries were located using hybrid functional theory (B3LYP) 
and the 6-31G(d, p) basis set using the continuum solvation model  with chloroform 
(ε = 4.71) as the solvent conforming to the experimental conditions. All calculations 
were carried out using the Gaussian 09 program.1 
                                                                 
1 Gaussian 09, Revision D.01, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; 
Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, 
X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, 
K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; 
Montgomery Jr., J. A. J.; Peralta, E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; 
Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; 
Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; 
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Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; 
Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. 
J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian, 
Inc., Wallingford CT, 2013. 
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Chapter 10 
 
Mannich type reactions of 1,3-dicarbonyl compounds with 
trifluoromethyl aldimines 
Synthesis of trifluoromethyl imines (1a-c). The trifluoromethyl imines were 
synthesized following a procedure reported in the literature.1 1a-c are known 
compounds. 
General procedure for the ZrCl4-Catalyzed Mannich-type reactions.  
To a mixture of trifluoromethyl aldimines 1a-c (1 mmol) and diethyl malonate (2) 
or β-keto esters 6, 9-11, and 15-16 (1 mmol), ZrCl4 (10 mol %) was added. The 
reactions were performed under solvent-free conditions and stirred at room 
temperature for 10-30 min. After H2O addition, the crude mixtures were extracted 
with Et2O. The collected organic layers were dried on anhydrous Na2SO4, the 
solvent evaporated in vacuo and the residues purified by flash chromatography on 
silica gel (eluent hexane/ethyl acetate = 8:2). 
 Diethyl 2-[1-(benzylamino)-2,2,2-trifluoroethyl]malonate 
(3a). Yellow oil (299 mg, 80%). IR: 1748, 1760. 1H NMR 
(CDCl3): 1.22–1.33 (m, 6H), 2.40 (br, 1H), 3.71 (d, J = 6.0 
Hz, 1H), 3.86–4.07 (m, 3H), 4.15–4.29 (m, 4H), 7.21–7.31 (m, 5H). 19F NMR 
(CDCl3):–72.2 (d, J = 7.2 Hz). 13C NMR (CDCl3): 13.8, 13.9, 52.0, 52.3, 58.7 (q, J 
= 28.4 Hz), 61.8, 62.1, 125.8 (q, J = 286.3 Hz), 127.2, 128.1 (2C), 128.2 (2C), 
139.2, 166.5, 166.6. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C16H21F3NO4 
348.1423, found 348.1424. 
 
                                                                 
1 See ref.17 in the Chapter 1. 
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Diethyl 2-[2,2,2-trifluoro-1-(4-
methoxyphenylamino)ethyl]malonate (3b). Brown 
oil (287 mg, 79%). IR: 1750, 1758. 1H NMR (CDCl3): 
1.15 (t, J = 7.1 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H), 3.74 
(s, 3H), 3.82 (d, J = 3.5 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 4.25 (q, J = 7.1 Hz, 
2H), 4.61–4.76 (m, 2H), 6.69–6.79 (m, 4H). 19F NMR (CDCl3): –74.1 (d, J = 7.2 
Hz). 13C NMR (CDCl3): 13.8, 13.9, 50.7, 55.6, 57.3 (q, J = 30.2 Hz), 62.1, 62.5, 
114.7 (2C), 115.7 (2C), 125.1 (q, J = 284.7 Hz), 139.8, 153.3, 166.0, 167.0. HR-
MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C16H21F3NO5 364.1372, found 
364.1375. 
 Diethyl 2-[2,2,2-trifluoro-1-{[(R)-1-
phenylethyl]amino}ethyl]malonate (4/5c). Colorless oil 
(263 mg, 73%). IR: 1743, 1751. 1H NMR (CDCl3): 1.28–1.35 
(m, 18H), 2.73 (br, 2H), 3.64 (d, J = 5.1 Hz, 1H), 3.71 (d, J = 
5.1 Hz, 1H), 3.93–4.31 (m, 12H), 7.24–7.34 (m, 10H). 19F NMR (CDCl3): –73.4 (d, 
J = 7.4 Hz), –70.66 (d, J = 7.0 Hz). 13C NMR (CDCl3): 13.8, 13.9 (2C), 14.0, 23.6, 
25.1, 51.3, 51.7, 55.4, 55.7, 56.4 (q, J = 28.0 Hz), 56.5 (q, J = 28.8 Hz), 61.7, 61.8, 
62.0, 62.2, 125.5 (q, J = 284.3 Hz), 126.0 (q, J = 288.4 Hz), 126.8 (2C), 127.1 
(2C), 127.2, 127.3, 128.3 (2C), 128.4 (2C), 143.7, 144.7, 166.4, 166.8 (2C), 166.9. 
HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C17H23F3NO4 362.1579, found 
362.1582. 
Methyl 2-acetyl-3-(benzylamino)-4,4,4-trifluorobutanoate 
(7/7'a). Yellow oil (227 mg, 75%). IR: 1740, 1715. 1H NMR 
(CDCl3): 1.84 (br, 1H), 2.01 (br, 1H), 2.20 (s, 3H), 2.24 (s, 
3H), 3.73 (s, 3H), 3.75 (s, 3H), 3.78 (d, J = 2.1 Hz, 1H), 3.79 (d, J = 3.7 Hz, 1H), 
3.82–3.86 (m, 2H), 3.92–4.05 (m, 4H), 7.23–7.34 (m, 10H). 19F NMR (CDCl3): –
72.0 (d, J = 7.2 Hz) –71.9 (d, J = 7.1 Hz). 13C NMR (CDCl3): 29.1, 29.8, 52.3 (2C), 
52.7, 52.9, 58.0 (q, J = 28.6 Hz), 58.6, 58.9 (q, J = 28.1 Hz), 59.4, 127.3, 127.4, 
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127.5 (q, J = 282.5 Hz, 2C), 128.3 (4C), 128.4 (4C), 138.8, 139.1, 167.2, 167.5, 
198.8, 199.8. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C14H17F3NO3 
304.1161, found 304.1165. 
Methyl (Z)-3-(benzylamino)but-2-enoate (8). Colorless oil 
(68%). IR: 1740, 1650. 1H NMR (CDCl3): 1.93 (s, 3H), 3.65 
(s, 3H), 4.44 (d, J = 6.4 Hz, 2H), 4.55 (s, 1H), 7.22−7.42 (m, 5H), 8.95 (br, 1H). 
13C NMR (CDCl3): 19.4, 46.8, 50.0, 82.8, 126.7 (2C), 127.3, 128.8 (2C), 138.7, 
161.9, 179.8. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C12H16NO2 206.1181, 
found 206.1203. 
 Ethyl 2-acetyl-3-(benzylamino)-4,4,4-trifluoro-2-
methylbutanoate (12/12'a). Red oil (215 mg, 65%). IR: 
1743, 1720. 1H NMR (CDCl3): 1.21–1.28 (m, 6H), 1.40 (s, 
3H, minor syn isomer), 1.48 (s, 3H, major anti isomer), 1.83 
(br, 2H), 2.18 (s, 6H), 3.79–3.85 (m, 2H), 4.07–4.30 (m, 7H), 4.38 (q, J = 7.3 Hz, 
1H), 7.26–7.34 (m, 10H). 19F NMR (CDCl3): –65.60 (d, J = 7.6 Hz, minor syn 
isomer), –65.4 (d, J = 7.0 Hz, major anti isomer). 13C NMR (CDCl3): 13.4, 13.8, 
13.9, 15.5, 25.8, 26.3, 52.7, 53.1, 61.9, 62.1, 62.2 (q, J = 26.6 Hz), 62.3, 62.6 (q, J 
= 26.7 Hz), 63.2, 126.0 (q, J = 288.6 Hz), 126.2 (q, J = 288.2 Hz), 127.3, 127.5, 
128.0 (2C), 128.2 (2C), 128.3 (2C), 128.4 (2C), 138.8, 139.3, 169.4, 169.5, 200.7, 
202.2. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C16H21F3NO3 332.1474, 
found 332.1570. 
Ethyl 2-acetyl-4,4,4-trifluoro-3-(4-
methoxyphenylamino)-2-methylbutanoate (12/12'b). 
Red oil (236 mg, 68%). IR: 1750, 1729. 1H NMR 
(CDCl3): 1.16 (t, J = 7.1 Hz, 3H, major anti isomer), 
1.25 (t, J = 7.0 Hz, 3H, minor syn isomer), 1.54 (s, 3H, syn isomer), 1.56 (s, 3H, 
major anti isomer), 2.19 (s, 6H), 3.73 (s, 6H), 4.02–4.27 (m, 6H), 4.76–4.87 (m, 
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1H, major anti isomer), 4.92–5.03 (m, 1H, minor syn isomer), 6.67–6.78 (m, 8H). 
19F NMR (CDCl3): –67. 3 (d, J = 7.4 Hz, minor syn isomer), –67.6 (d, J = 8.0 Hz, 
major anti isomer). 13C NMR (CDCl3): 13.7, 13.8, 15.1, 16.4, 26.2, 26.5, 55.5 (2C), 
58.7 (q, J = 28.4 Hz), 59.8 (q, J = 28.2 Hz), 61.3 (2C), 62.0, 62.3, 114.7 (2C), 
114.8 (2C), 115.2 (2C), 115.5 (2C), 125.3 (q, J = 286.9 Hz), 125.4 (q, J = 286.5 
Hz), 139.3, 139.6, 153.2, 153.4, 169.5, 169.6, 201.8, 202.0. HR-MS (ESI Q-TOF) 
(m/z) [M + H]+ calcd for C16H21F3NO4 348.1423, found 348.1425. 
 Ethyl 1-[1-(benzylamino)-2,2,2-trifluoroethyl]-2-
oxocyclopentanecarboxylate (13/13'a). Red oil (257 mg, 75%). 
IR: 1758, 1725. 1H NMR (CDCl3): 1.21–1.31 (m, 6H), 1.59 (br, 
2H), 1.98–2.05 (m, 6H), 2.17–2.76 (m, 6H), 3.78–4.09 (m, 4H), 4.12–4.41 (m, 6H), 
7.24–7.34 (m, 10H). 19F NMR (CDCl3): –65.25 (d, J = 8.4 Hz, minor syn isomer), 
–65.5 (d, J = 8.4 Hz, major anti isomer). 13C NMR (CDCl3): 13.8, 13.9, 19.5, 20.2, 
27.0, 27.1, 37.2, 38.5, 52.7, 54.2, 62.0, 62.2 (q, J = 26.5 Hz, 2C), 62.2, 63.1, 64.5, 
125.9 (q, J = 287.6 Hz, 2C), 127.3, 127.4, 128.0 (4C), 128.3 (4C), 139.0, 139.3, 
166.7, 166.8, 210.1, 210.4. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C17H21F3NO3 344.1474, found 344.1471. 
 Ethyl 2-oxo-1-[2,2,2-trifluoro-1-(4-
methoxyphenylamino)ethyl]cyclopentanecarboxylate 
(13/13'b). Brown oil (262 mg, 73%). IR: 1762, 1759. 1H 
NMR (CDCl3): 1.04 (t, J = 7.1 Hz, 3H, major anti isomer), 
1.23 (t, J = 7.1 Hz, 3H, minor syn isomer), 1.93–2.47 (m, 
10H), 2.54–2.83 (m, 2H), 3.54 (br, 1H), 3.74 (s, 6H), 3.85 (br, 1H), 3.90–4.04 (m, 
2H), 4.10–4.25 (m, 2H), 4.82–4.96 (m, 2H), 6.69–6.78 (m, 8H). 19F NMR (CDCl3): 
–69.9 (d, J = 7.2 Hz, minor syn isomer), –68.37 (d, J = 7.0 Hz, major anti isomer). 
13C NMR (CDCl3): 13.7, 13.9, 19.5, 20.0, 27.2, 28.2, 37.1, 38.3, 55.6 (2C), 59.7 (q, 
J = 28.1 Hz), 61.0 (q, J = 27.7 Hz), 62.0, 62.3, 62.5, 63.9, 114.7 (4C), 115.7 (2C), 
116.4 (2C), 125.1 (q, J = 285.9 Hz), 125.6 (q, J = 286.6 Hz), 139.5, 139.9, 153.5, 
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153.8, 166.4, 167.2, 209.4, 210.7. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C17H21F3NO4 360.1423, found 360.1427. 
 Ethyl 1-[1-(benzylamino)-2,2,2-trifluoroethyl]-2-
oxocyclohexanecarboxylate (14a). White oil (278 mg, 78%). 
IR: 1743, 1729.1H NMR (CDCl3): 1.21 (t, J = 7.1 Hz, 3H), 
1.64–1.94 (m, 6H), 2.36–2.52 (m, 3H), 3.73–4.10 (m, 2H), 4.13–4.28 (m, 3H), 
7.22–7.33 (m, 5H). 19F NMR (CDCl3): –63.8 (d, J = 7.8 Hz). 13C NMR (CDCl3): 
13.8, 21.9, 25.9, 30.9, 40.7, 52.8, 61.6 (q, J = 27.4 Hz), 61.9, 64.3, 126.0 (q, J = 
288.7 Hz), 127.3, 128.1 (2C), 128.3 (2C), 139.1, 168.5, 203.8. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C18H23F3NO3 358.1630, found 358.1635. 
Ethyl 2-oxo-1-[2,2,2-trifluoro-1-(4-
methoxyphenylamino)ethyl]cyclohexanecarboxylate 
(14b). White oil (317 mg, 85%). IR: 1745, 1728. 1H NMR 
(CDCl3): 1.11 (t, J = 7.1 Hz, 3H), 1.63–2.03 (m, 6H), 
2.42–2.54 (m, 3H), 3.73 (s, 3H), 3.97 (q, J = 7.2 Hz, 1H), 
4.08 (q, J = 7.1 Hz, 1H), 4.83–4.91 (m, 1H), 6.66–6.76 (m, 4H). 19F NMR (CDCl3): 
–67.0 (d, J = 7.5 Hz). 13C NMR (CDCl3): 13.7, 22.0, 26.2, 31.4, 40.8, 55.7, 58.9 (q, 
J = 29.1 Hz), 62.2, 63.8, 114.8 (2C), 115.3 (2C), 125.1 (q, J = 286.2 Hz), 139.8, 
153.3, 168.3, 203.9. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C18H23F3NO4 
374.1579, found 374.1571. 
Methyl 2-acetyl-4,4,4-trifluoro-3-{[(R)-1-
phenylethyl]amino}butanoate (anti-17,18/syn-17',18'). 
Yellow oil (228 mg, 72%). IR: 1739, 1725. 1H NMR (CDCl3): 
1.29–1.34 (m, 12H), 1.67 (br, 1H), 2.05 (s, 3H), 2.12 (s, 3H), 
2.21 (br, 1H), 2.29 (s, 3H), 2.32 (s, 3H), 2.50 (br, 1H), 3.65–3.81 (m, 20H), 3.98–
4.09 (m, 5H), 7.23–7.36 (m, 20H). 19F NMR (CDCl3): –73.2 (d, J = 7.6 Hz), –72.63 
(d, J = 6.9 Hz), –70.52 (d, J = 6.9 Hz), –70.07 (d, J = 7.9 Hz). 13C NMR (CDCl3): 
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22.7, 23.1, 24.7, 24.8, 28.7, 29.3, 29.9, 30.9, 52.5, 52.7 (2C), 52.9, 55.3, 55.4, 55.6 
(q, J = 26.3 Hz), 55.7 (2C), 55.7 (q, J = 27.8 Hz), 56.6 (q, J = 28.3 Hz), 56.7 (q, J = 
27.7 Hz), 57.6, 58.2, 59.0, 59.1, 125.6 (q, J = 277.4 Hz), 126.0 (q, J = 288.1 Hz), 
126.6 (2C), 126.7 (2C), 127.1 (q, J = 284.4 Hz), 127.2 (q, J = 280.4 Hz), 127.3 
(2C), 127.4 (4C), 127.6 (2C), 128.3 (2C), 128.4 (4C), 128.5 (2C), 143.1, 143.2, 
144.7, 144.8, 167.3, 167.5, 167.7, 167.8, 199.0, 199.1, 200.4 (2C). HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C15H19F3NO3 318.1317, found 318.1312. 
 Ethyl (2S,3R)-2-acetyl-4,4,4-trifluoro-2-methyl-3-{[(R)-1-
phenylethyl]amino}butanoate (19). Light yellow oil (234 
mg, 68%). [α]D = +86.0 (c = 1 g/100 mL, CHCl3). IR: 1742, 
1726. 1H NMR (CDCl3): 1.28–1.31 (m, 6H), 1.46 (s, 3H), 1.97 
(br, 1H), 2.22 (s, 3H), 4.04 (q, J = 6.2 Hz, 1H), 4.18 (q, J = 7.1 Hz, 1H), 4.29 (q, J 
= 7.1 Hz, 1H), 4.36 (q, J = 8.1 Hz, 1H), 7.22−7.32 (m, 5H). 19F NMR (CDCl3): –
65.0 (d, J = 8.5 Hz). 13C NMR (CDCl3): 13.9, 15.3, 21.6, 26.6, 55.5, 59.1 (q, J = 
26.7 Hz), 62.1, 63.2, 126.0 (q, J = 288.4 Hz), 126.5 (2C), 127.4, 128.5 (2C), 145.5, 
169.4, 202.2. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C17H23F3NO3 
346.1630, found 346.1633. 
 Ethyl (1S)-2-oxo-1-[(1R)-2,2,2-trifluoro-1-{[(R)-1-
phenylethyl]amino}ethyl]cyclopentanecarboxylate (20). Light 
yellow oil (278 mg, 78%). [α]D = +54.0 (c = 1 g/100 mL, 
CHCl3). IR: 1731, 1718. 1H NMR (CDCl3): 1.23–1.28 (m, 6H), 
1.60 (br, 1H), 1.85–1.96 (m, 3H), 2.12–2.23 (m, 1H), 2.19–2.28 
(m, 1H), 2.59–2.63 (m, 1H), 3.96 (q, J = 6.5 Hz, 1H), 4.15 (q, J = 7.1 Hz, 1H), 4.21 
(q, J = 7.1 Hz, 1H), 4.29 (q, J = 7.3 Hz, 1H), 7.16−7.29 (m, 5H). 19F NMR 
(CDCl3): –65.0 (d, J = 8.5 Hz). 13C NMR (CDCl3): 14.0, 19.6, 21.6, 27.2, 37.2, 
55.3, 59.2 (q, J = 26.3 Hz), 62.3, 64.5, 126.5 (2C), 126.9 (q, J = 288.4 Hz), 127.5, 
128.6 (2C), 146.4, 166.8, 210.0. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C18H23F3NO3 358.1630, found 358.1636. 
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 Ethyl (1S)-2-oxo-1-[(1R)-2,2,2-trifluoro-1-{[(R)-1-
phenylethyl]amino}ethyl]cyclohexanecarboxylate (21). 
Colorless oil (289 mg, 78%). [α]D = +79.0 (c = 1 g/100 mL, 
CHCl3). IR: 1740, 1715. 1H NMR (CDCl3): 1.26–1.30 (m, 6H), 
1.57–1.67 (m, 3H), 1.84–1.99 (m, 4H), 2.37–2.41 (m, 1H), 2.52–2.65 (m, 1H), 4.02 
(q, J = 7.1 Hz, 1H), 4.20 (q, J = 7.1 Hz, 1H), 4.22 (q, J = 7.2 Hz, 1H), 4.31 (q, J = 
7.2 Hz, 1H), 7.23−7.33 (m, 5H). 19F NMR (CDCl3): –65.0 (d, J = 8.5 Hz). 13C 
NMR (CDCl3): 13.9, 21.5, 22.1, 25.7, 30.3, 40.9, 55.2, 58.2 (q, J = 26.6 Hz), 61.9, 
64.3, 126.4 (q, J = 287.8 Hz), 126.5 (2C), 127.4, 128.5 (2C), 146.6, 168.4, 203.6. 
HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C19H25F3NO3 372.1787, found 
372.1785. 
tert-Butyl 2-acetyl-4,4,4-trifluoro-3-{[(R)-1-
phenylethyl]amino}butanoate (anti-22,23/syn-22',23'). 
Colorless oil (233 mg, 65%). IR: 1737, 1712. 1H NMR 
(CDCl3): 1.48–1.58 (m, 52H), 2.04 (s, 3H), 2.07 (s, 3H), 
2.29–2.30 (m,6H), 3.50– 3.73 (m, 6H), 3.99–4.08 (m, 6H), 7.26−7.36 (m, 20H). 19F 
NMR (CDCl3): –70.1 (d, J = 8.6 Hz), –70.50 (d, J = 7.7 Hz), –72.21 (d, J = 8.5 
Hz), –72.83 (d, J = 7.5 Hz). 13C NMR (CDCl3): 22.6, 23.3, 24.9, 25.5, 27.6 (2C), 
27.8 (12C), 28.3 (2C), 54.6, 55.3, 55.4, 55.6, 56.1 (q, J = 28.0 Hz), 56.3 (q, J = 
27.5 Hz), 56.4 (q, J = 30.0 Hz), 56.5 (q, J = 28.0 Hz), 59.2, 59.7, 59.9, 60.5, 82.8, 
82.9, 83.0, 83.1, 125.7 (q, J = 278.8 Hz), 125.8 (q, J = 279.8 Hz), 125.9 (q, J = 
285.5 Hz), 126.1 (q, J = 288.5 Hz), 126.7 (2C), 126.9 (2C), 127.0 (2C), 127.3 (2C), 
127.4, 127.5, 127.6 (2C), 128.4 (4C), 128.5 (2C), 128.7 (2C), 143.0, 143.4, 143.8, 
144.8, 165.9, 166.1, 166.7, 166.8, 199.7, 199.8, 200.5, 200.8. HR-MS (ESI Q-TOF) 
(m/z) [M + H]+ calcd for C18H25F3NO3 360.1787, found 360.1789. 
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 tert-Butyl (2S,3R)-2-acetyl-4,4,4-trifluoro-2-methyl-3-{[(R)-1-
phenylethyl]amino}butanoate  (24). Yellow oil (238 mg, 
64%). [α]D = +123.0 (c = 1 g/100 mL, CHCl3). IR: 1752, 
1719. 1H NMR (CDCl3): 1.25 (d, J = 6.4 Hz, 3H) 1.34 (s, 
3H), 1.40 (s, 9H), 1.95 (br, 1H), 2.15 (s, 3H), 3.98 (q, J = 6.4 Hz, 1H), 4.15−4.24 
(m, 1H), 7.14−7.26 (m, 5H). 19F NMR (CDCl3): –64.3 (d, J = 6.3 Hz). 13C NMR 
(CDCl3): 15.8, 21.4, 26.5, 27.7 (3C), 55.3, 59.5 (q, J = 26.5 Hz), 63.6, 82.7, 126.1 
(q, J = 288.9 Hz), 126.4 (2C), 127.2, 128.4 (2C), 146.5, 168.4, 202.6. HR-MS (ESI 
Q-TOF) (m/z) [M + H]+ calcd for C19H27F3NO3 374.1943 found 374.1941. 
(3R,4R)-5,5,5-trifluoro-3-methyl-4-{[(R)-1-
phenylethyl]amino}pentan-2-one (25). Yellow oil (75 mg, 
43%). [α]D = +72.0 (c = 1 g/100 mL, CHCl3). IR: 1715. 1H 
NMR (CDCl3): 1.19 (d, J = 7.1 Hz, 3H), 1.26 (d J = 6.4 Hz, 
3H), 1.51 (br, 1H), 2.15 (s, 3H), 2.76–2.83 (m, 1H), 3.60–3.67 (m, 1H), 3.91 (q, J = 
6.4 Hz, 1H), 7.20−7.29 (m, 5H). 19F NMR (CDCl3): –72.3 (d, J = 8.9 Hz). 13C 
NMR (CDCl3): 11.1, 23.3, 28.6, 46.4, 55.6, 56.4 (q, J = 27.0 Hz), 126.8 (2C), 
127.4, 127.7 (q, J = 245.8 Hz), 128.5 (2C), 144.7, 208.8. HR-MS (ESI Q-TOF) 
(m/z) [M + H]+ calcd for C14H19F3NO 274.1419, found 274.1421. 
General procedure for the AlCl3-Catalyzed Mannich-type reactions of β-keto 
ester 9 with aldimine 1c. 
To a mixture of trifluoromethyl aldimines 1c (1 mmol) and β-keto esters 9 (1 
mmol), AlCl3 (10 mol %) was added. The reaction was performed under solvent-
free conditions and stirred at room temperature for 30 min. After H2O addition, the 
crude mixtures were extracted with Et2O. The collected organic layers were dried 
on anhydrous Na2SO4, the solvent evaporated in vacuo and the residues purified by 
flash chromatography on silica gel (eluent hexane/ethyl acetate = 8:2). 
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Ethyl 2-acetyl-4,4,4-trifluoro-2-methyl-3-{[(R)-1-
phenylethyl]amino}butanoate (anti-19,26/syn-19',26'). 
Yellow oil (169 mg, 49%). IR: 1751, 1715. 1H NMR (CDCl3): 
1.12−1.41 (m, 36H), 1.46−1.58 (br, 4H), 1.81 (s, 3H), 2.04 (s, 
3H), 2.22 (s, 3H), 2.32 (s, 3H), 3.89–4.39 (m, 16H), 7.22−7.35 (m, 20H). 19F NMR 
(CDCl3): –63.3 (d, J = 7.0 Hz), –63.54 (d, J = 6.7 Hz), –64.99 (d, J = 8.3 Hz), –
65.22 (d, J = 6.8 Hz). 13C NMR (CDCl3): 13.6, 13.7, 13.8, 13.9, 14.2, 15.2, 16.5 
(2C), 21.3 (2C), 21.6 (2C), 24.3, 24.8, 26.1, 26.4, 53.1, 55.3, 55.5, 55.8, 59.0 (q, J 
= 27.3 Hz), 59.1 (q, J = 26.6 Hz), 60.0 (q, J = 26.6 Hz), 60.8 (q, J = 26.3 Hz), 61.9, 
62.0, 62.2 (2C), 62.6 (3C), 63.2, 125.8 (q, J = 280.8 Hz ), 125.9 (q, J = 267.5 Hz ), 
125.9 (q, J = 288.1 Hz ), 126.4 (2C), 127.0 (2C), 127.4 (4C), 127.7 (2C), 128.0 
(2C), 128.3 (2C), 128.4 (2C), 128.6 (4C), 127.7 (q, J = 245.8 Hz), 142.8, 143.4, 
145.2, 145.5, 169.4 (2C), 169.8, 169.9, 201.2, 201.3, 202.4, 202.6. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C17H23F3NO3 346.1630 found 346.1623. 
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2D NMR spectra and optimized geometries to determine the absolute 
configuration of the new chiral centers. 
1. To determine the absolute configuration of the new trifluoromethyl substituted 
chiral-center (Cβ), 2D NMR spectra and optimized geometries of β'-amino β-
dicarbonyl compound 24 was considered. 
2D NMR spectra and optimized geometries of 24 
 
 
Figure 1. 2D NOESY spectrum of 24. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Hb and Ha was measured 1.55 a.u. 
(corresponding to an interproton distance of 3.62 Å), in order to determine the absolute 
configuration. 
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Figure 2. Optimized geometries of all possible diastereomers. By NOESY analysis coupled with 
computational studies the R absolute configuration can be assigned to Cβ  
Calculated Coordinates: 
(R,R,S) 
-------------------------------------------------------------  
Center     Atomic      Atomic      Coordinates (Angstroms) 
Number     Number       Type      X        Y           Z 
 ------------------------------------------------------------ 
 1         7           0       1.353000   1.281210    0.374545 
 2         6           0       2.634923   1.445779    0.369280 
 3         6           0       0.231243   0.578607    0.257404  
 4         6           0      -1.117646   0.914567    0.484439 
 5         6           0       0.511232  -0.935341   -0.281814 
 6         1           0       0.073892   0.849472   -1.310867 
 7         6           0      -1.441875   2.440723    0.389550 
 8         6           0      -2.865231   2.872160    0.684341 
 9         8           0      -0.600533   3.274706    0.102997 
10         6           0      -1.071981   0.539603    1.983105 
11         1           0      -1.00374   -0.541088    2.104431 
12         1           0      -0.194811   0.994347    2.446201 
13         6           0      -2.278150   0.247562   -0.298806 
14         8           0      -2.456305   0.492086   -1.478559 
15         8           0      -3.038662  -0.528972    0.469784 
16         6           0      -4.207689  -1.283163   -0.065690 
17         6           0      -3.733754  -2.270561   -1.133846 
18         6           0      -5.257150  -0.302849   -0.592669 
19         6           0      -4.715811  -2.01815     1.174932 
20         1           0      -3.364603  -1.75216    -2.019084 
21         1           0      -4.572380  -2.909560   -1.426748 
Ha/Hb : 3.616 Å 
(R,R,S) 
possible diastereomer anti-24 
Ha/Hb : 3.646 Å 
(R,S,R) 
Ha/Hb : 3.540 Å 
(R,R,R) 
possible diastereomer syn-24 
Ha/Hb : 3.605 Å 
(R,S,S) 
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22         1           0      -2.938509  -2.908240 -0.739137 
23         9           0       0.914712  -1.426436  0.905353 
24         9           0       1.469300  -1.231893  -1.18866 
25         9           0      -0.583459  -1.653149 -0.647891 
26         1           0       1.009073   2.221562  0.535895 
27         6           0       3.650213   0.345746 -0.037899 
28         6           0       4.530156  -0.181004 -0.991362 
29         1           0       4.468211   0.136904 -2.026467 
30         6           0       5.496458  -1.125954 -0.634165 
31         1           0       6.164617  -1.522293 -1.393812 
32         6           0       5.601617  -1.560287  0.686400 
33         1           0       6.352222  -2.294445  0.964846 
34         6           0       4.729534  -1.041666  1.647458 
35         1           0       4.799334  -1.372365  2.680247 
36         6           0       3.766839  -0.100539  1.287030 
37         1           0       3.080078   0.290652  2.030027 
38         1           0       3.052143   2.358590  0.077756 
39         6           0       2.472565   1.743256 -1.868307 
40         1           0       2.154168   0.863492 -2.433473 
41         1           0       3.414766   2.095842 -2.296937 
42         1           0       1.730530   2.534912 -2.008778 
43         1           0      -1.967867   0.877623  2.506345 
44         1           0      -3.399926   2.181477  1.338202 
45         1           0      -2.852409   3.873062  1.118320 
46         1           0      -3.406698   2.919852 -0.266848 
47         1           0      -4.895210   0.232370 -1.470620 
48         1           0      -5.529449   0.420705  0.181669 
49         1           0      -6.159239  -0.857538 -0.868492 
50         1           0      -3.943714  -2.680225  1.576588 
51         1           0      -5.589010  -2.622905  0.914945 
52         1           0      -5.006395  -1.308683  1.954920 
--------------------------------------------------------------- 
 
(R,S,R) 
--------------------------------------------------------------- 
Center     Atomic      Atomic            Coordinates (Angstrom) 
Number     Number       Type             X           Y        Z 
 -------------------------------------------------------------- 
 1        7           0       -1.357758   -1.547574    0.569733 
 2        6           0       -2.737391   -1.227190    0.117875  
 3        6           0       -0.161322   -1.002971    0.044267 
 4        6           0        1.027518   -1.130858    0.971198 
 5        1           0       -0.326339    0.055219    0.246899 
 6        6           0        0.196281   -1.621553    1.417692 
 7        6           0        0.506876   -0.611060    2.360289 
 8        6           0        0.036108    0.821188    2.482677 
 9        8           0        0.544968   -1.345084    3.327657 
10        6           0        2.235864   -0.246981    0.577982 
11        8           0        3.377847   -0.531952    0.878236 
12        8           0        1.855242    0.861662   -0.071816 
13        6           0        3.759187    1.164273   -1.607990 
14        6           0        3.594969    2.496152    0.557829 
15        6           0        1.926260    2.866530   -1.297122 
16        1           0       -1.273111   -2.549523    0.706910 
17        6           0       -2.971902    0.277920    0.036463 
18        6           0       -2.735238    1.021414   -1.129193 
19        1           0       -2.360108    0.530388   -2.019906  
20        6           0       -2.972016    2.398061   -1.160270 
21        1           0       -2.782174    2.954415   -2.073611 
22        6           0       -3.454846    3.055559   -0.028180 
23        1           0       -3.644447    4.124525   -0.055476  
24        6           0       -3.697350    2.327540    1.138604 
25        1           0       -4.078726    2.827021    2.024462  
26        6           0       -3.456342    0.953578    1.166667 
27        1           0       -3.649128    0.392318    2.077304 
28        1           0       -3.356209   -1.580920    0.951382 
29        6           0       -3.219497   -2.000065   -1.124199  
30        1           0       -2.687255   -1.723840   -2.034258 
31        1           0       -4.287393   -1.818905   -1.282992 
32        1           0       -3.080605   -3.075034   -0.968602 
33        1           0       -0.696248    1.083477    1.717574 
34        1           0       -0.401138    0.959412    3.472275 
35        1           0        0.886536    1.501451    2.370226 
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36        9           0       -0.522373   -1.057478   -2.421792 
37        9           0       -0.054337   -2.949735   -1.454945 
38        9           0        1.499142   -1.458361   -1.756726 
39        6           0        2.832733    1.850528   -0.601249 
40        1           0        1.359755    2.391514   -2.103088 
41        1           0        2.531503    3.669945   -1.726287 
42        1           0        1.219468    3.306671   -0.588057 
43        1           0        3.172176    0.640254   -2.367216 
44        1           0        4.420529    0.449888   -1.117299 
45        1           0        4.370368    1.921739   -2.108129 
46        1           0        2.899188    2.946779    1.272439 
47        1           0        4.237466    3.291862    0.168112 
48        1           0        4.218276    1.768164    1.077371 
49        6           0        1.516452   -2.578072    1.148035 
50        1           0        1.915510   -2.976366    0.214741 
51        1           0        0.706474   -3.221009    1.497136 
52        1           0        2.305542   -2.607223    1.897568 
 --------------------------------------------------------------- 
 
(R,R,R) 
 -------------------------------------------------------------- 
Center     Atomic      Atomic           Coordinates (Angstroms) 
Number     Number       Type          X           Y         Z 
--------------------------------------------------------------- 
 1         6          0        4.364189    1.189489   -0.795717 
 2         6          0        5.498809    0.394555   -0.949026 
 3         6          0        5.374628   -0.994514   -0.862977 
 4         6          0        4.129563   -1.570876   -0.618485 
 5         6          0        2.981107   -0.781221   -0.442337 
 6         6          0        3.117385    0.607359   -0.548181 
 7         6          0        1.632525   -1.487461   -0.214327 
 8         7          0        0.444864   -0.624902   -0.310054 
 9         6          0       -0.317848   -0.088201    0.797005 
10         6          0       -1.675542    0.474218    0.239694 
11         6          0       -1.406783    1.687834   -0.691771 
12         8          0       -2.382213    2.599583   -0.623172 
13         6          0       -2.252407    3.726103   -1.515894 
14         6          0        1.644334   -2.357673    1.052430 
15         6          0        0.380646    0.933748    1.735659 
16         9          0        1.628871    0.539159    2.065999 
17         9          0       -0.300483    1.051073    2.904362 
18         9          0        0.489555    2.181468    1.221785 
19         6          0       -2.682616    0.858813    1.352993 
20         6          0       -2.344597   -0.572208   -0.724749 
21         6          0       -2.871403   -1.981158   -0.320302 
22         8          0       -2.583139   -0.195658   -1.860348 
23         8          0       -0.442473    1.805199   -1.424018 
24         1          0       -0.562615   -0.899275    1.484564 
25         6          0       -4.418346   -1.859894   -0.306626 
26         6          0       -2.409387   -2.571300    1.022005 
27         6          0       -2.452155   -2.950216   -1.449777 
28         1          0       -1.332144    4.273644   -1.303850 
29         1          0       -3.124168    4.349611   -1.324475 
30         1          0       -2.241368    3.384539   -2.552627 
31         1          0        0.507556    0.048692   -1.065530 
32         1          0        2.251900    1.250533   -0.443103 
33         1          0        4.442485    2.270539   -0.870227 
34         1          0        6.466582    0.848359   -1.141397 
35         1          0        6.246339   -1.629859   -0.992760 
36         1          0        4.049542   -2.654360   -0.573951 
37         1          0        1.537299   -2.188920   -1.056859 
38         1          0        1.765243   -1.762000    1.958268 
39         1          0        2.475434   -3.064080    1.006137 
40         1          0        0.725709   -2.945542    1.130591 
41         1          0       -3.665299    1.055787    0.922328 
42         1          0       -2.775701    0.064589    2.093415 
43         1          0       -2.364253    1.763363    1.870647 
44         1          0       -2.867185   -3.944105   -1.254624 
45         1          0       -2.815344   -2.600812   -2.417552 
46         1          0       -1.362484   -3.035914   -1.501983 
47         1          0       -4.858958   -2.850689   -0.155515 
48         1          0       -4.768480   -1.212193    0.503312  
49         1          0       -4.783168   -1.458016   -1.254670 
50         1          0       -2.914923   -3.531289    1.169846 
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51         1          0       -1.337074   -2.773881    1.031340 
52         1          0       -2.660475   -1.947113    1.882333 
 --------------------------------------------------------------- 
 
 
(R,S,S) 
 -------------------------------------------------------------- 
Center     Atomic      Atomic           Coordinates (Angstroms) 
Number     Number       Type           X           Y        Z 
--------------------------------------------------------------- 
 1          6           0      3.022367    1.192352    0.748443 
 2          6           0      3.117871    0.035683   -0.036349 
 3          6           0      3.637700    0.156904   -1.334034 
 4          6           0      4.050025    1.391146   -1.833729 
 5          6           0      3.946591    2.537378   -1.040494 
 6          6           0      3.430802    2.433605    0.250785 
 7          6           0      2.670064   -1.338303    0.456772 
 8          6           0      2.829155   -1.536212    1.974907 
 9          7           0      1.335535   -1.675461   -0.096017 
10          6           0      0.191399   -0.835655    0.195053 
11          6           0     -0.499815   -1.147072    1.559181 
12          9           0     -0.123349   -2.326988    2.088490 
13          6           0     -0.803303   -0.811568   -1.019619 
14          6           0     -0.058746   -0.236222   -2.253616 
15          6           0     -2.000101    0.132148   -0.764460 
16          8           0     -3.131012   -0.073377   -1.161388 
17          8           0     -1.590159    1.221643   -0.105738 
18          6           0     -2.518217    2.299757    0.328318 
19          6           0     -3.103721    2.993475   -0.902617 
20          6           0     -1.585669    3.232094    1.102701 
21          6           0     -3.593401    1.716080    1.247855 
22          6           0     -1.324299   -2.239340   -1.322864 
23          8           0     -1.133613   -3.135791   -0.517695 
24          6           0     -2.014019   -2.510743   -2.639813 
25          9           0     -1.854869   -1.164485    1.501147 
26          9           0     -0.177619   -0.194702    2.479838 
27          1           0     -2.151416    4.079812    1.499178 
28          1           0      0.543747    0.190421    0.302327 
29          1           0      1.109340   -2.649820    0.072279 
30          1           0      2.630302    1.133473    1.758708 
31          1           0      3.347876    3.316849    0.877602 
32          1           0      4.269642    3.500162   -1.425487 
33          1           0      4.456715    1.458866   -2.838740 
34          1           0      3.722089   -0.731149   -1.955310 
35          1           0      3.336713   -2.065903   -0.022596 
36          1           0      2.178075   -0.881286    2.557406 
37          1           0      3.864114   -1.343625    2.275853 
38          1           0      2.583013   -2.567302    2.243546 
39          1           0     -1.272116   -2.515597   -3.446745 
40          1           0     -2.488358   -3.492030   -2.595309 
41          1           0     -2.750517   -1.737111   -2.862059 
42          1           0     -1.122467    2.698643    1.937452 
43          1           0     -0.793796    3.616447    0.453430 
44          1           0     -3.131411    1.151321    2.061744 
45          1           0     -4.269136    1.057250    0.702176 
46          1           0     -4.175444    2.534435    1.682429 
47          1           0     -2.303131    3.341916   -1.562071 
48          1           0     -3.685287    3.864328   -0.584818 
49          1           0     -3.757427    2.322564   -1.460974 
50          1           0      0.323451    0.760906   -2.023620 
51          1           0     -0.727796   -0.156093   -3.113125 
52          1           0      0.787182   -0.876519   -2.506377 
 ---------------------------------------------------------------- 
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2. In order to determine the absolute configuration of the new quaternary chiral center 
(Cα) of β'-amino β-dicarbonyl compound 24, and thus also the syn or anti configuration, a 
diastereoselective decarboxylation, in which the same high selectivity was retained, was 
performed (Scheme 1), following the procedure reported in the literature.2 Then, the 
absolute configuration of α-methyl substituted carbon in 25 was determined.  
 
Scheme 1. Decarboxylation reaction of 24. 
2D NMR spectra and optimized geometries of (R,R,R)-β-amino ketone 25 
 
Figure 3. 2D NOESY spectrum of 25. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Hd and He was measured 0.83 a.u. 
(corresponding to an interproton distance of 4.03 Å), in order to determine the absolute 
configuration. 
                                                                 
2 See ref.40 in the Chapter 2. 
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Figure 4. Optimized geometries of obtained (R,R,R)-25 and of its possible diastereomer (R,R,S). 
Calculated Coordinates: 
(R,R,R)-25 obtained diastereomer 
--------------------------------------------------------------- 
Center     Atomic      Atomic           Coordinates (Angstroms) 
Number     Number       Type           X           Y        Z 
 -------------------------------------------------------------- 
 1          6           0      2.344535    0.480449    2.184862 
 2          6           0      1.942853    0.800232    0.736815 
 3          6           0      3.086614    0.743194   -0.290658 
 4          6           0      4.337350   -0.044564    0.023824 
 5          6           0      0.684603    0.009201    0.218786 
 6          6           0      0.966201   -1.480156   -0.019376 
 7          9           0      1.518605   -2.084496    1.065269 
 8          7           0      0.096047    0.541655   -1.001704 
 9          6           0     -1.070497    1.440629   -0.882846 
10          6           0     -2.286049    0.670209   -0.360558 
11          6           0     -2.679599   -0.499106   -1.031769 
12          6           0     -3.797120   -1.221543   -0.622346 
13          6           0     -4.547314   -0.792287    0.477278 
14          6           0     -4.166820    0.363776    1.155381 
15          6           0     -3.045578    1.089791    0.737902 
16          9           0     -0.155196   -2.163222   -0.309526 
17          9           0      1.829788   -1.668867   -1.048802 
18          1           0     -0.063960    0.032050    1.018203 
19          1           0     -2.775562    1.990685    1.278480 
20          1           0     -4.739794    0.708062    2.011724 
21          1           0     -5.418619   -1.355180    0.799360 
22          1           0     -4.084433   -2.121256   -1.159236 
23          1           0     -2.087541   -0.843324   -1.873351 
24          6           0     -0.797691    2.764820   -0.148884 
25          1           0      0.820975    0.972254   -1.570260 
26          8           0      2.964770    1.341347   -1.351838 
27          1           0      4.858309    0.394096    0.881788 
28          1           0      4.997038   -0.039321   -0.844410 
29          1           0      1.474041    0.571917    2.842134 
30          1           0      3.095935    1.193728    2.536793 
31          1           0     -0.585157    2.620208    0.915712 
32          1           0     -1.656514    3.439101   -0.226594 
33          1           0      0.062067    3.266991   -0.602235 
34          1           0     -1.299927    1.705807   -1.923667 
35          1           0      2.745551   -0.525740    2.306368 
36          1           0      1.615239    1.843051    0.708745 
37          1           0      4.084161   -1.074091    0.294140 
--------------------------------------------------------------- 
 
(R,R,S) 
 ---------------------------------------------------------------- 
Center     Atomic      Atomic           Coordinates (Angstroms) 
Number     Number       Type           X           Y         Z 
 ---------------------------------------------------------------- 
 1          1           0     -3.408971   -2.079919    1.591569 
Ha/He : 3.857 Å 
(R,R,R)-25 
Ha/He : 2.950 Å 
(R,R,S)-25 
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 2          6           0     -2.384202   -1.876822    1.265944 
 3          9           0     -1.460800    1.967745   -0.711449 
 4          6           0     -0.679765    1.481862    0.288022 
 5          9           0      0.574479    1.898513    0.051212 
 6          6           0     -2.256478   -0.426248    0.769538 
 7          6           0     -3.232134   -0.226168   -0.401133 
 8          6           0     -4.374564    0.739268   -0.200064 
 9          6           0     -0.785533   -0.047729    0.401086 
10          7           0     -0.268273   -0.656401   -0.811994 
11          6           0      0.924780   -1.526402   -0.762197 
12          6           0      2.172723   -0.731461   -0.376654 
13          6           0      2.801353   -0.853864    0.867452 
14          6           0      3.940944   -0.102135    1.173469 
15          6           0      4.473103    0.779173    0.234334 
16          6           0      3.856873    0.907445   -1.014573 
17          6           0      2.719554    0.161000   -1.311306 
18          9           0     -1.088166    2.091580    1.433177 
19          8           0     -3.104837   -0.869018   -1.434173 
20          6           0      0.751070   -2.828372    0.039202 
21          1           0     -0.161709   -0.305504    1.266022 
22          1           0      2.413833   -1.543891    1.610241 
23          1           0      4.412182   -0.212826    2.146061 
24          1           0      5.361007    1.359209    0.468660 
25          1           0      4.265553    1.588271   -1.755966 
26          1           0      2.237191    0.271935   -2.278910 
27          1           0     -1.019322   -1.077434   -1.349456 
28          1           0     -4.953923    0.457411    0.686969 
29          1           0     -5.021247    0.750572   -1.078268 
30          1           0      0.526288   -2.646806    1.094413 
31          1           0      1.660222   -3.436431   -0.009064 
32          1           0     -0.070392   -3.416685   -0.379514 
33          1           0      1.069154   -1.822990   -1.808486 
34          1           0     -3.976143    1.742520   -0.016514 
35          1         0       -1.720880   -2.053169    2.117470 
36          1         0       -2.137252   -2.585291    0.473356 
37          1         0       -2.554959    0.240150    1.583569 
---------------------------------------------------------------- 
As a consequence of the results obtained from the above reported procedure, the (R,R,R) 
absolute configuration can be assigned to the obtained syn isomer 25. As a consequence, 
the (R,R,S) absolute configuration can be assigned to the starting β′-amino β-keto ester anti 
isomer 24. The (R,R,S) absolute configuration can be assigned to all obtained β'-amino β-
keto ester anti-isomer 19, 20, and 21. 
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2D NMR spectra and optimized geometries of 19 
 
Figure 5. 2D NOESY spectrum of 19. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Hb and Ha was measured 1.56 a.u. 
(corresponding to an interproton distance of 3.61 Å), in order to determine the absolute 
configuration. 
 
Figure 6. Optimized geometries of obtained (R,R,S)-19 and of its possible diastereomer (R,S,R). 
Ha/Hb : 3.634 Å 
(R,R,S)-19 
obtained diastereomer 
Ha/Hb : 4.027 Å 
(R,S,R) 
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Calculated Coordinates: 
(R,R,S)-19 obtained diastereomer  
----------------------------------------------------------------- 
Center     Atomic      Atomic           Coordinates (Angstroms) 
Number     Number       Type           X           Y         Z 
--------------------------------------------------------------- 
 1          6           0     -2.142829   -0.801206   -1.767907 
 2          6           0     -1.734012   -0.468322   -0.304854 
 3          6           0     -2.628199   -1.243960    0.717752 
 4          6           0     -4.047223   -1.580227    0.315303 
 5          6           0     -0.187537   -0.703983   -0.067084 
 6          6           0      0.222576   -2.118281   -0.569691 
 7          9           0      0.317187   -2.159946   -1.925040 
 8          7           0      0.286530   -0.509381    1.277207 
 9          6           0      1.265387    0.515652    1.667517 
10          6           0      2.494556    0.501241    0.758756 
11          6           0      3.469702   -0.489728    0.949495 
12          6           0      4.608582   -0.544692    0.149161 
13          6           0      4.794697    0.393651   -0.870333 
14          6           0      3.833867    1.382435   -1.075001 
15          6           0      2.695192    1.436295   -0.264596 
16          9           0      1.417430   -2.498918   -0.094626 
17          9           0     -0.669000   -3.080658   -0.213814 
18          1           0      0.338558   -0.022446   -0.742604 
19          1           0      1.966713    2.222061   -0.437376 
20          1           0      3.967928    2.118571   -1.862589 
21          1           0      5.682192    0.354167   -1.495190 
22          1           0      5.352537   -1.317463    0.320676 
23          1           0      3.326002   -1.226455    1.735023 
24          6           0      0.662608    1.914668    1.870415 
25          1           0     -0.405777   -0.732865    1.978013 
26          8           0     -2.215187   -1.553332    1.821299 
27          1           0     -4.568029   -0.693467   -0.055736 
28          1           0     -4.569968   -1.977847    1.185517 
29          1           0     -1.462086   -0.315758   -2.467164 
30          1           0     -3.151872   -0.440204   -1.978788 
31          1           0      0.266669    2.325393    0.940803 
32          1           0      1.409933    2.613659    2.261618 
33          1           0     -0.162419    1.858809    2.587043 
34          1           0      1.618632    0.183616    2.652371 
35          1           0     -2.122074   -1.875013   -1.952893 
36          6           0     -2.095589    1.016274   -0.094934 
37          1           0     -4.055234   -2.329389   -0.482785 
38          8           0     -2.902007    1.405059    0.727379      
39          8           0     -1.500000    1.811329   -0.999156 
40          6           0     -2.045654    3.156828   -1.167659 
41          6           0     -1.396787    4.185731   -0.260586 
42          1           0     -3.122793    3.106276   -0.996042 
43          1           0     -1.857050    3.379382   -2.219627 
44          1           0     -1.592864    3.965445    0.790638 
45          1           0     -1.817224    5.170646   -0.488893 
46          1           0     -0.316505    4.235519   -0.421855 
--------------------------------------------------------------- 
 
(R,S,R) 
---------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
----------------------------------------------------------------- 
1          6           0       -2.949619   -1.491353   -0.228916 
2          6           0       -1.898939   -0.718703    0.637835 
3          6           0       -2.164727   -1.223182    2.076314 
4          6           0       -0.440441   -1.226806    0.205589 
5          1           0       -0.653741   -2.281273    0.001859 
6          7           0        0.626570   -1.240046    1.179931 
7          6           0        1.513037   -0.152371    1.641990 
8          6           0        2.772322   -0.028278    0.764244 
9          6           0        3.452605   -1.196417    0.388248 
10         6           0        4.634845   -1.138827   -0.346250 
11         6           0        5.165204    0.097047   -0.727804 
12         6           0        4.498460    1.265802   -0.365085 
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13          6           0        3.313849    1.202414    0.375883 
14          6           0        0.038678   -0.720460   -1.158281 
15          1           0        2.816438    2.128285    0.642540 
16          1           0        4.895150    2.233744   -0.658773 
17          1           0        6.085614    0.145625   -1.302553 
18          1           0        5.142648   -2.058437   -0.623929 
19          1           0        3.032847   -2.158051    0.666501 
20          6           0        0.842889    1.190683    1.958193 
21          1           0        0.431437   -1.905083    1.911278 
22          8           0       -2.726175   -2.642348   -0.556385 
23          1           0        0.506885    1.701608    1.054344 
24          1           0        1.547267    1.850278    2.473757 
25          1           0       -0.017243    1.047328    2.613270 
26          1           0        1.878014   -0.538252    2.602878 
27          6           0       -2.156242    0.793094    0.601840 
28          8           0       -2.374521    1.473330    1.586154 
29          8           0       -2.164398    1.272831   -0.652967 
30          6           0       -2.465670    2.683917   -0.841177 
31          6           0       -1.205744    3.531360   -0.797379 
32          1           0       -3.184628    2.991474   -0.079410 
33          1           0       -2.937811    2.723769   -1.824705 
34          1           0       -0.769133    3.531559    0.204257 
35          1           0       -1.452491    4.564267   -1.062687 
36          1           0       -0.463629    3.157966   -1.507388 
37          6           0       -4.274772   -0.835987   -0.545835 
38          1           0       -4.636721   -0.220202    0.282741 
39          1           0       -5.004942   -1.608739   -0.788571 
40          1           0       -4.147618   -0.178475   -1.411172 
41          1           0       -3.193111   -1.011462    2.378343 
42          1           0       -1.503823   -0.726963    2.786733 
43          1           0       -2.006761   -2.303540    2.128497 
44          9           0       -0.948488   -0.778700   -2.081975 
45          9           0        1.044907   -1.490010   -1.620675 
46          9           0        0.494215    0.554577   -1.141594 
 --------------------------------------------------------------- 
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2D NMR spectra and optimized geometries of 20 
 
Figure 7. 2D NOESY spectrum of 20. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Hb and Ha was measured 1.57 a.u. 
(corresponding to an interproton distance of 3.61 Å), in order to determine the absolute 
configuration. 
 
Figure 8. Optimized geometries of obtained (R,R,S)-20 and of its possible diastereomer (R,S,R). 
Ha/Hb : 3.615 Å 
(R,R,S)-20 
obtained diastereomer 
Ha/Hb : 3.583 Å 
(R,R,S) 
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Calculated Coordinates: 
(R,R,S)-20 obtained diastereomer 
----------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
----------------------------------------------------------------- 
 1          7           0       -0.862956    1.225425    0.198722 
 2          6           0       -2.132198    1.218481    0.984814 
 3          6           0        0.153985    0.202471    0.465011 
 4          6           0        1.530362    0.635273   -0.130648 
 5          6           0       -0.277195   -1.155892   -0.111881 
 6          1           0        0.326749    0.024372    1.533161 
 7          6           0        1.906503    2.076895    0.357338 
 8          6           0        2.474554    2.869516   -0.810408 
 9          8           0        1.729569    2.481466    1.486013 
10          6           0        2.646758    1.859576   -1.954065 
11          1           0        3.382120    3.400180   -0.509103 
12          1           0        1.727818    3.636021   -1.058391 
13          6           0        1.593368    0.766876   -1.668243 
14          1           0        3.649824    1.426612   -1.927932 
15          1           0        2.504735    2.314007   -2.937443 
16          1           0        1.825118   -0.179841   -2.156772 
17          1           0        0.609490    1.094874   -2.015147 
18          6           0        2.623099   -0.266267    0.490096 
19          8           0        2.643807   -0.558994    1.667715 
20          8           0        3.554093   -0.636056   -0.400137 
21          6           0        4.617088   -1.508410    0.082576 
22          6           0        4.194043   -2.965328    0.005591 
23          1           0        4.871242   -1.214421    1.102439 
24          1           0        5.457799   -1.294770   -0.579659 
25          1           0        3.341057   -3.157105    0.660739 
26          1           0        5.024013   -3.603971    0.323730 
27          1           0        3.921683   -3.239008   -1.017496 
28          9           0       -0.741206   -1.076232   -1.372722 
29          9           0       -1.243368   -1.725244    0.642632 
30          9           0        0.757022   -2.038996   -0.132626 
31          1           0       -0.429229    2.120474    0.394294 
32          6           0       -3.247416    0.444947    0.273319  
33          6           0       -4.149838   -0.378983    0.956289 
34          1           0       -4.041610   -0.542161    2.023038 
35          6           0       -5.199746   -1.009165    0.281747 
36          1           0       -5.884490   -1.647160    0.833497 
37          6           0       -5.366630   -0.823833   -1.089820 
38          1           0       -6.182163   -1.312950   -1.614681 
39          6           0       -4.472686   -0.002728   -1.782699 
40          1           0       -4.590814    0.149772   -2.852037 
41          6           0       -3.426918    0.622794   -1.106858 
42          1           0       -2.726404    1.249882   -1.648589 
43          1           0       -2.444051    2.270815    0.944556 
44          6           0       -1.956457    0.878359    2.472381 
45          1           0       -1.739880   -0.180880    2.633428 
46          1           0       -2.862358    1.125384    3.032758 
47          1           0       -1.135798    1.467330    2.893027 
 ---------------------------------------------------------------- 
 
(R,S,R) 
----------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
----------------------------------------------------------------- 
 1          6           0       -1.477806   -0.623951   -0.415874 
 2          6           0       -2.286933    0.677486   -0.531469 
 3          8           0       -3.494352    0.719174   -0.665353 
 4          8           0       -1.490842    1.756511   -0.542970 
 5          6           0       -2.130624    3.055209   -0.679719 
 6          6           0       -2.573629    3.588738    0.672536 
 7          6           0       -0.192058   -0.450617    0.450391 
 8          6           0       -0.530152   -0.130249    1.924491 
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 9          9           0       -0.705918   -1.259982    2.656594 
10          6           0       -2.376563   -1.827863   -0.037501 
11          6           0       -1.983970   -2.997219   -0.973276 
12          6           0       -1.559461   -2.320512   -2.280137 
13          6           0       -0.993069   -0.969748   -1.874804 
14          8           0       -0.317222   -0.235935   -2.558329 
15          7           0        0.662856   -1.615673    0.286938 
16          6           0        2.129789   -1.558811    0.541650 
17          6           0        2.526409   -1.790160    2.009279 
18          6           0        2.754507   -0.325862   -0.102736 
19          6           0        2.862658   -0.276302   -1.500903 
20          6           0        3.437388    0.821291   -2.138793 
21          6           0        3.918976    1.895316   -1.385789 
22          6           0        3.815869    1.860423    0.004457 
23          6           0        3.236406    0.758925    0.640638 
24          9           0       -1.658517    0.602910    2.074734 
25          9           0        0.464490    0.570103    2.519293 
26          1           0        0.338693    0.420867    0.066175 
27          1           0       -2.297793   -2.095072    1.018218 
28          1           0       -2.813070   -3.695716   -1.110778 
29          1           0       -1.144848   -3.564780   -0.561336 
30          1           0       -2.431304   -2.112997   -2.916883 
31          1           0       -0.839633   -2.874954   -2.886967 
32          1           0       -2.970902    2.958955   -1.369773 
33          1           0       -1.360987    3.684526   -1.129875 
34          1           0       -3.349761    2.953367    1.105583 
35          1           0       -2.981401    4.597371    0.551968 
36          1           0       -1.730630    3.638039    1.367118 
37          1           0        0.273714   -2.417169    0.773935 
38          1           0        3.168321    0.751784    1.722868 
39          1           0        4.187155    2.689702    0.599761 
40          1           0        3.512110    0.837443   -3.222176 
41          1           0        2.484570   -1.105524   -2.091258 
42          1           0        2.520239   -2.420094   -0.016867 
43          1           0        2.173923   -1.001774    2.675078      
44          1           0        3.614934   -1.860583    2.101764 
45          1           0        2.101683   -2.736724    2.359570 
46          1           0       -3.413824   -1.539206   -0.222015 
47          1           0        4.371243    2.750398   -1.879688 
---------------------------------------------------------------- 
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2D NMR spectra and optimized geometries of 21 
 
Figure 9. 2D NOESY spectrum of 21. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Hb and Ha was measured 1.56 a.u. 
(corresponding to an interproton distance of 3.61 Å), in order to determine the absolute 
configuration. 
 
Figure 10. Optimized geometries of obtained (R,R,S)-21 and of its possible diastereomer (R,S,R). 
Ha/Hb : 3.607 Å 
(R,R,S)-21 
obtained diastereomer 
Ha/Hb : 3.572 Å 
(R,S,R)-21 
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Calculated Coordinates: 
(R,R,S)-21 obtained diastereomer 
---------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
----------------------------------------------------------------- 
 1          6           0        1.477156   -0.539713    0.013753 
 2          6           0        1.947897   -1.846825   -0.703341 
 3          6           0        3.210569   -2.479387   -0.158697 
 4          6           0        3.084815   -2.732384    1.357325 
 5          6           0        2.774328   -1.427048    2.093691 
 6          6           0        1.506195   -0.745579    1.556793 
 7          8           0        1.325770   -2.337111   -1.628262 
 8          6           0        0.049652   -0.151379   -0.523639 
 9          6           0       -0.425052    1.211751   -0.000192 
10          9           0       -1.518285    1.634389   -0.674223 
11          6           0        2.490379    0.510424   -0.509716 
12          8           0        3.135376    1.162016    0.463315 
13          6           0        4.108528    2.170007    0.058245 
14          6           0        3.444865    3.518991   -0.157671 
15          7           0       -0.919777   -1.193787   -0.166584 
16          6           0       -2.213996   -1.287592   -0.903414 
17          6           0       -2.111551   -1.005100   -2.410637 
18          6           0       -3.349639   -0.551174   -0.183778 
19          6           0       -4.387576    0.084320   -0.876689 
20          6           0       -5.452499    0.676680   -0.191975 
21          6           0       -5.499737    0.642618    1.201095 
22          6           0       -4.470386    0.010879    1.903698 
23          6           0       -3.409897   -0.578637    1.217537 
24          8           0        2.686375    0.675269   -1.698355 
25          9           0        0.517731    2.174016   -0.178639 
26          9           0       -0.737905    1.210203    1.309918 
27          1           0        1.366746    0.220595    2.044780 
28          1           0        4.614006    1.819811   -0.843569 
29          1           0        4.818094    2.197795    0.886972 
30          1           0        2.748323    3.482960   -0.997810 
31          1           0        4.212525    4.267756   -0.376954 
32          1           0        2.901486    3.834078    0.737118 
33          1           0       -4.374521    0.128372   -1.960304 
34          1           0       -6.243294    1.167143   -0.752870 
35          1           0       -6.326647    1.103078    1.734069 
36          1           0       -4.493377   -0.021984    2.989643 
37          1           0       -2.604173   -1.056475    1.764151 
38          1           0       -2.463175   -2.353468   -0.809514 
39          1           0       -1.988124    0.059656   -2.625104 
40          1           0       -3.009101   -1.351231   -2.930375 
41          1           0       -1.257382   -1.546384   -2.827071 
42          1           0        2.637143   -1.622886    3.163000 
43          1           0        3.627521   -0.746407    2.004758 
44          1           0        4.051718   -1.797059   -0.341652 
45          1           0        3.395404   -3.397575   -0.721219 
46          1           0        2.288285   -3.466114    1.536107 
47          1           0        4.013462   -3.178319    1.728019 
48          1           0       -0.450674   -2.074042   -0.340929 
49          1           0        0.164073   -0.013778   -1.606784 
50          1           0        0.631773   -1.352982    1.810218 
 ---------------------------------------------------------------- 
 
(R,S,R) 
---------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
------------------------------------------------------------------ 
 1          7           0        0.725579    1.110976   -1.264172 
 2          6           0        2.214487    1.149765   -1.326188 
 3          6           0       -0.034435    0.005918   -0.712750 
 4          6           0       -0.289675   -1.093547   -1.760522 
 5          6           0       -2.271443    1.278030   -1.083433 
 6          6           0       -3.369571    2.154830   -0.465566 
 7          1           0       -2.717403    0.545906   -1.761350 
 8          6           0       -2.031952    2.415855    1.648365 
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 9          6           0       -0.971691    1.456002    1.137521 
10          8           0        0.107935    1.355442    1.683008 
11          6           0       -2.165996   -0.620252    0.596942 
12          8           0       -3.348844   -0.831590    0.424899 
13          8           0       -1.385370   -1.328409    1.430106 
14          6           0       -1.997595   -2.445254    2.133882 
15          6           0       -1.963912   -3.713150    1.297078 
16          1           0       -3.019105   -2.168530    2.402059 
17          1           0       -1.398550   -2.545968    3.040588 
18          1           0       -2.582437   -3.609091    0.403136 
19          1           0       -2.351054   -4.548327    1.889366 
20          1           0       -0.941473   -3.952069    0.992252 
21          1           0        0.355876    1.386270   -2.167465 
22          6           0        2.897212    0.562773   -0.096525 
23          6           0        3.195576   -0.802853    0.022324 
24          1           0        2.906655   -1.492618   -0.762740 
25          6           0        3.858287   -1.295349    1.148758 
26          1           0        4.078848   -2.356649    1.220282 
27          6           0        4.242212   -0.430050    2.173995 
28          1           0        4.762857   -0.812883    3.046967 
29          6           0        3.954016    0.931757    2.067102 
30          1           0        4.248733    1.615825    2.857679 
31          6           0        3.287861    1.418044    0.942532 
32          1           0        3.063613    2.478525    0.867758 
33          1           0        2.448579    2.222079   -1.311333 
34          6           0        2.789212    0.609434   -2.649470 
35          1           0        2.618002   -0.460010   -2.777409 
36          1           0        3.866907    0.796078   -2.696500 
37          1           0        2.325148    1.127004   -3.496764 
38          6           0       -2.783075    3.156355    0.531003 
39          1           0       -1.546374    3.094825    2.354073 
40          1           0       -2.753686    1.813942    2.220853 
41          1           0       -4.110108    1.522621    0.033961 
42          1           0       -3.890468    2.682875   -1.272301 
43          1           0       -2.093348    3.837748    0.016308 
44          1           0       -3.570576    3.777258    0.971137 
45          9           0        0.840941   -1.789296   -2.036624 
46          9           0       -0.721747   -0.576925   -2.937936 
47          9           0       -1.210695   -2.011251   -1.380107 
48          6           0       -1.370063    0.533223   -0.061755 
49          1           0        0.542399   -0.454878    0.089021 
50          1           0       -1.625069    1.927755   -1.682227 
 --------------------------------------------------------------
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Chapter 11 
 
Synthesis of trifluoromethyl 2-imidazolines through Mannich-
type reactions with isocyano acetates 
General procedure for the synthesis of isocyano acetates (4-6). The methyl 
ester∙HCl salt (100 mmol) was added to a semisaturated Na2CO3 (aq) (100 mL) 
solution, and the mixture was extracted with DCM (4 × 100 mL). The organic 
layers were combined and dried over MgSO4. Removal of the solvent under 
reduced pressure allowed isolation of the corresponding methyl ester. Acetic 
formic anhydride (prepared by stirring 1 equiv of acetic anhydride and 1.1 equiv of 
formic acid for 2 h at 55 °C; 15 mL, 16.8 g, 110 mmol) was added dropwise at 0 °C 
to a stirred solution of the appropriate methyl ester (50 mmol) in DCM (135 mL), 
and the mixture was stirred for 2 h at room temperature. All volatiles were 
evaporated under reduced pressure, and the corresponding formamides 7-9 were 
isolated (68-95%). 
A solution of POCl3 (2.9 mL, 4.8 g, 31 mmol) in CH2Cl2 (20 mL) was added 
dropwise to a solution of a formamide (25 mmol) in Et3N (17 mL) and CH2Cl2 (60 
mL) at -25 °C. The reaction mixture was stirred for 5 h at the same temperature, 
and the resulting red mixture was added to cold H2O (60 mL) and extracted with 
Et2O (3 × 60 mL). The organic layers were combined, washed with H2O (2 × 50 
mL), dried (MgSO4), filtered, and concentrated in vacuo to yield the desired 
(racemic) isocyano acetates 4-6 (64-93%), which was sufficiently pure for follow-
up chemistry. 
The formamides 7-9 and the isocyano acetates 4-6 are known in literature.1 
                                                                 
1 Elders, N.; Schmitz, R. F.; Kanter, F. J. J.; Ruijter, E.; Groen, M. B.; Orru, R. V. A. J. Org. Chem. 2007, 72, 
6135-6142 
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Synthesis of trifluoromethyl imines (1a-f). The trifluoromethyl imines were 
synthesized following the procedures reported in the literature.2,3 1a-f are known 
compounds. 
General procedure for the Ag2O-Catalyzed Mannich-type reactions.  
Method A: To a mixture of trifluoromethyl aldimines 1a-c (0.18 mmol) and Ag2O 
(0.015 mmol), isocyano acetates 2 or 4 (0.15 mmol) was added. The reactions were 
performed under solvent-free conditions and stirred at room temperature (3-5 h, see 
Tables 1,2, Chap. 6 ). EtOAc was added to the mixture and the mixture filtered 
through a pad of celite. Then, the solvent was evaporated in vacuo and the residues 
purified by flash chromatography on silica gel (eluent hexane/ethyl acetate = 3:7). 
Method B: To a mixture of trifluoromethyl aldimines 1a-c (0.18 mmol) and Ag2O 
(0.018 mmol) in CH2Cl2, isocyano acetates (0.18 mmol) was added. The reactions 
were stirred at room temperature (see Tables 2,3, Chap.6 ). EtOAc was added to 
the mixture and the mixture filtered through a pad of celite. Then, the solvent was 
evaporated in vacuo and the residues purified by flash chromatography on silica gel 
(eluent hexane/ethyl acetate = 3:7). 
Methyl 1-benzyl-5-(trifluoromethyl)-4,5-dihydro-1H-
imidazole-4-carboxylate (trans-3a). 
Method A: colorless oil (44 mg, 85 %). 1H NMR (CDCl3): 
3.77 (s, 3H), 4.25−4.39 (m, 2H), 4.77 (d, J = 15.1 Hz, 1H), 7.20–7.43 (m, 6H). 19F 
NMR (CDCl3): –74.6 (d, J = 6.9 Hz). 13C NMR (CDCl3): 50.6, 52.9, 60.9 (q, J = 
31.9 Hz), 70.3, 124.8 (q, J = 280.3 Hz), 128.0 (2C), 128.4, 129.0 (2C), 134.5, 
157.4, 169.1. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C13H14F3N2O2 
287.1007, found 287.1068. 
                                                                 
2 See ref.17 in the Chapter 1. 
3 See ref.17 in the Chapter 2. 
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 Methyl 1-(4-methoxyphenyl)-5-(trifluoromethyl)-
4,5-dihydro-1H-imidazole-4-carboxylate (trans-3b). 
Method A: red oil (48 mg, 88 %). 1H NMR (CDCl3): 
3.79 (s, 3H), 3.85 (s, 3H), 4.87−4.99 (m, 2H), 6.88 (d, J 
= 9.0 Hz, 2H), 7.12 (d, J = 8.9 Hz, 2H), 7.20 (s, 1H). 19F NMR (CDCl3): –74.8 (d, J 
= 6.1 Hz). 13C NMR (CDCl3): 53.2, 55.5, 63.1 (q, J = 31.7 Hz), 70.3, 114.9 (2C), 
123.8 (2C), 124.4 (q, J = 281.2 Hz), 131.3, 155.5, 158.1, 170.0. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C13H14F3N2O3 303.0957, found 303.0905.  
Methyl 1-benzyl-4-methyl-5-(trifluoromethyl)-4,5-
dihydro-1H-imidazole-4-carboxylate (cis-7a, trans-7′a). 
Method A: yellow oil (32 mg, 26 %). 1H NMR (CDCl3): 
1.38 (s, 3H), 1.58 (s, 3H), 3.50 (q, J = 6.9 Hz, 1H), 3.70 (s, 3H), 3.73 (s, 3H), 4.19–
4.29 (m, 3H), 4.37 (d, J = 7.5 Hz, 1H), 4.56–4.64 (m, 1H), 6.93 (s, 1H), 7.09 (s, 
1H), 7.19–7.39 (m, 10H). 19F NMR (CDCl3): –69.3 (d, J = 7.3 Hz), –67.1 (d, J = 
8.5 Hz). 13C NMR (CDCl3): 19.7 (q, J =3.0 Hz, 2C), 50.6 (2C), 52.2, 52.7, 52.8, 
53.0, 62.8 (q, J = 30.4 Hz), 67.8 (q, J = 31.0 Hz), 124.3 (q, J = 282.0 Hz), 124.9 (q, 
J = 282.3 Hz), 128.1 (2C), 128.2 (2C), 128.3, 128.5, 128.9 (2C), 129.1 (2C), 134.5, 
134.7, 155.5, 156.2, 170.8, 173.0. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C14H16F3N2O2 301.1164, found 301.1189. 
Methyl 1-(4-methoxyphenyl)-4-methyl-5-
(trifluoromethyl)-4,5 dihydro-1H-imidazole-4-
carboxylate (cis-7b).  
Method A: red oil (15 mg, 26 %). Separated by flash 
chromatography on silica gel (eluent: hexane/ethyl acetate = 30:70). 1H NMR 
(CDCl3): 1.71 (s, 3H), 3.80 (s, 3H), 3.84 (s, 3H), 5.08 (q, J = 7.3 Hz, 1H), 6.89 (d, J 
= 8.9 Hz, 2H), 7.01 (s, 1H), 7.13 (d, J = 8.8 Hz, 2H). 19F NMR (CDCl3): –67.8 (d, J 
= 7.5 Hz). 13C NMR (CDCl3): 19.5 (q, J = 2.9 Hz), 53.3, 55.5, 60.3, 65.4 (q, J = 
30.2 Hz), 114.8 (2C), 124.5 (q, J = 281.2 Hz), 124.9 (2C), 131.7, 154.1, 158.3, 
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173.2. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C14H16F3N2O3 317.1113, 
found 317.1154. 
trans- 7′b: Method A: red oil (8 mg, 14 %). Separated by flash chromatography on 
silica gel (eluent: hexane/ethyl acetate = 30:70). 1H NMR (CDCl3): 1.68 (s, 3H), 
3.81 (s, 6H), 4.23 (q, J = 6.9 Hz, 1H), 6.90 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.9 Hz, 
2H), 7.17 (s, 1H). 19F NMR (CDCl3): –69.5 (d, J = 6.9 Hz). 13C NMR (CDCl3): 
27.6, 53.0, 55.5, 70.8 (q, J = 30.4 Hz), 76.0, 114.9 (2C), 123.8 (q, J = 282.3 Hz), 
124.1 (2C), 131.7, 153.9, 158.0, 170.7. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd 
for C14H16F3N2O3 317.1113, found 317.1137. 
 Methyl 1-benzyl-4-isobutyl-5-(trifluoromethyl)-4,5-
dihydro-1H-imidazole-4-carboxylate (cis-8a). 
Method B: colorless oil (12 mg, 19 %). Separated by 
HPLC (eluent: hexane/ethyl acetate = 70:30). 1H NMR 
(CDCl3): 0.86 (d, J = 6.6 Hz, 3H), 0.99 (d, J=6.6 Hz, 
3H), 1.72 (dd, J = 5.2, 13.9 Hz, 1H), 1.83–1.92 (m, 1H), 2.02 (dd, J = 5.7, 13.5 Hz, 
1H), 3.62 (s, 3H), 3.84 (q, J = 7.6 Hz, 1H), 4.21 (d, J = 15.2 Hz, 1H), 4.58 (d, J = 
15.2 Hz, 1H), 7.06 (s, 1H), 7.15 (d, J = 6.6, 2H), 7.28–7.37 (m, 3H). 19F NMR 
(CDCl3): –66.9 (d, J = 7.4 Hz). 13C NMR (CDCl3): 23.4, 24.5, 25.3, 41.3 (q, J = 2.5 
Hz), 50.6 (q, J = 1.4 Hz), 52.6, 64.6 (q, J = 30.0 Hz), 80.2, 124.8 (q, J = 283.7 Hz), 
128.0 (2C), 128.3, 128.9 (2C), 135.1, 155.7, 174.1. HR-MS (ESI Q-TOF) (m/z) [M 
+ H]+ calcd for C17H22F3N2O2 343.1633, found 343.1659.  
(trans-8′a): Method B: colorless oil (10 mg, 16%). Separated by HPLC (eluent: 
hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 0.81 (d, J=6.7 Hz, 3H), 0.83 (d, 
J=6.7 Hz, 3H), 1.19 (dd, J = 5.3, 13.5 Hz, 1H), 1.66–1.70 (m, 1H), 1.93 (dd, J = 
6.6, 13.6 Hz, 1H), 3.45 (q, J = 7.2 Hz, 1H), 3.74 (s, 3H), 4.21 (d, J = 15.1 Hz, 1H), 
4.61 (d, J = 15.0 Hz, 1H), 7.09 (s, 1H), 7.21 (d, J = 6.6, 2H), 7.29–7.45 (m, 3H). 
19F NMR (CDCl3): –69.2 (d, J = 6.7 Hz). 13C NMR (CDCl3): 23.1, 24.2, 24.6, 49.8, 
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50.9, 52.6, 67.4 (q, J = 30.4 Hz), 79.7, 124.5 (q, J = 283.2 Hz), 128.5 (3C), 129.0 
(2C), 134.6, 156.0, 170.8. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C17H22F3N2O2 343.1633, found 343.1602.  
Methyl 4-isobutyl-1-(4 methoxyphenyl)-5-
(trifluoromethyl)-4,5-dihydro-1H-imidazole-4-
carboxylate (cis-8b). Method B: brown oil (15 mg, 
23%). Separated by HPLC (eluent: hexane/ethyl acetate 
= 70:30). 1H NMR (CDCl3): 1H NMR (CDCl3): 0.92 (d, J=6.5 Hz, 3H), 1.04 (d, 
J=6.5 Hz, 3H), 1.83–1.85 (m, 1H), 1.89–2.00 (m, 1H), 2.11 (dd, J = 5.1, 13.3 Hz, 
1H), 3.80 (s, 3H), 3.82 (s, 3H), 4.67 (q, J = 7.1 Hz, 1H), 6.87 (d, J = 8.9 Hz, 2H), 
7.06 (d, J = 8.9 Hz, 2H), 7.16 (s, 1H). 19F NMR (CDCl3): –67.2 (d, J = 8.3 Hz). 13C 
NMR (CDCl3): 23.7, 24.5, 25.2, 41.5, 52.9, 55.5, 67.4 (q, J = 29.4 Hz), 80.3, 114.8 
(2C), 124.2 (2C), 124.3 (q, J = 284.9 Hz), 131.9, 153.6, 157.9, 174.2. HR-MS (ESI 
Q-TOF) (m/z) [M + H]+ calcd for C17H22F3N2O3 359.1583, found 359.1553.  
(trans-8′b): Method B: brown oil (10 mg, 15%). Separated by HPLC (eluent: 
hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 0.94 (d, J=6.7 Hz, 3H), 1.00 (d, 
J=6.7 Hz, 3H), 1.67 (dd, J = 5.1, 13.3 Hz, 1H), 1.90–1.99 (m, 1H), 2.21 (dd, J = 
13.4, 6.7 Hz, 1H), 3.81 (s, 6H), 4.20 (q, J = 7.3 Hz, 1H), 6.90 (d, J = 8.9 Hz, 2H), 
7.07 (d, J = 8.9 Hz, 2H), 7.20 (s, 1H). 19F NMR (CDCl3): –69.5 (d, J = 7.0 Hz). 13C 
NMR (CDCl3): 23.2, 24.5, 24.7, 50.2, 52.7, 55.5, 70.4 (q, J = 29.9 Hz), 79.6, 114.9 
(2C), 123.4 (2C), 123.4 (q, J = 284.3 Hz), 132.1, 153.3, 157.7, 170.7. HR-MS (ESI 
Q-TOF) (m/z) [M + H]+ calcd for C17H22F3N2O3 359.1583, found 359.1565 
 Methyl 1,4-dibenzyl-5-(trifluoromethyl) 4,5-dihydro-
1H-imidazole-4-carboxylate (cis-9a). Method B: yellow 
oil (12 mg, 17%). Separated by HPLC (eluent: hexane/ethyl 
acetate = 70:30). 1H NMR (CDCl3): 3.13 (d, J=13.1 Hz, 
1H), 3.34–3.37 (m, 4H), 4.13 (q, J = 7.5 Hz, 1H), 4.30 (d, J = 15.1 Hz, 1H), 4.75 
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(d, J = 15.2 Hz, 1H), 7.14–7.33 (m, 10H), 7.51 (s, 1H). 19F NMR (CDCl3): –67.3 
(d, J = 9.9 Hz). 13C NMR (CDCl3): 39.2, 51.0, 52.5, 64.2 (q, J = 30.5 Hz), 80.2, 
124.6 (q, J = 284.0 Hz), 127.1, 128.0 (2C), 128.1 (2C), 128.4, 129.0 (2C), 130.4 
(2C), 134.6, 135.2, 156.6, 172.6. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C20H20F3N2O2 377.1477, found 377.1405.  
trans-9′a: Method B: yellow oil (12 mg, 17%). Separated by HPLC (eluent: 
hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 3.09 (d, J = 13.7 Hz, 1H), 3.33 
(d, J=13.4 Hz, 1H), 3.78 (s, 3H), 4.04 (q, J = 7.6 Hz, 1H), 4.32 (d, J = 15.0 Hz, 
1H), 4.63 (d, J = 15.1 Hz, 1H), 6.91 (s, 1H), 7.13–7.39 (m, 10H). 19F NMR 
(CDCl3): –68.5 (d, J = 9.9 Hz). 13C NMR (CDCl3): 38.8, 51.4, 52.9, 64.6 (q, J = 
30.8 Hz), 78.8, 124.2 (q, J = 284.2 Hz), 127.4, 128.2 (2C), 128.4 (2C), 128.7, 129.1 
(2C), 130.3 (2C), 133.9, 134.3, 157.7, 171.8. HR-MS (ESI Q-TOF) (m/z) [M + H]+ 
calcd for C20H20F3N2O2 377.1477, found 377.1428. 
Methyl 4-benzyl-1-(4-methoxyphenyl)-5-
(trifluoromethyl)-4,5-dihydro-1H-imidazole-4-
carboxylate (cis-9b). Method B: brown oil (14 mg, 
19%). Separated by HPLC (eluent: hexane/ethyl acetate = 
70:30). 1H NMR (CDCl3): 3.26 (d, J=12.6 Hz, 1H), 3.45 (d, J=13.2 Hz, 1H), 3.52 
(s, 3H), 3.80 (s, 3H), 4.93 (br, 1H), 6.89 (d, J = 8.7 Hz, 2H), 7.10 (d, J = 8.7 Hz, 
2H), 7.22–7.35 (m, 6H). 19F NMR (CDCl3): –67.4 (d, J = 7.5 Hz). 13C NMR 
(CDCl3): 39.5, 52.7, 55.5, 66.8 (br), 80.9, 114.8 (2C), 124.0 (2C), 124.3 (q, J = 
286.0 Hz), 127.1, 128.2 (2C), 130.3 (2C), 131.5, 135.5, 153.7, 158.0 173.2. HR-
MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C20H20F3N2O3 393.1426, found 
393.1432.  
(trans-9′b): Method B: brown oil (10 mg, 14%). Separated by HPLC (eluent: 
hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 3.34 (d, J=13.9 Hz, 1H), 3.46 (d, 
J=13.7 Hz, 1H), 3.73 (s, 3H), 3.85 (s, 3H), 4.39 (q, J = 6.8 Hz, 1H), 6.40 (d, J = 8.8 
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Hz, 2H), 6.69 (d, J = 8.9 Hz, 2H), 7.22–7.33(m, 6H). 19F NMR (CDCl3): –68.7 (d, 
J = 7.0 Hz). 13C NMR (CDCl3): 44.2, 53.2, 55.4, 67.6 (q, J=30.8 Hz,), 79.1, 114.5 
(2C), 123.8 (q, J = 287.7 Hz), 125.2 (2C), 127.5, 128.5 (2C), 131.3 (2C), 130.0, 
134.4, 155.3, 158.4 170.2. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C20H20F3N2O3 393.1426, found 393.1468.   
 Methyl (4S,5S)-1-[(R)-1-phenylethyl]-5-(trifluoromethyl)-
4,5-dihydro-1H-imidazole-4-carboxylate (10). Method A: 
colorless oil (17 mg, 38 %). Separated by HPLC (eluent: 
hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 1.62 (d, J = 
6.9 Hz, 3H), 3.82 (s, 3H), 4.48−4.62 (m, 1H), 4.69 (q, J = 6.8 Hz, 1H), 4.78 (d, J = 
5.6 Hz, 1H), 6.91 (s, 1H), 7.30–7.48 (m, 5H). 19F NMR (CDCl3): –75.0 (d, J = 7.7 
Hz). 13C NMR (CDCl3): 18.4, 53.3, 56.2, 61.7 (q, J = 31.5 Hz), 68.9, 124.6 (q, J = 
280.7 Hz), 127.2 (2C), 128.6, 129.1 (2C), 138.5, 156.4, 169.5. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C14H16F3N2O2 301.1164, found 301.1103. 
 
 Methyl (4R,5R)-1-[(R)-1-phenylethyl]-5-
(trifluoromethyl)-4,5-dihydro-1H-imidazole-4-
carboxylate (10′). Method A: colorless oil (11 mg, 24 
%). Separated by HPLC (eluent: hexane/ethyl acetate = 70:30). 1H NMR (CDCl3): 
1.71 (d, J = 7.0 Hz, 3H), 3.72 (s, 3H), 4.03−4.16 (m, 1H), 4.57 (q, J = 6.8 Hz, 1H), 
4.73 (d, J = 5.9 Hz, 1H), 7.15–7.39 (m, 6H). 19F NMR (CDCl3): –75.1 (d, J = 7.5 
Hz). 13C NMR (CDCl3): 22.1, 52.9, 56.8, 61.3 (q, J = 34.5 Hz), 69.8, 124.5 (q, J = 
280.4 Hz), 126.2 (2C), 128.4, 129.1 (2C), 137.7, 154.5, 160.5. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C14H16F3N2O2 301.1164, found 301.1153. 
150 
 
2D NMR spectra and optimized geometries to determine the absolute 
configuration of the new chiral centers. 
 
1. To determine the absolute configuration of the new chiral centers 2D NOESY 
NMR spectra and optimized geometries of the 2-imidazolines trans-10 and trans-
10′ were considered. 
ppm (t2)
1.02.03.04.05.06.07.0
0.0
5.0
ppm (t1)
10.005.06
 
Figure 1. 2D NOESY spectrum of trans-10. 
 
Figure 2. 2D NOESY spectrum of trans-10′ 
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The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Ha and the protons Hc of the methyl group 
can be easily determinate for 10, the value is 5.06 a.u. (corresponding to an interproton 
distance of 2.99 Å). The NOESY spectrum of 10′ did not show the correlation between Ha 
and Hc  
                
 
 
Figure 3. Optimized geometries of (R,S,S)-10 and (R,R,R)-10′. 
(R,S,S) 
---------------------------------------------------------------- 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
---------------------------------------------------------------- 
 1          1           0       -1.140000   -4.367000   -3.224000  
 2          1           0       -2.572000   -1.001000    0.074000  
 3          6           0       -0.407000   -3.878000   -2.574000  
 4          1           0        0.589000   -4.027000   -3.000000  
 5          7           0       -4.081000   -0.060000   -1.064000  
 6          6           0       -4.240000   -0.082000   -2.336000  
 7          8           0       -2.743000   -2.906000   -1.636000  
 8          6           0       -1.880000   -2.137000   -2.046000  
 9          7           0       -3.176000   -0.322000   -3.029000  
10          8           0       -0.656000   -2.470000   -2.510000  
11          6           0       -2.652000   -0.234000   -0.703000  
12          1           0       -0.428000   -4.313000   -1.571000  
13          6           0       -5.155000    0.088000   -0.042000  
14          6           0       -2.092000   -0.634000   -2.055000  
15          9           0       -2.598000    1.440000    0.941000  
16          6           0       -2.055000    1.073000   -0.239000  
17          1           0       -1.165000   -0.116000   -2.322000  
18          9           0       -0.726000    0.958000   -0.067000  
19          9           0       -2.288000    2.063000   -1.122000  
20          1           0       -4.660000    0.317000    0.909000  
21          6           0       -5.836000   -1.272000    0.133000  
22          6           0       -6.065000    1.237000   -0.386000  
23          6           0       -5.613000    2.608000   -0.144000  
Hc/Ha : 3.590 Å 
 (R,S,S) 
possible diastereomer trans-10 
 
Hc/Ha : 4.308 Å 
 (R,R,R) 
possible diastereomer trans-10′ 
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24          6           0       -6.266000    3.738000   -0.792000  
25          6           0       -7.370000    3.557000   -1.541000  
26          6           0       -7.936000    2.228000   -1.718000  
27          6           0       -7.326000    1.064000   -1.097000  
28          1           0       -4.880000    2.827000    0.627000  
29          1           0       -5.860000    4.733000   -0.629000  
30          1           0       -7.881000    4.398000   -2.002000  
31          1           0       -8.925000    2.141000   -2.159000  
32          1           0       -7.937000    0.176000   -0.976000  
33          1           0       -6.628000   -1.217000    0.888000  
34          1           0       -6.279000   -1.641000   -0.799000  
35          1           0       -5.115000   -2.028000    0.468000  
36          1           0       -5.225000    0.101000   -2.794000  
 
(R,R,R) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
---------------------------------------------------------------- 
 1         1           0       -1.140000   -4.367000   -3.224000  
 1         1           0       -2.258000    0.060000   -0.121000  
 2         6           0       -1.658000    0.071000   -2.673000  
 3         1           0       -5.293000    4.448000   -1.995000  
 4         1           0       -4.090000    2.621000   -0.871000  
 5         6           0       -2.730000   -0.816000   -0.579000  
 6         6           0       -2.274000   -1.145000   -1.990000  
 7         6           0       -2.600000   -2.007000    0.329000  
 8         6           0       -5.864000    3.571000   -1.704000 
 9         6           0       -5.168000    2.520000   -0.973000  
10         1           0       -4.393000    0.655000    0.823000  
11         7           0       -3.523000   -1.522000   -2.718000  
12         7           0       -4.159000   -0.532000   -0.868000  
13         1           0       -7.678000    4.210000   -2.597000  
14         6           0       -7.160000    3.436000   -2.040000  
15         6           0       -4.465000   -0.949000   -2.041000  
16         6           0       -5.046000    0.182000    0.078000  
17         6           0       -5.841000    1.275000   -0.601000  
18         1           0       -5.505000   -0.896000   -2.397000  
19         1           0       -5.294000   -1.553000    1.392000  
20         6           0       -7.895000    2.238000   -1.670000  
21         6           0       -7.254000    1.153000   -0.948000  
22         6           0       -5.906000   -0.853000    0.816000  
23         1           0       -6.582000   -0.363000    1.526000  
24         1           0       -6.511000   -1.456000    0.128000  
25         1           0       -8.955000    2.184000   -1.891000  
26         1           0       -7.881000    0.349000   -0.583000  
27         9           0       -3.396000   -3.032000   -0.053000  
28         9           0       -2.986000   -1.667000    1.585000  
29         9           0       -1.338000   -2.466000    0.416000  
30         8           0       -2.243000    1.166000   -2.457000  
31         8           0       -0.515000   -0.243000   -3.382000  
32         6           0        0.014000    0.852000   -4.128000  
33         1           0        0.338000    1.661000   -3.465000  
34         1           0        0.892000    0.491000   -4.672000  
35         1           0       -0.711000    1.215000   -4.865000  
36         1           0       -1.570000   -1.986000   -2.013000  
---------------------------------------------------------------- 
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Methyl (4S,5S)-1-[(S)-1-methoxy-3-methyl-1-oxobutan-
2-yl]-5-(trifluoromethyl)-4,5-dihydro-1H-imidazole-4-
carboxylate (18). Method B: colorless oil (22 mg, 39 %). 
[α]D = 22.6 (c = 1 g/100 mL, CHCl3). 1H NMR (CDCl3): 
1.00 (d, J = 6.6 Hz, 3H), 1.09 (d, J = 6.6 Hz, 3H), 2.20−2.29 (m, 1H), 3.52 (d, J = 
10.4 Hz, 1H), 3.75 (s, 3H), 3.81 (s, 3H), 4.29–4.35 (m, 1H), 4.70 (dd, J = 1.97, 6.5 
Hz, 1H), 7.14 (s, 1H) 19F NMR (CDCl3): –75.3 (d, J = 6.4 Hz). 13C NMR (CDCl3): 
19.2, 19.6, 29.8, 52.4, 53.4, 62.7 (q, J = 31.8 Hz), 67.3, 69.9, 124.8 (q, J = 279.9 
Hz), 154.7, 169.9, 171.1. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for 
C12H18F3N2O4 311.1219, found 311.1274. 
Methyl (4S,5S)-1-[(S)-1-methoxy-4-methyl-1-
oxopentan-2-yl]-5-(trifluoromethyl)-4,5-dihydro-1H-
imidazole-4-carboxylate (19). Method B: colorless oil 
(14 mg, 30 %). [α]D = 31.3 (c = 2 g/100 mL, CHCl3). 
1H NMR (CDCl3): 0.96 (d, J = 6.1 Hz, 3H), 0.99 (d, J = 
6.2 Hz, 3H), 1.74−1.88 (m, 3H), 3.73 (s, 3H), 3.84 (s, 3H), 4.03 (dd, J = 10.3, 5.0 
Hz, 1H), 4.38 (p, J = 6.6 Hz, 1H), 4.74 (dd, J = 6.9, 1.9 Hz, 1H), 7.07 (s, 1H) 19F 
NMR (CDCl3): –75.2 (d, J = 6.7 Hz). 13C NMR (CDCl3): 21.0, 22.8, 24.5, 39.5, 
52.8, 53.3, 58.5, 62.8 (q, J = 31.5 Hz), 68.8, 124.6 (q, J = 279.6 Hz), 155.3, 169.3, 
171.6. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C13H20F3N2O4 325.1375, 
found 325.1342. 
Methyl (4S,5S)-1-[(S)-1-methoxy-1-oxo-3-
phenylpropan-2-yl]-5-(trifluoromethyl)-4,5-dihydro-
1H-imidazole-4-carboxylate (20). Method B: colorless 
oil (18 mg, 28 %). [α]D = 19.3 (c = 1 g/100 mL, CHCl3). 
1H NMR (CDCl3): 3.10 (dd, J = 8.6, 14.2 Hz, 1H), 3.31 (d, J = 6.6, 14.2 Hz, 1H), 
3.67 (s, 3H), 3.76 (s, 3H), 4.20 (dd, J = 6.7, 8.6 Hz, 1H), 4.33 (p, J = 6.5 Hz, 1H), 
4.61 (dd, J = 2.0, 6.7 Hz, 1H), 6.98 (s, 1H), 7.12–7.28 (m, 5H). 19F NMR (CDCl3): 
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–75.6 (d, J = 7.5 Hz). 13C NMR (CDCl3): 37.2, 52.7, 53.1, 58.6, 62.6 (q, J = 31.6 
Hz), 70.1, 124.6 (q, J = 279.9 Hz), 127.3, 128.7 (2C), 128.9 (2C), 135.5, 154.3, 
169.9, 170.8. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C16H18F3N2O4 
359.1219, found 359.1258. 
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2D NMR spectra and optimized geometries to determine the absolute 
configuration of the new chiral centers. 
 
1. To determine the absolute configuration of the new chiral centers 2D NOESY NMR 
spectra and optimized geometries of the 2-imidazoline and 20 was considered. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its 
volume was set to 10.00 a.u.; the cross peak between Ha and the protons Hb can be 
easily determinate for 20, the value is 3.19 a.u. (corresponding to an interproton 
distance of 3.38 Å). 
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Figure 4. 2D NOESY spectrum of 20. 
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Figure 5. Optimized geometries of obtained (S,S,S)-20 and of its possible diastereomer (S,R,R). 
(S,R,R) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 1         1           0       -1.140000   -4.367000   -3.224000  
 1         7           0       -3.219000    1.078000   -0.121000  
 2         6           0       -3.408000   -0.277000   -0.690000  
 3         6           0       -2.022000    0.978000    0.661000  
 4         7           0       -1.248000   -0.066000    0.343000  
 5         6           0       -1.942000   -0.776000   -0.744000  
 6         6           0       -1.868000   -2.293000   -0.623000  
 7         8           0       -2.870000   -3.008000   -0.576000  
 8         8           0       -0.643000   -2.887000   -0.668000  
 9         6           0        0.565000   -2.121000   -0.747000  
10         6           0       -4.305000    1.813000    0.562000  
11         6           0       -4.390000    3.289000    0.066000  
12         6           0       -5.690000    1.138000    0.461000  
13         8           0       -6.024000    0.133000    1.081000  
14         8           0       -6.531000    1.801000   -0.390000  
15         6           0       -7.809000    1.189000   -0.554000  
16         6           0       -4.038000   -0.355000   -2.094000  
17         1           0       -1.516000   -0.508000   -1.722000  
18         1           0        0.517000   -1.352000   -1.522000  
19         1           0        1.368000   -2.810000   -1.025000  
20         1           0        0.816000   -1.706000    0.232000  
21         1           0       -8.393000    1.810000   -1.239000  
22         1           0       -8.339000    1.141000    0.402000  
23         1           0       -7.707000    0.192000   -0.993000  
24         9           0       -5.349000   -0.001000   -2.080000  
25         9           0       -3.433000    0.466000   -2.991000  
26         9           0       -3.995000   -1.600000   -2.629000  
27         1           0       -3.985000   -0.902000    0.004000  
28         6           0       -3.201000    4.191000    0.285000  
29         6           0       -3.061000    4.958000    1.553000  
30         6           0       -2.042000    4.123000   -0.655000  
31         1           0       -4.122000    1.851000    1.647000 
32         1           0       -4.623000    3.300000   -1.007000  
33         1           0       -5.252000    3.768000    0.551000  
34         1           0       -4.028000    5.357000    1.877000  
35         1           0       -2.387000    5.811000    1.417000  
36         1           0       -2.660000    4.323000    2.348000  
37         1           0       -2.266000    3.505000   -1.529000  
Hb/Ha : 3.21 Å 
 (S,R,R ) 
possible diastereomer 20 
 
Hb/Ha: 3.646 Å 
(S,S,S) 
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38        1           0       -1.161000    3.709000   -0.156000  
39        1           0       -1.794000    5.126000   -1.016000  
40        1           0       -3.713211    4.995265   -0.200486  
41        1           0       -1.778613    1.651815    1.403805  
 
(S,S,S) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 1         7           0       -3.968970    0.886210   -1.132160  
 1         7           0       -3.658000    1.157000   -0.838000 
 2         6           0       -3.698000   -0.336000   -0.644000  
 3         6           0       -2.347000    1.461000   -1.3100000  
 4         7           0       -1.569000    0.396000   -1.539000  
 5         6           0       -2.232000   -0.774000   -0.899000  
 6         1           0       -1.752000   -0.917000    0.0850000  
 7         6           0       -4.281000    2.059000    0.143000  
 8         6           0       -4.062000    3.568000   -0.167000  
 9         6           0       -4.709000    4.574000    0.815000  
10         6           0       -4.437000    6.005000    0.338000  
11         6           0       -4.197000    4.404000    2.246000  
12         6           0       -5.805000    1.840000    0.207000  
13         8           0       -6.471000    1.978000    1.233000  
14         8           0       -6.354000    1.585000   -1.016000  
15         6           0       -7.735000    1.248000   -0.980000  
16         1           0       -4.362000   -0.693000   -1.441000  
17         6           0       -1.974000   -2.095000   -1.676000  
18         1           0       -3.865000    1.839000    1.132000  
19         1           0       -4.436000    3.782000   -1.177000  
20         1           0       -2.987000    3.787000   -0.173000  
21         1           0       -5.797000    4.440000    0.816000  
22         1           0       -4.922000    6.733000    0.997000  
23         1           0       -4.830000    6.159000   -0.673000  
24         1           0       -3.364000    6.223000    0.323000 
25         1           0       -4.622000    5.171000    2.903000  
26         1           0       -3.106000    4.491000    2.289000  
27         1           0       -4.478000    3.432000    2.660000  
28         1           0       -8.040000    0.956000   -1.989000  
29         1           0       -8.331000    2.114000   -0.676000  
30         1           0       -7.913000    0.401000   -0.310000  
31         6           0       -4.203000   -0.960000    0.671000  
32         9           0       -3.617000   -0.411000    1.775000  
33         9           0       -5.543000   -0.721000    0.829000  
34         9           0       -4.073000   -2.298000    0.802000  
35         8           0       -2.991000   -2.739000   -2.057000  
36         8           0       -0.699000   -2.627000   -1.498000  
37         6           0        0.249000   -1.902000   -2.268000  
38         1           0        1.095000   -2.570000   -2.463000  
39         1           0        0.637000   -1.052000   -1.700000  
40         1           0       -0.145000   -1.582000   -3.240000  
41         1           0       -2.022708    2.428644   -1.463375  
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Chapter 12 
 
Reactivity of trifluoromethyl aldimines in the aza-
Reformatsky reaction 
All experiments were carried out under nitrogen atmosphere in flame-dried 
glassware using standard inert techniques for introducing reagents and solvents 
unless otherwise noted.  
Synthesis of trifluoromethyl imines (1a,c,g). The trifluoromethyl imines were 
synthesized following the procedures reported in the literature.1,2 1a,c and 1g are 
known compounds. 
Activation Zinc dust. Zinc dust was activated by stirring with dilute HCl during 
10-15 min, and then washed several times with distilled H2O, EtOH and absolute 
Et2O before rigorous drying. This procedure removes oxides from the surface of 
zinc, which form slowly upon standing in air.  
Preparation of the solution of Reformatsky reagent.Under N2 atmosphere, to a 
two-neck round bottom flask were added the above activated zinc (3 mmol) and 
dry THF (4 mL). The suspension was warmed to 40−50 °C, and methyl 
bromoacetate (2a, 3 mmol) in THF (1 mL) was added dropwise. After insoluble 
matter precipitated, the light yellow supernatant solution was decanted and used for 
subsequent experiments.  
General procedure for the zinc promoted aza-Reformatsky reaction.  
Method A (two-step protocol): to a solution of trifluoromethyl aldimines (1a,c 0.5 
mmol) in THF (1 mL) warmed to 40 °C, the above methyl bromozincacetate/THF 
                                                                 
1 See ref.17 in the Chapter 1. 
2 See ref.54 in the Chapter 2. 
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solution was added. The resulting mixture was stirred at the same temperature for 
18 h. The mixture was quenched with saturated aqueous NH4Cl, and then extracted 
with AcOEt. The organic layer was concentrated in vacuo to give the crude oil. The 
residues purified by flash chromatography on silica gel (eluent hexane/ethyl acetate 
= 80:20). 
Method B (one-pot protocol): Under N2 atmosphere, to a two-neck round bottom 
flask the above activated zinc (3 mmol), dry THF (4 mL), the trifluoromethyl 
aldimines 1a,c or 1g (0.5 mmol) and α-bromo esters (2b-c) were added. The 
suspensions were warmed to 40-60 °C. The resulting mixtures were stirred at same 
temperature for the reaction time shown in Table 2-3 and 8 (Chap. 7). The mixture 
was quenched with saturated aqueous NH4Cl, and then extracted with AcOEt. The 
organic layer was concentrated in vacuo to give the crude mixture. The residues 
purified by flash chromatography on silica gel (eluent hexane/ethyl acetate = 
80:20). 
1-Benzyl-4-(trifluoromethyl)azetidin-2-one (3).  
Method A: colorless oil (90 mg, 79 %). IR: 1788, 1200. 1H NMR 
(CDCl3): 2.92−3.07 (m, 2H), 3.70–3.78 (m, 1H), 3.92 (d, J = 15.1 
Hz, 1H), 4.75 (d, J = 15.1 Hz, 1H), 7.35–7.14 (m, 5H). 19F NMR 
(CDCl3): –74.9 (d, J = 5.9 Hz). 13C NMR (CDCl3): 38.5 (q, J = 1.8 Hz), 45.7, 49.6 
(q, J = 35.0 Hz), 124.4 (q, J = 279.3 Hz), 128.1, 128.4 (2C), 128.9 (2C), 134.5, 
165.1. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C11H11F3NO 230.0793, 
found 230.0785. 
1-Benzyl-3-methyl-4-(trifluoromethyl)azetidin-2-one (trans-4). 
Method B: colorless oil (85 mg, 70 %). IR: 1782. 1H NMR 
(CDCl3): 1.31 (d, J = 7.4 Hz, 3H), 3.30 (qd, J= 7.8, 1.9 Hz, 1H), 
3.39 (qd, J = 6.0, 2.2 Hz, 1H), 3.95 (d, J = 15.1 Hz, 1H), 4.85 (d, J = 15.2 Hz, 1H), 
7.24–7.42 (m, 5H). 19F NMR (CDCl3): –74.1 (d, J = 5.8 Hz). 13C NMR (CDCl3): 
12.3, 45.4, 46.9 (q, J = 1.8 Hz), 57.2 (q, J = 34.2 Hz), 124.4 (q, J = 279.3 Hz), 
161 
 
128.1, 128.4 (2C), 129.0 (2C), 134.8, 169.1. HR-MS (ESI Q-TOF) (m/z) [M + H]+ 
calcd for C12H13F3NO 244.0949, found 244.0953. 
1-Benzyl-3-phenyl-4-(trifluoromethyl)azetidin-2-one (trans-
5).  Method B: colorless oil (126 mg, 83 %). IR: 1780. 1H 
NMR (CDCl3): 3.80 (qd, J = 5.9, 2.4, 1H), 4.05 (d, J = 15.1 Hz, 
1H), 4.46 (J = 2.1 Hz, 1H), 4.98 (d, J = 15.0 Hz, 1H), 7.14–
7.42 (m, 10H). 19F NMR (CDCl3): –73.8 (d, J = 6.5 Hz). 13C NMR (CDCl3): 45.7, 
56.3, 57.9 (q, J = 34.0 Hz), 124.3 (q, J = 279.9 Hz), 127.2 (2C), 128.3 (2C), 128.5 
(2C), 129.0 (2C), 129.1 (2C), 132.6, 134.6, 166.5. HR-MS (ESI Q-TOF) (m/z) [M 
+ H]+ calcd for C17H15F3NO 306.1106, found 306.1153. 
(R)-1-[(R)-1-Phenylethyl]-4-(trifluoromethyl)azetidin-2-one 
(7). Method A: colorless oil (38 mg, 31 %) Separated by HPLC 
(eluent: hexane/ethyl acetate = 90:10). IR: 1775. [α]D = 43.8 (c = 
4 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.82 (d, J = 7.2 Hz, 
3H), 3.01 (m, 2H), 3.71–3.87 (m, 1H), 4.51 (q, J = 7.1 Hz, 1H), 7.28–7.39 (m, 5H). 
19F NMR (CDCl3): –74.8 (d, J = 7.5 Hz). 13C NMR (CDCl3): 19.7, 37.9, 49.4 (q, J 
= 34.9 Hz), 56.0, 124.5 (q, J = 279.6 Hz), 126.6 (2C), 128.0, 128.9 (2C), 135.8, 
165.3. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C12H13F3NO 244.0949 found 
244.0955. 
(S)-1-[(R)-1-Phenylethyl]-4-(trifluoromethyl)azetidin-2-one 
(7′). Method A: colorless oil (40 mg, 33 %) Separated by HPLC 
(eluent: hexane/ethyl acetate = 90:10). IR: 1778. [α]D: 28.2 (c = 
4 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.62 (d, J = 7.3 Hz, 
3H), 2.92–3.09 (m, 1H), 3.68–3.73 (m, 1H), 5.06 (q, J = 7.3 Hz, 1H), 7.31–7.41 
(m, 5H). 19F NMR (CDCl3): –74.8 (d, J = 5.4 Hz). 13C NMR (CDCl3): 18.0, 38.1, 
49.7 (q, J = 35.7 Hz ), 52.1, 124.3 (q, J = 279.0 Hz), 127.2, 128.1 (2C), 128.9 (2C), 
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138.6, 165.3. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C12H13F3NO 
244.0949, found 244.0951. 
 (3S,4R)-3-Methyl-1-[(R)-1-phenylethyl]-4-
(trifluoromethyl)azetidin-2-one (trans-8). Method B: colorless 
oil (43 mg, 33 %). Separated by HPLC (eluent: hexane/ethyl 
acetate = 90:10). IR: 1780. [α]D = 30.1 (c = 3 g/100 mL, CHCl3). 
1H NMR (CDCl3): 1.30 (d, J = 7.4 Hz, 3H), 1.82 (d, J = 7.2 Hz, 3H), 3.20 (qd, 
J=7.4, 2.1 Hz, 1H), 3.36 (qd, J=6.0, 2.2 Hz, 1H), 4.48 (q, J=7.2 Hz, 1H), 7.27–7.41 
(m, 5H). 19F NMR (CDCl3): –74.1 (d, J= 6.4 Hz). 13C NMR (CDCl3): 12.4, 19.9, 
46.0, 55.8, 57.0 (q, J=34.0 Hz ), 124.4 (q, J=279.4 Hz), 126.5 (2C), 127.9, 128.9 
(2C), 140.9, 169.3. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C13H15F3NO 
258.1106, found 258.1115. 
(3R,4S)-3-Methyl-1-[(R)-1-phenylethyl]-4 
(trifluoromethyl)azetidin-2-one (trans-8′).  
Method B: colorless oil (40 mg, 31 %). Separated by HPLC 
(eluent: hexane/ethyl acetate = 90:10). IR: 1779. [α]D = 38.3 (c = 
3 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.25 (d, J = 7.3 Hz, 3H), 1.60 (d, J = 7.4 
Hz, 3H), 3.16–3.28 (m, 2H), 5.10 (q, J = 7.4 Hz, 1H), 7.30–7.41 (m, 5H). 19F NMR 
(CDCl3): –74.1 (d, J = 6.0 Hz). 13C NMR (CDCl3): 12.2, 17.6, 46.3, 51.3, 57.2 (q, J 
= 34.7 Hz ), 124.3 (q, J = 279.1 Hz), 127.2 (2C), 128.1, 128.9 (2C), 138.5, 169.3 
HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C13H15F3NO 258.1106, found 
258.1130. 
 (3S,4R)-3-Phenyl-1-[(R)-1-phenylethyl]-4-
(trifluoromethyl)azetidin-2-one (trans-9). Method B 
colorless oil (40 mg, 25 %). Separated by HPLC (eluent: 
hexane/ethyl acetate = 90:10). IR: 1779, 1500. [α]D: 38.3 (c = 
3 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.89 (d, J = 7.2 Hz, 3H), 3.77 (qd, J = 5.9, 
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2.4 Hz, 1H), 4.36 (d, J = 2.4 Hz, 1H), 4.59 (q, J = 7.1 Hz, 1H), 7.15–7.52 (m, 10H). 
19F NMR (CDCl3): –73.7 (d, J = 5.9 Hz). 13C NMR (CDCl3): 19.8, 55.5 (q, J = 1.7 
Hz), 56.1, 57.7 (q, J = 33.9 Hz), 124.3 (q, J = 280.01 Hz), 126.7 (2C), 127.3 (2C), 
128.1, 128.2, 128.9 (2C), 129.1 (2C), 132.9, 140.7, 166.6. HR-MS (ESI Q-TOF) 
(m/z) [M + H]+ calcd for C18H17F3NO 320.1262, found 320.1280. 
(3R,4S)-3-Phenyl-1-[(R)-1-phenylethyl]-4-
(trifluoromethyl)azetidin-2-one (trans-9′). Method B: 
colorless oil (59 mg, 37 %). Separated by HPLC (eluent: 
hexane/ethyl acetate = 90:10). IR: 1779, 1500. [α]D = 19.5 (c = 
3 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.68 (d, J = 7.2 Hz, 3H), 3.69 (qd, J = 5.8, 
2.4 Hz, 1H), 4.33 (d, J = 2.4 Hz, 1H), 5.20 (q, J = 7.2 Hz, 1H), 7.15–7.39 (m, 10H). 
19F NMR (CDCl3): –73.7 (d, J = 5.9 Hz). 13C NMR (CDCl3): 17.8, 52.0, 55.8 (q, J 
= 1.77 Hz), 58.0 (q, J = 34.5 Hz), 124.2 (q, J = 279.4 Hz), 127.3 (4C), 128.2 (2C), 
128.9 (2C), 129.1 (2C), 132.8, 138.5, 166.6. HR-MS (ESI Q-TOF) (m/z) [M + H]+ 
calcd for C18H17F3NO 320.1262, found 320.1235.  
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2D NMR spectra and optimized geometries to determine the absolute configuration of 
the new chiral centers. 
1. To determine the absolute configuration of the new chiral centers 2D NOESY NMR 
spectra and optimized geometries of the β-lactams 8 and 8′ were considered. 
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Figure 1. 2D NOESY NMR spectrum of 8. 
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Figure 2. 2D NOESY NMR spectrum of 8′. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Ha and the protons Hc of the methyl group 
can be easily determinate for 8, the value is 1.33 a.u. (corresponding to an interproton 
distance of 3.73 Å). The NOESY spectrum of 8′ did not show the correlation between Ha 
and Hc. The same correlation value (5.99 a.u. corresponding to an interproton distance of 
2.90 Å) was found for the cross peak between Ha and the protons Hd of the methyl group in 
the NOESY spectra of 8 and 8′.3 
                                                                 
3 The 2D NOESY 1H NMR analysis permit to determinate the relative interproton distances and thus 
molecular geometry, by the following equation:  
VR
VX
dX
dR
6
=
 
in which VR is the volume of the reference cross peak, dR is the corresponding interproton distance and VX is the 
volume relative to the unknown distance dX.. As suggested by the equation, if the protons are too far apart do 
not generate a NOESY correlation. 
  
Ha−Hd 
Hb−Hc 
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Figure 3. Optimized geometries. 
By NOESY analysis coupled with computational studies, the (R,R,S) absolute 
configurations can be assigned to trans-8, and the (R,S,R) to trans-8′. 
Calculated Coordinates: 
(R,R,R) 
Center        Atomic      Atomic          Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
----------------------------------------------------------------- 
 1          6           0       -0.030770    0.044215    0.016045 
 2          7           0        0.050861   -0.112647    1.480246 
 3          6           0        1.414475    0.115317    1.535185 
 4          6           0        1.492488    0.417950    0.033493 
 5          8           0        2.206231    0.014185    2.449538 
 6          6           0        1.952799    1.822866   -0.358470 
 7          1           0        2.080738   -0.336511   -0.493770 
 8          1           0       -0.238063   -0.878839   -0.537118 
 9          6           0       -1.016806    1.083784   -0.492209 
10          6           0       -0.727092   -0.888853    2.471065 
11          6           0       -1.023381   -0.032013    3.696199 
12          6           0       -0.747454   -0.520739    4.975982 
13          1           0       -0.283746   -1.497887    5.086563 
14          6           0       -1.060909    0.234255    6.108360 
15          1           0       -0.838996   -0.158893    7.096141 
16          6           0       -1.649838    1.491348    5.969295 
17          1           0       -1.891049    2.081565    6.848118 
Hc/Ha : 3.084 Å 
Ha/Hd : 3.117 Å 
(R,R,S) 
possible diastereomer trans-8 
 
Hc/Ha : 3.564 Å 
Ha/Hd : 3.102 Å 
(R,S,R) 
possible diastereomer trans-8′ 
 
Hc/Ha : 3.200 Å 
Ha/Hd : 4.030 Å 
(R,R,R) 
Hc/ Ha: 3.515 Å 
Ha/Hd : 3.879 Å 
(R,S,S) 
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18          6           0       -1.919493    1.991736    4.691728 
19          1           0       -2.368084    2.974164    4.575472 
20          6           0       -1.608736    1.235263    3.563105 
21          1           0       -1.793014    1.639930    2.572501 
22          1           0       -0.079694   -1.715513    2.787095 
23          6           0       -1.998635   -1.478539    1.852358 
24          1           0       -2.693364   -0.697718    1.540980 
25          1           0       -2.495171   -2.101700    2.600967 
26          1           0       -1.764710   -2.107832    0.989057 
27          9           0       -2.281525    0.599509   -0.515700 
28          9           0       -0.706061    1.427025   -1.763571 
29          9           0       -1.033302    2.207830    0.255023 
30          1           0        1.396566    2.592325    0.180243 
31          1           0        1.824333    1.987713   -1.430422 
32          1           0        3.014291    1.931289   -0.118777  
 
(R,S,S) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
---------------------------------------------------------------- 
 1          6           0       -0.098754   -0.173634    0.049758 
 2          7           0        0.007023   -0.373175    1.504604 
 3          6           0        1.296867    0.099245    1.593654 
 4          6           0        1.330596    0.483710    0.103792 
 5          8           0        2.070444    0.173283    2.526327 
 6          1           0        1.225414    1.568660    0.001578 
 7          6           0        2.505259   -0.007080   -0.734670 
 8          6           0       -0.207741   -1.439734   -0.793839 
 9          1           0       -0.902477    0.496261   -0.270421 
10          6           0       -0.887377   -0.827922    2.583427 
11          6           0       -0.945260    0.194939    3.715779 
12          6           0       -0.782006   -0.223409    5.039791 
13          1           0       -0.555983   -1.266156    5.247888 
14          6           0       -0.899504    0.684452    6.094454 
15          1           0       -0.765125    0.343100    7.116695 
16          6           0       -1.178304    2.026637    5.834310 
17          1           0       -1.264905    2.735665    6.652296 
18          6           0       -1.339770    2.454427    4.513859 
19          1           0       -1.553742    3.498124    4.302345 
20          6           0       -1.225623    1.544354    3.463570 
21          1           0       -1.347995    1.886840    2.439669 
22          1           0       -0.459983   -1.753232    2.989608 
23          6           0       -2.297135   -1.139284    2.062791 
24          1           0       -2.764700   -0.250109    1.629027 
25          1           0       -2.915432   -1.463216    2.903179 
26          1           0       -2.288662   -1.932992    1.315667 
27          1           0        2.388798    0.271013   -1.784867 
28          1           0        2.629737   -1.089707   -0.674365 
29          1           0        3.419683    0.459984   -0.357816 
30          9           0       -1.463966   -1.945910   -0.806072 
31          9           0        0.609672   -2.420651   -0.360995 
32          9           0        0.107587   -1.166687   2.079470 
 
(R,R,S) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 ---------------------------------------------------------------- 
 1          6           0       -0.069121    0.098485    0.093862 
 2          7           0        0.251663   -0.144559    1.510361 
 3          6           0        1.609352    0.023121    1.333152 
 4          6           0        1.436182    0.440595   -0.140369 
 5          8           0        2.545265   -0.175393    2.079123 
 6          1           0        1.600662    1.512482   -0.282614 
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 7          6           0        2.200665   -0.379192   -1.171220 
 8          1           0       -0.411679   -0.788633   -0.448298 
 9          6           0       -1.052235    1.218094   -0.195151 
10          6           0       -0.427576   -0.880433    2.583959 
11          6           0       -0.933109    0.011217    3.718325 
12          6           0       -1.222973   -0.586203    4.953905 
13          1           0       -1.056533   -1.652739    5.086940 
14          6           0       -1.713185    0.169737    6.017506 
15          1           0       -1.927733   -0.311359    6.967425 
16          6           0       -1.917998    1.543298    5.863545 
17          1           0       -2.296512    2.136180    6.690935 
18          6           0       -1.623070    2.147353    4.641699 
19          1           0       -1.770408    3.215928    4.513236 
20          6           0       -1.132915    1.387434    3.575965 
21          1           0       -0.892711    1.874249    2.638820 
22          1           0        0.346815   -1.532772    3.006829 
23          6           0       -1.543812   -1.768510    2.011373 
24          1           0       -2.321188   -1.163263    1.538974 
25          1           0       -2.005538   -2.342669    2.817459 
26          1           0       -1.145574   -2.474820    1.276492 
27          9           0       -2.291597    0.947588    0.274300 
28          9           0       -1.152809    1.400747   -1.529142 
29          9           0       -0.670836    2.396768    0.348081 
30          1           0        1.901018   -0.104949   -2.186754 
31          1           0        2.026518   -1.451602   -1.038253 
32          1           0        3.274044   -0.196349    1.070399 
 
(R,S,R) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 ----------------------------------------------------------------     
 1          6           0       -0.021747   -0.051731    0.036410 
 2          7           0        0.014262   -0.203351    1.500542 
 3          6           0        1.331175    0.172964    1.623394 
 4          6           0        1.455429    0.441039    0.117030 
 5          8           0        2.072158    0.231045    2.582172 
 6          6           0        1.734319    1.883501   -0.291653 
 7          1           0        2.151161   -0.248511   -0.370060 
 8          6           0       -0.169826   -1.318382   -0.802772 
 9          1           0       -0.745172    0.684344   -0.330035 
10          6           0       -0.881625   -0.732212    2.548785 
11          6           0       -0.974406    0.260767    3.699293 
12          6           0       -0.673779   -0.146090    5.003085 
13          1           0       -0.333318   -1.163065    5.182805 
14          6           0       -0.801265    0.742141    6.073074 
15          1           0       -0.560930    0.412046    7.079611 
16          6           0       -1.227133    2.050873    5.847927 
17          1           0       -1.322043    2.744565    6.677950 
18          6           0       -1.524342    2.468513    4.548055 
19          1           0       -1.851937    3.488180    4.366127 
20          6           0       -1.400154    1.578998    3.481726 
21          1           0       -1.626302    1.914081    2.472882 
22          1           0       -0.417792   -1.650818    2.927123 
23          6           0       -2.268327   -1.080240    2.002013 
24          1           0       -2.749043   -0.204791    1.555211 
25          1           0       -2.901597   -1.425420    2.824407 
26          1           0       -2.213678   -1.871168    1.255628 
27          9           0       -1.459051   -1.702618   -0.949362 
28          9           0        0.511016   -2.358855   -0.277842 
29          9           0        0.309988   -1.094877   -2.048280 
30          1           0        1.024296    2.570717    0.178949 
31          1           0        1.660305    1.995882   -1.376781 
32          1           0        2.742980    2.175103    0.014936  
As a consequence of the reported procedure the following absolute configurations can be 
assigned: (R,R)-7, (R,S)-7′, (R,R,S)-9, (R,R,S)-9′.  
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2D NMR spectra and optimized geometries of 7 and 7′ 
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Figure 4. 2D NOESY NMR spectrum of 7. 
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Figure 5. 2D NOESY NMR spectrum of 7′. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u. The cross peak between Ha and the protons Hc of the methyl group 
can be easily determinate for 7, the value is 1.22 a.u. (corresponding to an interproton 
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distance of 3.791 Å). The NOESY spectrum of 7′ did not show the correlation between Ha 
and Hc. 
        
 
 
 
Figure 6. Optimized geometries of obtained (R,R)-7 and of (R,R)-7′. 
Calculated Coordinates: 
(R,R) 
----------------------------------------------------------------- 
Center    Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 ---------------------------------------------------------------- 
 1          6           0        2.028801    0.319294    0.300927 
 2          7           0        0.715638    0.981742    0.322350 
 3          6           0        1.085742    1.992429   -0.533913 
 4          6           0        2.486676    1.388023   -0.732120 
 5          8           0        0.493405    2.982503   -0.910293 
 6          1           0        2.683296    1.012710   -1.737874 
 7          1           0        3.308552    2.024038   -0.400594 
 8          1           0        2.566211    0.341955    1.253854 
 9          6           0        2.050834   -1.110589   -0.210281 
10          6           0       -0.482403    0.894058    1.174012 
11          6           0       -1.651047    0.215583    0.461519 
12          6           0       -2.720813    0.999103    0.012164 
13          1           0       -2.696649    2.074350    0.168955 
14          6           0       -3.811076    0.419241   -0.639666 
15          1           0       -4.631410    1.044585   -0.979708 
16          6           0       -3.842915   -0.958895   -0.853860 
17          1           0       -4.688681   -1.414516   -1.360364 
18          6           0       -2.778233   -1.749468   -0.414323 
19          1           0       -2.793979   -2.822955   -0.579476 
20          6           0       -1.690923   -1.168176    0.238356 
21          1           0       -0.871723   -1.798432    0.565975 
22          1           0       -0.772685    1.938067    1.336354 
23          6           0       -0.139963    0.276548    2.534084 
24          1           0        0.223514   -0.749042    2.435687 
25          1           0       -1.033771    0.260546    3.162295 
26          1           0        0.626988    0.867485    3.043609 
27          9           0        1.372789   -1.254345   -1.363371 
Hc/Ha : 3.020 Å 
 (R,R) 
possible diastereomer 7 
 
Hc/Ha : 3.450 Å 
 (R,S) 
possible diastereomer 7′ 
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28          9           0        1.514919   -1.978148    0.686917 
29          9           0        3.325132   -1.502386   -0.424013  
 
(R,S) 
Center     Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
--------------------------------------------------------------- 
 1          6           0       -1.928509    0.385909    0.700578 
 2          7           0       -0.519464    0.296556    0.292456 
 3          6           0       -0.423043    1.632777   -0.057770 
 4          6           0       -1.854828    1.912608    0.434081 
 5          8           0        0.458896    2.297556   -0.554536 
 6          1           0       -1.908099    2.529374    1.332515 
 7          1           0       -2.532966    2.299026   -0.327996 
 8          6           0       -2.900352   -0.348107   -0.210706 
 9          1           0       -2.131445    0.082407    1.731244 
10          6           0        0.347349   -0.881456    0.126494 
11          6           0        1.810751   -0.482483   -0.000373 
12          6           0        2.542097   -0.875347   -1.125476 
13          1           0        2.044071   -1.416417   -1.925870 
14          6           0        3.903126   -0.578857   -1.231292 
15          1           0        4.455810   -0.890893   -2.112594 
16          6           0        4.546714    0.119776   -0.210198 
17          1           0        5.603858    0.354989   -0.290747 
18          6           0        3.822768    0.518522    0.917111 
19          1           0        4.316132    1.066416    1.714650 
20          6           0        2.466418    0.216755    1.022110 
21          1           0        1.911553    0.536711    1.899511 
22          1           0        0.054284   -1.389881   -0.801556 
23          6           0        0.135999   -1.859275    1.294956 
24          1           0        0.405012   -1.395141    2.247981 
25          1           0        0.771771   -2.736164    1.148954 
26          1           0       -0.900912   -2.198203    1.346883 
27          9           0       -2.751097   -1.692433   -0.131841 
28          9           0       -2.734356   -0.006220   -1.504928 
29          9           0       -4.173983   -0.063958    0.133326 
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2D NMR spectra and optimized geometries of 9 and 9′ 
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Figure 7. 2D NOESY NMR spectrum of 9. 
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Figure 8. 2D NOESY NMR spectrum of 9′. 
The cross peak between the protons Hb and Hc was used as a distance ruler and its volume 
was set to 10.00 a.u.; the cross peak between Ha and the protons Hc of the methyl group 
can be easily determinate for 9, the value is 2.84 a.u. (corresponding to an interproton 
distance of 3.041 Å). The NOESY spectrum of 9′ did not show the correlation between Ha 
and Hc 
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Figure 9. Optimized geometries of obtained (R,R,S)-9 and of (R,S,S)-9′. 
Calculated Coordinates: 
(R,R,S) 
----------------------------------------------------------------- 
Center    Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 ----------------------------------------------------------------  
     1        6            0       1.696227 -0.562460   0.347369  
     2        7            0       0.531688  0.240467  -0.091987  
     3        6            0       1.255292  0.968340  -0.992088  
     4        6            0       2.442949 -0.031342  -0.913761  
     5        8            0       1.002826  2.009651  -1.550193  
     6        1            0       2.439984 -0.716517  -1.773065  
     7        6            0       3.865988  0.639264  -0.708583  
     8        1            0       2.108799 -0.198162   1.296351  
     9        6            0       1.498787 -2.062538   0.347213  
    10        6            0      -0.545201  0.805136   0.701029  
    11        6            0      -1.906254  0.446549   0.121153  
    12        6            0      -2.932336  1.406022   0.109780  
    13        1            0      -2.749032  2.412074   0.481552  
    14        6            0      -4.202961  1.088087  -0.374881  
    15        1            0      -4.987065  1.840765  -0.377140  
    16        6            0      -4.466607 -0.191975  -0.855870  
    17        1            0      -5.454426 -0.438513  -1.235732  
    18        6            0      -3.461777 -1.155939  -0.849394  
    19        1            0      -3.664895 -2.155451  -1.225246  
    20        6            0      -2.192564 -0.841878  -0.358726  
    21        1            0      -1.431066 -1.616982  -0.357301  
    22        1            0      -0.431355  1.896336   0.646291  
    23        6            0      -0.498861  0.416927   2.180474  
    24        1            0      -0.612593 -0.661842   2.325031  
    25        1            0      -1.304044  0.908062   2.739048  
    26        1            0       0.448531  0.721882   2.636932  
    27        9            0       0.685154 -2.443929   1.356831  
    28        9            0       2.687486 -2.686126   0.518116  
    29        9            0       0.961577 -2.501512  -0.813244  
    30        6            0       4.879939 -0.023623   0.018427  
    31        6            0       4.220591  1.889060  -1.255376  
    32        1            0       3.496886  2.446494  -1.850175  
    33        6            0       5.486687  2.453535  -1.066980  
    34        6            0       6.449864  1.775892  -0.329560  
    35        1            0       5.716084  3.422594  -1.503295  
    36        6            0       6.148166  0.532742   0.211364  
    37        1            0       7.434495  2.211995  -0.184820  
    38        1            0       6.899523 -0.010551   0.778906  
    39        1            0       4.684970 -1.007935   0.442339   
 
Hc/Ha : 3.041 Å 
 (R,R,R) 
possible diastereomer 9 
 
Hc/Ha : 3.608 Å 
 (R,R,S) 
possible diastereomer 9′ 
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(R,R,S) 
----------------------------------------------------------------- 
Center    Atomic      Atomic             Coordinates (Angstroms) 
Number     Number       Type             X           Y         Z 
 ----------------------------------------------------------------  
     1        6            0       1.690260  0.248200  -0.559510  
     2        7            0       0.334370  0.173480   0.034880  
     3        6            0       0.544110  1.207990   0.896600  
     4        6            0       1.854740  1.609410   0.182300  
     5        8            0      -0.048530  1.554390   1.891600  
     6        6            0       1.793260  2.834660  -0.657400  
     7        6            0       2.730360 -0.761510  -0.116680  
     8        1            0       1.632030  0.322400  -1.652150  
     9        6            0      -0.551560 -0.938470   0.303950  
    10        6            0      -1.993180 -0.515910   0.045030  
    11        6            0      -2.916470 -0.473690   1.100830  
    12        1            0      -2.606200 -0.719680   2.114280  
    13        6            0      -4.242610 -0.102010   0.871260  
    14        1            0      -4.946850 -0.070370   1.698480  
    15        6            0      -4.661720  0.236260  -0.413610  
    16        1            0      -5.693450  0.528580  -0.589360  
    17        6            0      -3.754060  0.211610  -1.469860  
    18        1            0      -4.077770  0.485340  -2.470460  
    19        6            0      -2.427550 -0.158770  -1.242930  
    20        1            0      -1.731480 -0.161810  -2.078390  
    21        1            0      -0.443400 -1.179130   1.369820  
    22        6            0      -0.243630 -2.206930  -0.492370  
    23        1            0      -0.107890 -2.002050  -1.559780  
    24        1            0      -1.046100 -2.946350  -0.387670  
    25        1            0       0.667360 -2.683080  -0.120920  
    26        9            0       2.657280 -1.889810  -0.856570  
    27        9            0       2.584990 -1.093310   1.185090  
    28        9            0       3.973600 -0.251540  -0.282500  
    29        6            0       2.817560  3.017670  -1.690690  
    30        6            0       2.884480  4.261960  -2.443960  
    31        1            0       3.641830  2.318090  -1.780320  
    32        6            0       0.937890  3.964660  -0.297720  
    33        1            0       2.697200  1.653410   0.885540  
    34        6            0       1.016000  5.210390  -1.048040  
    35        1            0       0.336970  3.946090   0.606310  
    36        6            0       1.997050  5.364620  -2.110230  
    37        1            0       0.465140  6.076050  -0.699400  
    38        1            0       3.720260  4.437780  -3.111000  
    39        1            0       2.181620  6.347350  -2.528900   
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Methyl 3-[2-oxo-4-(trifluoromethyl)azetidin-1-
yl]propanoate (18).  
Method B: colorless oil (38 mg, 34 %). purified by flash 
chromatography on silica gel (eluent CH2Cl2 with 2% of 
MeOH). 1H NMR (CDCl3): 2.59−2.74 (m, 2H), 2.95−3.17 (m, 1H), 3.34–3.42 (m, 
1H), 3.67–3.75 (m, 4H), 4.07–4.15 (m, 1H). 19F NMR (CDCl3): −75.3 (d, J = 7.1 
Hz). 13C NMR (CDCl3): 32.3, 37.9, 38.5, 51.2 (q, J = 34.9 Hz), 52.0, 124.5 (q, J = 
279.4 Hz), 165.3, 171.4. (ESI Q-TOF) (m/z) [M + H]+ calcd for C8H11F3NO3 
226.0691, found 226.0635. 
Methyl 3-[3-methyl-2-oxo-4-(trifluoromethyl)azetidin-1-
yl]propanoate (trans-19).  
Method B: colorless oil (48 mg, 40 %). The residue purified 
by flash chromatography on silica gel (eluent CH2Cl2 with 
2% of MeOH). 1H NMR (CDCl3): 1.35 (d, J = 7.4 Hz, 3H), 
2.6 (dt, J = 16.3, 6.6 Hz, 1H), 2.68–2.78 (m, 1H), 3.22 (qd, J = 7.2, 1.7 Hz, 1H), 
3.29–3.43 (m, 1H), 3.63–3.77 (m, 5H). 19F NMR (CDCl3): −74.7 (d, J=6.5 Hz). 13C 
NMR (CDCl3): 12.4, 32.3, 37.8, 46.9, 51.9, 58.8 (q, J = 34.1 Hz), 124.5 (q, J = 
279.2 Hz), 169.1, 171.4. (ESI Q-TOF) (m/z) [M + H]+ calcd for C9H13F3NO3 
240.0848, found 240.0865.  
Methyl 3-[2-oxo-3-phenyl-4-(trifluoromethyl)azetidin-
1-yl]propanoate (trans-20). 
Method B: colorless oil (63 mg, 42 %). The residue 
purified by flash chromatography on silica gel (eluent 
hexane/ethyl acetate = 80:20). 1H NMR (CDCl3): 2.63 (dt, 
J = 16.2, 6.3 Hz, 1H), 2.73–2.87 (m, 1H), 3.37–3.51 (m, 1H), 3.67 (s, 3H), 4.07–
4.13 (m, 1H), 4.39 (s, 1H), 7.23–7.40 (m, 5H). 19F NMR (CDCl3): −74.3 (d, J=6.3 
Hz). 13C NMR (CDCl3): 32.3, 37.9, 51.9, 56.2, 59.3 (q, J = 33.9 Hz), 124.3 (q, J = 
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279.7 Hz), 127.2 (2C), 128.2, 129.0, 132.6, 166.3, 171.2. (ESI Q-TOF) (m/z) [M + 
H]+ calcd for C14H15F3NO3 302.1004, found 302.1052. 
General procedure of the racemic Et2Zn-promoted aza-Reformatsky reaction 
α-Bromo ester 2a-c (1.0 mmol) was added to a solution of the corresponding imine 
1a,c or 1g (0.5 mmol) in CH2Cl2 (5 mL) at ambient temperature. Then, 1.0 M 
Et2Zn in hexane (1.0 mL, 1.0 mmol) was slowly added to the mixture at the 
appropriate temperature (reported in Table 4,5,7 and 9 Chap. 7, pp. 80, 81, 85, 
89). The whole mixture was stirred at the same temperature for the appropriate 
time. The mixture was quenched with saturated aqueous NaHCO3, and was 
extracted with AcOEt. Then the extract was washed with brine and dried over 
MgSO4. The solvent was removed in vacuo and the residue was purified by column 
chromatography (AcOEt: hexane = 5:95) to afford the corresponding β-amino 
esters. 
General procedure of the Et2Zn-promoted asymmetric aza-Reformatsky 
reaction  
α-Bromo ester 2a-c (1.0 mmol) was added to a solution of the corresponding imine 
1a,c or 1g (0.5 mmol) and (1R,2S)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol 6 (0.38 
mmol) in CH2Cl2 (5 mL) at ambient temperature. Then the mixture was cooled to 
−20 °C, and 1.0 M Et2Zn in hexane (1.2 mL, 1.2 mmol) was slowly added to the 
mixture at the same temperature. The whole mixture was stirred at the same 
temperature for the appropriate time (reported in Table 6, Chap 7, p. 83). The 
mixture was quenched with saturated aqueous NaHCO3, and extracted with AcOEt. 
Then the extract was washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(AcOEt: hexane: 5:95) to afford the corresponding β-amino esters. 
 
 
 
177 
 
 Methyl (S)-3-(benzylamino)-4,4,4-trifluorobutanoate 
(10'). Colorless oil (65 mg, 50%). IR: 1745. [α]D = −15.8 (c = 
2.7 g/100 mL, CHCl3). The ee was determined to be 98% by 
HPLC (Column Lux 5u Amylose-2), hexane/EtOH = 95:5, 0.7 ml/min, 206 nm, 
major 7.77 min and minor 6.91 min). 1H NMR (CDCl3): 1.65 (br, 1H), 2.50 (dd, J 
= 15.6, 9.7 Hz, 1H), 2.70 (dd, J = 15.5, 4.0 Hz, 1H), 3.56–3.68 (m, 1H), 3.69 (s, 
3H), 3.87 (d, J = 13.0 Hz, 1H), 4.01 (d, J = 13.0 Hz, 1H), 7.21–7.38 (m, 5H). 19F 
NMR (CDCl3): –74.8 (d, J = 7.5 Hz). 13C NMR (CDCl3): 34.7, 51.8, 52.1, 55.9 (q, 
J = 28.7 Hz), 126.2 (q, J = 284.4 Hz), 127.4, 128.4 (4C), 138.8, 170.4. HR-MS 
(ESI Q-TOF) (m/z) [M + H]+ calcd for C12H15F3NO2 262.1055, found 262.1068.    
 Methyl (2S,3S)-3-(benzylamino)-4,4,4-trifluoro-2-
methylbutanoate (syn-12'). Colorless oil (71 mg, 52%). IR: 
1758. [α]D = −20.0 (c = 2.4 g/100 mL, CHCl3) The ee was 
determined to be 98% by HPLC (Column Lux 5u Amylose-2), hexane/EtOH = 
95:5, 0.7 mL/min, 206 nm, major 9.12 min and minor 9.62 min). 1H NMR 
(CDCl3): 1.24 (d, J = 7.1 Hz, 3H), 1.76 (br, 1H), 2.86 (qd, J = 7.1, 4.5 Hz, 1H), 
3.63 (s, 3H), 3.64–3.73 (m, 1H), 3.84 (d, J = 13.1 Hz, 1H), 4.03 (d, J = 13.0 Hz, 
1H), 7.23–7.40 (m, 5H). 19F NMR (CDCl3): –71.1 (d, J = 7.3 Hz). 13C NMR 
(CDCl3): 10.8, 39.5, 52.0, 52.3, 59.4 (q, J = 27.0 Hz), 126.6 (q, J = 286.1 Hz), 
127.3, 128.3 (2C), 128.4 (2C), 139.3, 173.7. HR-MS (ESI Q-TOF) (m/z) [M + H]+ 
calcd for C13H17F3NO2 276.1211, found 276.1258. 
Methyl (2R,3S)-3-(benzylamino)-4,4,4-trifluoro-2-
phenylbutanoate (anti-13'). Colorless oil (98 mg, 58%). IR: 
1779. [α]D = 18.3 (c = 1.5 g/100 mL, CHCl3). The ee was 
determined to be 91% by HPLC of trans-5, obtained after 
cyclization of anti-13' (Column Lux 5u Amylose-2), 
hexane/EtOH = 95:5, 1.0 mL/min, 206 nm, major 5.24 min and minor 5.91 min). 
1H NMR (CDCl3): 1.64 (br, 1H), 3.63 (d, J = 12.9 Hz, 1H), 3.68 (s, 3H), 3.81 (d, J 
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= 12.9 Hz, 1H), 3.88 (d, J = 9.1 Hz, 1H), 3.93−4.03 (m, 1H), 6.97–7.35 (m, 10H). 
19F NMR (CDCl3): –73.0 (d, J = 6.5 Hz). 13C NMR (CDCl3): 51.4z, 52.5, 52.8, 
60.1 (q, J = 27.3 Hz), 126.3 (q, J = 284.6 Hz), 127.3, 128.3 (4C), 128.4, 128.9 
(2C), 129.3 (2C), 133.6, 138.8, 171.6. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd 
for C18H19F3NO2 338.1368, found 338.1397. 
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HPLC trace of racemic 10 
 
 
HPLC traces of 10' 
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HPLC trace of racemic syn-12 
 
 
HPLC trace of syn-12' 
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HPLC trace of racemic trans-5 
 
 
HPLC trace of enantioriched trans-54 
 
 
                                                                 
4 Obtained from the cyclization of anti-13′ 
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Methyl 4,4,4-trifluoro-2-methyl-3-{[(R)-1-
phenylethyl]amino}butanoate (syn-16, 16'). Colorless oil 
(98 mg, 68%). IR: 1780, 1785. 1H NMR (CDCl3): 1.15 (d, J 
= 7.0 Hz, 3H), 1.21 (d, J = 7.1 Hz, 3H), 1.27 (d, J = 6.6 Hz, 
3H), 1.30 (d, J = 6.6 Hz, 3H), 1.80 (br, 2H), 2.67–2.75 (m, 1H), 2.81–2.89 (m, 1H), 
3.38–3.44 (m, 4H), 3.61–3.68 (m, 4H), 3.92 (q, J = 6.3 Hz, 1H), 4.03 (d, J = 6.2 
Hz, 1H), 7.20–7.30 (m, 10H). 19F NMR (CDCl3): –70.0 (d, J = 10.0 Hz), –72.1 (d, 
J = 6.2 Hz). 13C NMR (CDCl3): 10.3, 10.7, 23.5, 24.8, 39.0, 39.3, 51.8, 52.1, 55.6, 
55.9, 57.2 (q, J = 26.4 Hz), 57.4 (q, J = 27.1 Hz), 126.2 (q, J = 284.8 Hz), 126.7 (q, 
J = 287.6 Hz), 126.8 (2C), 127.3 (2C), 127.4 (2C), 128.3 (2C), 128.5 (2C), 143.7, 
144.6, 173.3, 173.9. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C14H19F3NO2 
290.1368, found 290.1394. 
Methyl (2S,3S)-4,4,4-trifluoro-2-methyl-3-{[(R)-1-
phenylethyl]amino}butanoate (16'). Colorless oil (70 mg, 
49 %). IR: 1785. 1H NMR (CDCl3): 1.25 (d, J = 7.2 Hz, 3H), 
1.31 (d, J = 6.4 Hz, 3H), 1.81 (br, 1H), 2.86−2.94 (m, 1H), 
3.67–3.73 (m, 4H), 3.98 (q, J = 6.2 Hz, 1H), 7.26–7.39 (m, 5H). 19F NMR (CDCl3): 
–72.2 (d, J = 7.9 Hz). 13C NMR (CDCl3): 10.7, 23.5, 39.1, 52.0, 55.5, 57.4 (q, J = 
27.1 Hz), 126.3 (q, J = 284.8 Hz), 126.7 (2C), 127.4, 128.5 (2C), 144.8, 173.9. HR-
MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C14H19F3NO2 290.1368, found 
290.1385. 
 
Methyl (S)-4,4,4-trifluoro-3-[(3 methoxy-3-
oxopropyl)amino]butanoate (21'). 
Colorless oil (64 mg, 50%). [α]D = 23.2 (c = 3 g/100 mL, 
CHCl3). The ee was determined to be 74% by HPLC (Column Lux 5u Amylose-2), 
hexane/EtOAc = 95:5, 1.0 mL/min, 203 nm, major 7.82 min and minor 8.77 min). 
1H NMR (CDCl3): 2.47–2.55 (m, 4H), 2.7 (dd, J = 15.8, 3.9 Hz, 1H), 2.93−3.01 
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(m, 1H) , 3.0.9−3.17 (m 1H), 3.58–3.64 (m, 1H), 3.68 (s, 3H), 3.73 (s, 3H). 19F 
NMR (CDCl3): −75.5 (d, J=7.9 Hz). 13C NMR (CDCl3): 34.1, 43.4, 51.7, 52.2, 56.7 
(q, J = 29.4 Hz), 125.6 (q, J = 283.7 Hz), 170.2, 172.6. HR-MS (ESI Q-TOF) (m/z) 
[M + H]+ calcd for C9H15F3NO4 258.0953 found 258.0908. 
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HPLC trace of 21. 
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Methyl 4,4,4-trifluoro-3-[(3-methoxy-3-
oxopropyl)amino]-2-methylbutanoate (syn-22). 
Colorless oil (65 mg, 48%). 1H NMR (CDCl3): 1.21 (d, J 
= 7.1 Hz, 3H), 1.65 (br, 1H), 2.45 (t, J = 6.3 Hz, 2H), 
2.77–2.94 (m, 2H), 3.08–3.16 (m, 1H), 3.56–3.71 (m, 4H), 3.75 (s, 3H). 19F NMR 
(CDCl3): −72.1 (d, J = 8.1 Hz). 13C NMR (CDCl3): 11.2, 34.8, 39.4, 44.3, 51.6, 
52.2, 60.7 (q, J = 27.1 Hz), 126.2 (q, J = 217.9 Hz), 172.8, 173.6. HR-MS (ESI Q-
TOF) (m/z) [M + H]+ calcd for C10H17F3NO4 272.1110 found 272.1118. 
Methyl 4,4,4-trifluoro-3-(3-methoxy-3-
oxopropylamino)-2-phenylbutanoate (anti-23). 
Colorless oil (84 mg, 51%). 1H NMR (CDCl3): 2.25 (t, J 
= 6.3 Hz, 2H), 2.71−2.79 (m, 1H), 2.87−2.94 (m, 1H), 
3.55 (s, 3H), 3.68 (s, 3H), 3.77−3.92 (m, 2H), 7.26 
−7.48 (m, 5H). 19F NMR (CDCl3): −73.6 (d, J = 6.6 Hz). 13C NMR (CDCl3): 35.0, 
44.5, 51.4, 51.5, 52.4, 61.1 (q, J = 27.3 Hz), 126.2 (q, J = 284.1 Hz), 128.3, 128.8 
(2C), 129.3 (2C), 133.6, 171.6, 172.4. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd 
for C15H19F3NO4 334.1266 found 334.1208. 
 
General procedure for the benzyl group hydrogenolysis reaction  
To a solution of β-amino esters syn-12' or 16' (0.5 mmol) in MeOH (15 mL), 10 
mol % Pd(OH)2 on carbon (0.05 mmol) was added while being exposed to H2. 
After 12 hours, the reaction mixture was filtered through celite pad and 
concentrated in vacuo. The corresponding amines were used in the next 
experiments without further purification.     
 Methyl (2S,3S)-3-amino-4,4,4-trifluoro-
2methylbutanoate (syn-14'). Colorless oil (52 mg, 43 %). 
IR: 3338, 3400, 1788. The ee was determined to be 98% by 
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HPLC (Column Lux 5u Amylose-2), hexane/EtOH = 95:5, 1.0 mL/min, 203 nm, 
major 5.74 min and minor 6.25 min). 1H NMR (CDCl3): 1.26 (d, J = 7.1 Hz, 3H), 
1.65 (br, 2H), 2.85 (qd, J = 7.2, 4.6 Hz, 1H), 3.58–3.87 (m, 4H). 19F NMR 
(CDCl3): –75.8 (d, J = 7.9 Hz). 13C NMR (CDCl3): 12.3, 37.55, 53.0, 54.1 (q, J = 
29.7 Hz), 123.8 (q, J = 283.3 Hz), 172.1. HR-MS (ESI Q-TOF) (m/z) [M + H]+ 
calcd for C6H11F3NO2 186.0742, found 186.0758. 
187 
 
HPLC trace of racemic syn-14 
 
 
HPLC trace of syn-14', obtained starting from syn-12' 
 
 
HPLC trace of syn-14', obtained starting from 16' 
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Coupling reactions: general procedure . To a solution of syn-14′ (0.25  mmol) in 
7 mL of CH2Cl2 equimolar amounts of N-Boc-L-Val, N,N'-
dicyclohexylcarbodiimide (DCC) and catalytic amounts of 4-
dimethylaminopyridine (DMAP, 10 mol %) were added. After 24 h of stirring at 
room temperature, the crude mixture was filtered off to remove the formed N,N'-
dicyclohexylurea (DCU) and the solvent was evaporated under vacuum. Purified 
by flash chromatography on silica gel (eluent: hexane/ethyl acetate = 8:2) 
Methyl (2S,3S)-3-{(S)-2-[(tert-
butoxycarbonyl)amino]-3-
methylbutanamido}-4,4,4-trifluoro-2-
methylbutanoate (15'). White viscous oil. (80 
mg 56%). IR: 3440, 3342, 1708, 1670. [α]D= 21.2 (c =1 g/100 mL, CHCl3). 1H 
NMR (300 MHz, CDCl3) 0.93–0.97 (m, 6H), 1.24 (d, J = 7.2 Hz, 3H), 1.44 (s, 9H), 
2.09–2.23 (m, 1H), 2.82–2.91 (m, 1H), 3.71 (s, 3H), 3.83 (t, J = 7.6 Hz, 1H), 4.98–
5.13 (m, 2H), 6.60 (d, J = 7.2 Hz, 1H). 19F NMR (282 MHz, CDCl3) –73.3 (br). 13C 
NMR (75 MHz, CDCl3) 12.4, 19.1 (2C), 28.2 (3C), 30.0, 38.8, 51.6 (q, J = 30,3 
Hz), 52.3, 60.7, 80.5, 124.6 (q, J = 282.2 Hz), 156.0, 171.8, 172.6. HRMS: m/z [M 
+ H]+ calcd for C16H28F3N2O5 [M+H]+ 385.1950, found 385.1934. 
Synthesis of the cis-14 and trans-5 by Et2Zn promoted aza-Reformatsky 
reaction 
α-Bromo ester 2b-c (1.0 mmol) was added to a solution of the corresponding imine 
1a (0.5 mmol) in CH2Cl2 (5 mL) at ambient temperature. Then the mixture was 
cooled to −20 °C, and 1.0 M Et2Zn in hexane (1.0 mL, 1.0 mmol) was slowly 
added to the mixture at same temperature. The whole mixture was stirred at the 
same temperature for appropriate time (reported in Table 5, Chap 7, p. 83). The 
temperature was allowed to rise to room temperature and quenched with saturated 
aqueous NaHCO3 after 14 days. The mixture was extracted with AcOEt and then 
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the extract was washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(AcOEt: hexane: 5:95) to afford the corresponding β-lactams cis-14 and trans-5. 
1-benzyl-3-methyl-4-(trifluoromethyl)azetidin-2-one (cis-14). 
Colorless oil (52 mg, 43 %). IR: 1788. 1H NMR (CDCl3): 1.35 (d, J = 
7.7 Hz, 3H), 3.40–3.52 (m, 1H), 3.77–3.88 (m, 1H), 3.97 (d, J = 15.1 
Hz, 1H), 4.85 (d, J = 15. Hz, 1H), 7.22–7.41 (m, 5H). 19F NMR (CDCl3): –68.8 (d, 
J = 9.2 Hz). 13C NMR (CDCl3): 8.9, 45.3, 47.3, 53.9 (q, J = 32.8 Hz), 124.4 (q, J = 
280.3 Hz), 128.1, 128.5 (2C), 128.9 (2C), 134.7, 169.3. HR-MS (ESI Q-TOF) (m/z) 
[M + H]+ calcd for C12H13F3NO 244.0949, found 244.0965. 
Synthesis of the cis-17 by asymmetric Et2Zn promoted aza-Reformatsky 
reaction 
α-Bromo ester 2b (1.0 mmol) was added to a solution of the corresponding imine 
1c(0.5 mmol) and (1R,2S)-1-phenyl-2-(1-pyrrolidinyl)propan-1-ol 6 (0.38 mmol) in 
CH2Cl2 (5 mL) at ambient temperature. Then the mixture was cooled to −20 °C, 
and 1.0 M Et2Zn in hexane (1.2 mL, 1.2 mmol) was slowly added to the mixture at 
the same temperature. The whole mixture was stirred at the same temperature for 5 
days. The temperature was allowed to rise to room temperature and quenched with 
saturated aqueous NaHCO3 after 14 days. The mixture was extracted with AcOEt 
and then the extract was washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the residue was purified by column chromatography 
(AcOEt: hexane: 1:9) to afford the corresponding β-lactam cis-17. 
 (3S,4S)-3-methyl-1-[(R)-1-phenylethyl]-4-(trifluoromethyl)azetidin-
2-one (cis-17). White solid (55 mg, 43 %). IR: 1769. [α]D = 12.3 (c 
= 3 g/100 mL, CHCl3). 1H NMR (CDCl3): 1.32 (dq, J = 7.6, 3.4 
Hz, 3H), 1.62 (d, J = 7.3 Hz, 3H), 3.33–3.40 (m, 1H), 3.64–3.74 
(m, 1H), 5.07 (q, J = 7.4 Hz, 1H), 7.27–7.39 (m, 5H). 19F NMR (CDCl3): –68.5 (d, 
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J = 6.9 Hz). 13C NMR (CDCl3): 9.0, 17.9, 46.6, 51.6, 53.7 (q, J=34.7 Hz), 124.4 (q, 
J=279.8 Hz), 127.2 (2C), 128.0, 128.8 (2C), 138.6, 169.4. HR-MS (ESI Q-TOF) 
(m/z) [M + H]+ calcd for C13H15F3NO 258.1106, found 258.1167.  
2D NMR spectra and optimized geometries to determine the absolute 
configuration of the new chiral centers of cis-17. 
1. To determine the absolute configuration of the new chiral centers 2D NOESY NMR 
spectra and optimized geometries of the β-lactam cis-17 were considered. 
ppm (t2)
1.02.03.04.05.06.07.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
ppm (t1)
10.00
2.89
0.88
 
Figure 10. 2D NOESY spectrum of cis-17. 
 
The cross peak between the protons Hb and Hc was used as a distance ruler and its 
volume was set to 10.00 a.u.; the cross peak between Ha and the protons Hc of the 
methyl group can be easily determinate for cis-17, the value is 0.88 a.u. 
(corresponding to an interproton distance of 4.034 Å). The correlation between Ha 
and Hd shows a value equal to 2.89 a.u., corresponding to an interproton distance of 
3.27 Å, that confirms the cis configuration (compared to the distance determinate 
for the trans-8 and 8').  
The optimized geometries of all possible diastereomers (see pp.166-168) coupled 
with NOESY analysis permits to assign the (R,S,S) to cis-16
 Hb−Hc Ha−Hc 
Ha−Hd 
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Chapter 13 
 
Work towards the discovery of selective and potent PCAF 
inhibitors 
Synthesis of  6-chloro-3-methyl[1,2,4]triazolo[3,4-a]phthalazine (2). Multistep 
procedure for the synthesis of 2 was followed.1 
Synthesis of amines 5-8 
Synthesis of 3-methyl-2-phenylbutan-1-amine (4). The amine 5 was synthesized 
starting from (E)-(2-nitrovinyl)benzene which, following a reported procedure of 
Michael addition reaction with Grignard reagent,2 gave the corresponding adduct. 
The reported procedure of reduction of the nitro group3 lead to the amine 4. The 
Michael adduct4 and 4 are known.5  
 
Synthesis of N1-methyl-1-phenylethane-1,2-diamine (5). Procedure: To a stirred 
suspension of LiAIH4, (237.2 mg, 6.30 mmol) in Et2O (10 mL) under N2 was 
added dropwise, over 0.5 h, a solution of 2-(methylamino)-2-phenylacetonitrile 
(230.0 mg, 1.57 mmol) in Et2O (500 mL) at 0 ˚C. The mixture was stirred at this 
temperature for 5 h and then at room temperature overnight. H2O was then added, 
followed by 15% NaOH (2 mL), and finally another 10 mL of H2O. Inorganic 
material was removed by filtration. The solution was extracted with EtOAc, dried 
over MgSO4, filtered and the solvent was evaporated to give the product as yellow 
                                                                 
1 See ref. 19 in the Chapter 7. 
2 Yao, C.; Kao, K.; Liu, J.; Wang, Y.; Chen, W.; Lin, Y.; Yan, M.; Tetrahedron 1998, 54, 791-822. 
3 Martinelli, E.; Vicini, A. C.; Mancinelli, M.; Mazzanti, A.; Zania, P.; Bernardi, L.; Fochi, M. Chem. Commun. 
2015, 51, 658-660.  
4 Yao, C.; Kao, K.; Liu, J.; Wang, Y.; Chen, W.; Lin, Y.; Yan, M.; Tetrahedron 1998, 54, 791-822.  
5 Brenna, E.; Fuganti, C.; Gatti, F. G.; Passoni, M.; Serra, S. Tetrahedron Asymmetry 2003 , 14, 2401 -2406 
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oil.  The crude product (52% yield) was used in the next step without further 
purification. 5 is a known compound.6  
Synthesis of 2-(dimethylamino)-2-phenylpropanenitrile 
Procedure: LDA was prepared by adding BuLi (0.69 mL, 1.1 
mmol, 1.6 M in hexanes) to a solution of diisopropylamine (0.17 
mL, 1.2 mmol) in 2.5 mL of THF, at 0 °C under N2. The solution 
was stirred 15 min at 0 °C and then cooled to –78 °C. A solution of 2-
(dimethylamino)-2-phenylacetonitrile (160 mg, 1 mmol) in THF (2.5 mL) was 
added to the LDA solution and the mixture was stirred for 30 min at –78 °C. CH3I 
(0.07 mL, 1.1 mmol) was then added to the solution. The reaction mixture was 
stirred for 16 hours, while the temperature was allowed to rise to 0 °C and 
quenched with saturated aqueous NH4Cl solution. The aqueous phase was extracted 
with ethyl ether (3x20 mL), the combined organic phases were dried (MgSO4) and 
concentrated. The crude product (72% yield) was used in the next step without 
further purification.  
2-(Dimethylamino)-2-phenylpropanenitrile. Colorless oil. IR: 2230. 1H NMR 
(CDCl3): 1.60 (s, 3H), 2.17 (s, 6H), 7.19−7.28 (m, 3H), 7.46−7.48 (m, 2H). 13C 
NMR (CDCl3): 29.3, 40.7 (2C), 67.2, 117.6, 125.4 (2C), 141.0, 128.3, 128.7 (2C). 
HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C11H15N2 175.1235, found 
175.1242. 
Synthesis of N2,N2-dimethyl-2-phenylpropane-1,2-diamine (6) 
Procedure: To a stirred suspension of LiAIH4, (90.4 mg, 2.4 
mmol) in Et2O (5 mL) under N2 was added dropwise, over 0.5 h, a 
solution of 2-(dimethylamino)-2-phenylpropanenitrile (105 mg, 0.6 
mmol) in Et2O (5 mL) at 0 ˚C. The mixture was stirred at this temperature for 5 h 
                                                                 
6 Malkov, A.V.; Stewart-Liddon, A. J. P.; McGeoch, G. D.; Ramirez-Lopez, P.; Kocovsky, P. Org. Biomol. 
Chem. 2012 , 10, 4864-4877 
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and at room temperature overnight. H2O (1 mL) was then added, followed by 15% 
NaOH (1 mL), and finally another 2 mL of H2O. Inorganic material was removed 
by filtration. The solution was extracted with Et2O, dried over MgSO4, filtered and 
the solvent was evaporated to give the product (44%) as yellow oil. Purification by 
FCC (MeOH 10%/ EtOAc) yielded 6 (44%) as colorless oil. 
N2,N2-Dimethyl-2-phenylpropane-1,2-diamine.Colorless oil. IR: 3335. 1H NMR 
(CDCl3): 1.29 (s, 3H), 2.18 (s, 6H), 2.58 (d, J = 13.4 Hz, 1H), 2.99 (d, J = 13.4 Hz, 
1H), 7.23 (t, J = 7.3 Hz, 1H), 7.33 (t, J = 7.6 Hz, 2H), 7.48 (dd, J = 8.2, 0.8 Hz, 
2H). 13C NMR (CDCl3): 12.6, 38.8 (2C), 52.2, 63.8, 126.5, 127.1 (2C), 128.0 (2C), 
144.7. HR-MS (ESI Q-TOF) (m/z) [M + H]+ calcd for C11H19N2 179.15428, found 
179.15434. 
Synthesis of N1,N1-dimethyl-2-phenylethane-1,2-diamine (7). Procedure: 
Ammonium acetate (1.5 g, 20 mmol) and 2-(dimethylamino)-1-phenylethan-1-one 
(0.163 g, 1 mmol) were mixed in methanol (20 mL) and then treated with sodium 
cyanoborohydride (0.314 g, 5 mmol). The mixture was stirred at room tempearture 
under a N2 atmosphere for 4 days. The reaction mixture was quenched by adding 
1N NaOH, and the product was extracted with EtOAc (3 x 50 mL). The organic 
extract was dried (MgSO4) and the solvent was evaporated to give the crude free 
base. Purification by FCC (5% MeOH/CH2Cl2). 49% yield. 7 is a known 
compound.7 
Synthesis of 3-methyl-6-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[3,4-
a]phthalazine (11). Procedure: 3-Methyl-6-(piperazin-1-yl)-[1,2,4]triazolo[3,4-
a]phthalazine (11) (87.6 mg, 0.32 mmol) was added to CHCl3 followed by a 
formaldehyde solution 37 % (0.15 ml. 1.92 mmol) and formic acid (0.07 ml, 1.92 
mmol). The mixture was heated at 70 °C for 3h. The mixture was charged with 
aqueous 1N NaOH (50 mL), and the layers were separated. The aqueous layer was 
                                                                 
7 Ooka, H.; Arai, N.; Azuma, K.; Kurono, N.; Ohkuma, T. J. Org. Chem., 2008, 73, 9084−9093. 
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extracted with CHCl3 (2 x 50 mL). The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure. Purification by FCC ( MeOH-
NH3 10%/ EtOAc) yielded 11 (43%) as a white solid.  
 
White solid. Mpt: 210-212 ◦C; IR: 3400, 2938, 2847, 2800, 
2360, 2341, 1510, 708. 1H NMR (CDCl3): 8.58 (d, J = 7.6 Hz, 
1H), 8.00 (d, J = 8.1 Hz, 1H), 7.81 (t, J = 7.2, 1H), 7.69 (t, J = 
7.2, 1H), 3.43 (s, 4H), 2.72 (s, 3H), 2.70 (s, 4H), 2.41 (s, 3H); 
13C NMR (CDCl3): 157.5, 147.7, 142.4, 132.7, 129.8, 126.3, 
125.0, 123.7, 120.0, 54.7 (2C), 51.1 (2C), 46.1, 9.7. LR-ESI-
MS: C15H19N6 (m/z) [M + H]+found 283.1 calcd 283.2. HR-ESI-MS: C15H19N6 
(m/z) [M + H]+ found 283.16656 calcd 283.16657. 
General procedure for the coupling reactions of 2 with amines 4-7 
In a pressure tube, 6-chloro-3-methyl[1,2,4]triazolo[3,4-a]phthalazine (2) (20 mg, 
0.092 mmol) was dissolved in EtOH (0.2 mL), amine 4-7 (0.21 mmol), KI (1.5 mg, 
0.009 mmol) and concentrated HCl (2 μL, 0.002 mmol) were added, the tube was 
sealed and the reaction was stirred at 100 °C, until the complete disappearance of 
reactants was observed by TLC. The reaction mixture was concentrated, 1M NaOH 
(aq) (20 mL) was added and the aqueous phase was extracted with CHCl3-MeOH 
(10%) (3 × 20 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated. The compound 9 is known.8 
3-Methyl-N-(3-methyl-2-phenylbutyl)[1,2,4]triazolo[3,4-
a]phthalazin-6-amine (12). 
Brown oil (22 %). IR: 3292, 2957, 2928, 2800, 2360, 2341, 
1514, 701. 1H NMR (CDCl3): 0.82 (d, J = 6.7 Hz, 3H), 1.17 
(d, J = 6.6 Hz, 3H), 2.04 (ddt, J = 13.3, 8.5, 6.7 Hz, 1H), 
                                                                 
8 See ref. 18 in the Chapter 7. 
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2.72−2.80 (m, 1H2.73 (s, 3H), 3.49 (ddd, J = 14.0, 10.7, 3.5 Hz, 1H), 4.21 (ddd, J = 
13.0, 7.3, 4.5 Hz, 1H), 4.78 (d, J = 3.8 Hz, 1H), 7.20−7.38 (m, 6H), 7.53−7.61 (m, 
1H), 7.74−7.78 (m, 1H), 8.55 (dd, J = 7.9, 0.6 Hz, 1H). 13C NMR (CDCl3): 9.8, 
21.0, 21.1, 31.6, 44.9, 52.2, 118.2, 121.7, 123.8, 124.2, 127.0, 128.4 (2C), 128.8 
(2C), 150.7, 147.3, 142.0, 141.9, 132.4, 129.9. LR-ESI-MS: C21H24N5 (m/z) [M + 
H]+ found 346.2 calcd 346.2. HR-ESI-MS: C21H24N5 (m/z) [M + H]+ found 
346.20216. 
N1-Methyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-
yl)-1-phenylethane-1,2-diamine (13).  
White solid (30%). IR: 3275, 2926, 2853, 2360, 2343, 1518, 
701. 1H-NMR (CDCl3): 2.43 (s, 3H), 2.65 (s, 3H), 3.52–3.65 
(m, 1H), 3.81 (dt, J = 13.2, 5.3 Hz, 1H), 4.01 (dd, J = 8.2, 4.9 
Hz, 1H), 6.06 (br, 1H), 7.31–7.48 (m, 5H), 7.66–7.71 (m, 1H), 
7.75 (d, J = 8.0 Hz, 1H), 7.80 (t, J = 7.5 Hz, 1H), 8.56 (d, J = 7.8 Hz, 1H). 13C-
NMR (CDCl3): 9.7, 33.8, 47.0, 62.9, 118.3, 122.5, 123.7, 123.9, 127.2 (2C), 128.2, 
129.0 (2C), 130.0, 132.5, 140.1, 141.9, 147.2, 151.0. LR-ESI-MS: C19H21N6 (m/z) 
[M + H]+ found 333.1 calcd 333.2. HR-ESI-MS: C19H21N6 (m/z) [M + H]+ found 
333.18205 calcd 333.18222. 
N2,N2-Dimethyl-N1-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-
6-yl)-1 phenylethane-1,2-diamine 14). 
Yellow oil (21%). IR: 3334, 2926, 2856, 2360, 2342, 1510, 701. 
1H NMR (CDCl3): 2.39–2.40 (m, 9H), 2.54 (dd, J = 12.5, 4.5 Hz, 
1H), 2.90 (t, J = 11.7 Hz, 1H), 4.85 (dd, J = 11.4, 3.7 Hz, 1H), 
6.77 (br, 1H), 7.21–7.26 (m, 1H), 7.31 (t, J = 7.5 Hz, 2H), 7.40–
7.49 (m, 2H), 7.70–7.78 (m, 1H), 7.78–7.85 (m, 1H), 7.99 (d, J = 8.0 Hz, 1H), 8.56 
(dd, J = 7.9, 0.7 Hz, 1H). 13C NMR (CDCl3): 9.5, 45.1 (2C), 54.2, 64.9, 118.8, 
122.8, 123.7, 124.2, 126.7 (2C), 127.3, 128.3 (2C), 130.0, 132.5, 141.5, 141.8, 
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147.3, 150.6. LR-ESI-MS: C20H23N6 (m/z) [M + H]+ found 347.2 calcd 347.2. HR-
ESI-MS: C20H23N6 (m/z) [M + H]+ found 347.19788 calcd 347.19787 error = 0.01 
ppm. 
N2,N2-Dimethyl-N1-(3-methyl[1,2,4]triazolo[3,4-
a]phthalazin-6-yl)-2-phenylpropane-1,2-diamine (15). 
Brown oil (17 %). IR: 3368, 2941, 2829, 2784, 2360, 2341, 
1513, 701. 1H NMR (CDCl3): 1.53 (s, 3H), 2.31 (s, 6H), 2.66 (s, 
3H), 3.64 (s, 2H), 5.70 (br, 1H), 7.27 (d, J = 7.4 Hz, 1H), 7.39 
(dd, J = 10.6, 5.0 Hz, 2H), 7.59 (d, J = 8.0 Hz, 1H), 7.63 (dd, J 
= 8.3, 1.0 Hz, 2H), 7.67–7.72 (m, 1H), 7.78–7.83 (m, 1H), 8.56 (dd, J = 7.9, 0.7 
Hz, 1H). 13C NMR (CDCl3): 9.8, 14.9, 38.9 (2C), 50.6, 60.4, 118.4, 121.9, 123.8, 
124.2, 126.6 (2C), 127.2, 128.4 (2C), 129.9, 132.4, 141.9, 143.9, 147.2, 150.8. LR-
ESI-MS: C21H25N6 (m/z) [M + H]+ found 361.2 calcd 361.2. HR-ESI-MS: 
C21H25N6 (m/z) [M + H]+ found 361.21362 calcd 361.21352 error = 0.28 ppm. 
Synthesis of 2-{(3-methyl[1,2,4]triazolo[3,4-α]phthalazin-6-yl)amino}-1-
phenylethan-1-ol (17). Procedure: In a pressure tube, 6-chloro-3-
methyl[1,2,4]triazolo[3,4-a]phthalazine (1) (601 mg, 2.76 mmol) was dissolved in 
EtOH (2 mL), 2-amino-1-phenylethan-1-ol (862 mg, 6.29 mmol), KI (45.3 mg, 
0.27 mmol) and concentrated HCl (0.055ml) were added, the tube was sealed and 
the reaction was stirred at 100 °C for 4d. The reaction mixture was cooled to room 
temperature and filtered through a buchner funnel. The filter cake was washed with 
DCM and dried in vacuum. 23 (505mg, 57%) was obtained as a white solid.  
2-{(3-Methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-1-
phenylethan-1-ol (17). 
White solid (57 %). IR: 3400, 2938, 2801, 2360, 1511, 701. 
Mpt: 218-220 °C. 1H NMR (DMSO): 2.61 (s, 3H), 3.39 (ddd, J 
= 13.5, 8.5, 5.1 Hz, 1H), 3.71 (ddd, J = 13.4, 5.9, 3.9 Hz, 1H), 
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5.12 (dt, J = 8.3, 4.0 Hz, 1H), 5.55 (d, J = 4.4 Hz, 1H), 8.36–8.40 (m, 2H), 7.25 
(dd, J = 10.4, 4.3 Hz, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.46 (d, J = 7.2 Hz, 2H), 7.81–
7.87 (m, 2H), 7.91–7.97 (m, 1H). 13C NMR (DMSO): 9.4, 50.0, 69.4, 118.3, 122.5, 
123.4, 124.3, 125.8 (2C), 127.0, 128.1 (2C), 130.2, 132.8, 141.1, 144.1, 146.0, 
151.2; LR-ESI-MS: C18H18N5O (m/z) [M + H]+ found 320.2 calcd 320.2. HR-ESI-
MS: C18H18N5O (m/z) [M + H]+ found 320.15037 calcd 320.15059. 
 Synthesis of 3-methyl-6-phenyl-6,7-dihydroimidazo[2,1-a][1,2,4]triazolo[4,3-
c]phthalazine (18). Procedure: To a solution of 17 (0.123 mmol) in pyridine (3.7 
mL) was added methanesulfonyl chloride (5.5 mmol) and the mixture was stirred at 
room temperature for 1 h. Then, water (0.6 mL) was added to the solution. The 
mixture was concentrated to a small volume and the residue was partitioned 
between CHCl3 (20 mL) and water (20 mL). The organic layer was dried over 
MgSO4 and evaporated to give 18. 
3-Methyl-6-phenyl-6,7-dihydroimidazo[2,1 
a][1,2,4]triazolo[4,3-c]phthalazine (18). 
White solid (68 %). 1H-NMR (CHCl3): 2.42 (s, 3H), 4.09 (dd, 
J = 14.5, 2.6 Hz, 1H), 4.44 (dd, J = 14.5, 8.9 Hz, 1H), 5.62 
(dd, J = 8.8, 2.6 Hz, 1H), 7.03–7.29 (m, 5H), 7.64 (td, J = 7.8, 1.1 Hz, 1H), 7.76 
(td, J = 7.8, 1.1 Hz, 1H), 8.23 (d, J = 7.8 Hz, 1H), 8.38 (d, J = 7.9 Hz, 1H). 13C 
NMR (DMSO): 12.3, 61.8, 68.6, 121.6, 123.6, 123.8, 125.3 (2C), 127.1, 129.0, 
129.6 (2C), 130.9, 133.2, 137.5, 144.7, 144.9, 156.6; LR-ESI-MS: C18H16N5 [(m/z) 
[M + H]+ found 320.1 calcd 320.2.  
Synthesis of 2-{(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-1-
phenylethan-1-one (19). Procedure: To a solution of 23 (700 mg, 2.2 mmol) in 
DMF (11ml) was added pyridinium dichromate (5.640 g, 15 mmol). The mixture 
was stirred at room temperature for 14 hours. The mixture was poured into water 
(60 mL), and then filtered through a buchner funnel. The filter cake was washed 
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with EtOAc and filtered through the silica gel (CHCl3-MeOH). 25 was obtained 
(75% yield) as a beige solid.  
2-{(3-Methyl[1,2,4]triazolo[3,4-α]phthalazin-6-yl)amino}-1-
phenylethan-1-one (19). Beige solid (75 %). IR: 3268, 2929, 
2360, 1698, 1516, 700. Mpt: 240-242 °C; 1H NMR (CDCl3): 
2.63 (s, 3H), 4.90 (d, J = 4.1 Hz, 2H), 6.51 (br, 1H), 7.51 (t, J = 
7.7 Hz, 2H), 7.59–7.63 (m, 1H), 7.66 (dd, J = 11.3, 4.1 Hz, 1H), 
7.77 (t, J = 7.6 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 8.02–8.05 (m, 
2H), 8.53 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3): 9.8, 48.0, 118.1, 122.5, 123.8, 
124.2 (2C), 128.0, 129.0 (2C), 130.1, 132.8, 134.4 (2C), 142.0, 147.2, 150.3, 194.5. 
LR-ESI-MS: C18H15N5O (m/z) [M + H]+ found 318.1 calcd 318.1. HR-ESI-MS: 
C18H15N5O (m/z) [M + H]+ found 318.13459 calcd 318.13603. 
General procedure for the reductive amination reaction 
To a solution of ketone 19 (0.1mmmol) in 0.5 mL of a mixture CHCl3/MeOH (2:1), 
the amine (0.88 mmol) was added. AcOH was added until the pH is 5, then 
NaBH3CN (0.12 mmol), and stirred to 50 °C until the reactants are consumed. The 
reaction mixture was quenched by adding 1N NaOH, and the product was extracted 
with CHCl3/MeOH (10%) (3 × 50 mL). The organic extract was dried (MgSO4) 
and the solvent was evaporated to give the crude free base. Purification by FCC 
(CHCl3-iPrOH 5%).  
N1-Ethyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-
1-phenylethane-1,2-diamine (20) 
White solid (43 %). IR: 3232, 3068, 2963, 2361, 1515, 669. 
Mpt: 228-230 °C. 1H NMR (CDCl3): 1.20 (t, J = 7.0 Hz, 3H), 
2.73–2.62 (m, 4H), 3.58–3.68 (m, 1H), 3.75–3.83 (m, 1H), 4.20 
(br, 1H), 6.23 (br, 1H), 7.31–7.51 (m, 5H), 7.61–7.73 (m, 1H), 
7.77 (d, J = 7.2 Hz, 2H), 8.52 (d, J = 7.3 Hz, 1H); 13C NMR (CDCl3): 9.7, 15.0, 
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41.6, 47.1, 61.0, 118.3, 122.5, 123.7, 124.0, 127.1 (2C), 128.1, 129.0 (2C), 130.1, 
132.5, 141.9 (2C), 147.2, 151.0. LR-ESI-MS: C20H24N6 (m/z) [M + H]+ found 
347.2 calcd 347.2. HR-ESI-MS: C20H24N6 (m/z) [M + H]+ found 347.19784 calcd 
347.19787. 
N1-Isopropyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-
6-yl)-1-phenylethane-1,2-diamine (21) 
White solid (69 %). IR: 3228, 2968, 2360, 1517, 701. Mpt: 
258-260 °C; 1H NMR (CDCl3): 1.13 (d, J = 6.1 Hz, 6H), 2.64 
(s, 3H), 2.89– 2.80 (m, 1H), 3.50 (t, J = 10.2 Hz, 1H), 3.79 (dt, 
J = 13.1, 5.6 Hz, 1H), 4.22 (br, 1H), 6.25 (br, 1H), 7.47–7.32 
(m, 5H), 7.71–7.65 (m, 2H), 7.79 (t, J = 7.4 Hz, 1H), 8.53 (d, J = 7.9 Hz, 1H). 13C 
NMR (CDCl3): 9.8, 22.1, 23.9, 45.8, 47.5, 58.4, 118.4, 122.2, 123.7, 124.1, 126.9 
(2C), 127.9, 128.9 (2C), 130.0, 132.5, 141.9 (2C), 147.2, 151.0. LR-ESI-MS: 
C21H25N6 (m/z) [M + H]+ found 409.2 calcd 409.2. HR-ESI-MS: C21H25N6 (m/z) 
[M + H]+ found 361.21348 calcd 361.21352. 
N2-(3-Methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-1-phenyl-
N1-propylethane-1,2-diamine (22) 
White solid (28 %). IR: 3067, 2900, 2854, 2359, 2341, 1515, 
700. Mpt: 216-218 °C. 1H NMR (CDCl3): 0.94 (t, J = 7.4 Hz, 
3H), 1.55 (dq, J = 21.8, 7.2 Hz, 2H), 2.56 (ddd, J = 25.4, 14.7, 
7.6 Hz, 2H), 2.66 (s, 3H), 3.49–3.58 (m, 1H), 3.75– 3.84 (m, 
1H), 4.06 (dd, J = 7.7, 5.0 Hz, 1H), 6.10 (br, 1H), 7.47–7.30 (m, 5H), 7.71 (s, J = 
14.0 Hz, 2H), 7.81 (d, J = 7.7 Hz, 1H), 8.58 (d, J = 7.9 Hz, 1H). 13C NMR 
(CDCl3): 151.0, 147.3, 142.0, 141.6, 132.5, 130.0, 128.9 (2C), 127.8, 126.9 (2C), 
124.2, 123.8, 122.2, 118.4, 61.2, 49.1, 47.3, 23.3, 11.8, 9.8. LR-ESI-MS: C21H25N6 
(m/z) [M + H]+ 361.2 calcd 361.2. HR-ESI-MS: C21H25N6 (m/z) [M + H]+ 
361.21341 calcd 361.21352.  
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N1-Isobutyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-
yl)-1-phenylethane-1,2-diamine (23) 
White solid (68 %). IR: 3228, 3068, 2952, 2813, 1514, 700. 
Mpt: 218-220 °C. 1H NMR (CDCl3): 0.95 (dd, J = 6.6, 5.5 Hz, 
6H), 1.76 (tt, J = 13.3, 6.7 Hz, 1H), 2.41 (ddd, J = 42.4, 11.5, 
6.7 Hz, 2H), 2.66 (s, 3H), 3.51 (ddd, J = 8.4, 6.0, 3.0 Hz, 1H), 
3.82–3.77 (m, 1H), 4.02 (dd, J = 8.2, 5.0 Hz, 1H), 6.14 (s, 1H), 7.31–7.44 (m, 5H), 
7.70 (d, J = 3.8 Hz, 2H), 7.79 –7.85 (m, 1H), 8.60 (d, J = 7.9 Hz, 1H). 13C NMR 
(CDCl3): 9.8, 20.6, 20.8, 28.7, 47.3, 55.2, 61.4, 118.5, 122.1, 123.9, 124.3, 126.8 
(2C), 127.8, 128.8 (2C), 130.0, 132.5, 141.8, 142.0, 147.3, 151.0. LR-ESI-MS: 
C22H27N6 (m/z) [M + H]+ found 375.2 calcd 375.2. HR-ESI-MS: C22H27N6 (m/z) 
[M + H]+ found 375.22882 calcd 375.22917.  
N1-Benzyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-
yl)-1-phenylethane-1,2-diamine (24) 
White solid (34%). IR: 3230, 2970, 2360, 1515, 700. Mpt: 258-
260 °C; 1H NMR (CDCl3): 2.64 (s, 3H), 3.58–3.51 (m, 1H), 
3.66 (d, J = 13.2 Hz, 1H), 3.76–3.83 (m, 1H), 3.85 (d, J = 13.2 
Hz, 1H), 4.10 (dd, J = 8.4, 4.8 Hz, 1H), 5.90 (br, 1H), 7.48 – 
7.26 (m, 10H), 7.66 (d, J = 8.0 Hz, 1H), 7.69–7.74 (m, 1H), 7.83 (t, J = 7.7 Hz, 
1H), 8.59 (d, J = 7.8 Hz, 1H). 13C NMR (CDCl3): 9.8, 47.5, 51.1, 60.2, 118.4, 
122.1, 123.9, 124.3, 127.1 (2C), 127.3, 128.0, 128.3 (2C), 128.5 (2C), 129.0 (2C), 
130.0, 132.6, 140.0, 141.3, 142.0, 147.3, 150.9. LR-ESI-MS: C25H25N6 (m/z) [M + 
H]+ found 409.2 calcd 409.2. HR-ESI-MS: C25H25N6 (m/z) [M + H]+ found 
409.21341 calcd 409.21352. 
 
201 
 
N1-(2-(Dimethylamino)ethyl)-N2-(3-
methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-1-
phenylethane-1,2-diamine (25)  
White solid (72 %). IR: 3230, 2970, 2360, 1514, 751, 700. 
Mpt: 218-220 °C. 1H NMR (CDCl3): 2.23 (s, 6H), 2.47–2.37 
(m, 1H), 2.58–2.65 (m, 2H), 2.66 (s, 3H), 2.67–2.74 (m, 1H), 
3.52 (ddd, J = 13.1, 8.9, 4.0 Hz, 1H), 3.85 (ddd, J = 13.3, 6.0, 4.7 Hz, 1H), 8.56 (d, 
J = 7.9 Hz, 1H), 6.48 (br, 1H), 4.08 (dd, J = 8.9, 4.5 Hz, 1H), 7.29–7.45 (m, 5H), 
7.64–7.73 (m, 1H), 7.80 (t, J = 7.6 Hz, 1H), 7.90 (d, J = 8.1 Hz, 1H). 13C NMR 
(CDCl3): 9.8, 44.0, 44.9 (2C), 47.6, 58.5, 61.2, 118.6, 122.8, 123.6, 124.1, 126.9 
(2C), 127.8, 128.8 (2C), 129.9, 132.4, 141.5, 142.0, 147.2, 151.1. LR-ESI-MS: 
C22H28N7 (m/z) [M + H]+ found 390.3 calcd 390.2. HR-ESI-MS: C22H28N7 (m/z) 
[M + H]+ found 390.23943 calcd 390.24007.  
N1-Allyl-N2-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-1-
phenylethane-1,2-diamine (26) 
White solid (54 %). IR: 3228, 3069, 2927, 2361, 2341, 1515, 
700. Mpt: 246-247 °C. 1H NMR (CDCl3):  2.66 (s, 3H), 3.18 
(dd, J = 14.1, 6.2 Hz, 1H), 3.30 (dd, J = 14.1, 5.6 Hz, 1H), 3.53–
3.66 (m, 1H), 3.81 (dt, J = 13.2, 5.4 Hz, 1H), 4.13 (t, J = 7.1 Hz, 
1H), 5.09–5.27 (m, 2H), 5.93 (ddd, J = 16.3, 11.0, 5.9 Hz, 1H), 6.02 (s, 1H), 7.28–
7.48 (m, 5H), 7.65–7.76 (m, 2H), 7.76–7.87 (m, 1H), 8.58 (d, J = 7.9 Hz, 1H). 13C 
NMR (CDCl3): 9.8, 47.3, 49.6, 60.4, 116.5, 118.4, 122.2, 123.8, 124.2, 127.0 (2C), 
128.0, 128.9 (2C), 130.0, 132.5, 136.2, 141.1, 142.0, 147.3, 150.9. LR-ESI-MS: 
C21H23N6 (m/z) [M + H]+ found 359.2 calcd 359.2; HR-ESI-MS: C21H23N6 (m/z) 
[M + H]+ found 359.19799 calcd 359.19787.  
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N1-Cyclohexyl-N2-(3-methyl[1,2,4]triazolo[3,4-
a]phthalazin-6-yl)-1-phenylethane-1,2-diamine (27). 
White solid (5 %). IR: 3235, 2970, 2930, 950, 816. Mpt: 208-
210 °C. 1H NMR (CDCl3): 1.14–1.27 (m, 6H), 1.53–1.83 (m, 
6H), 2.48 (s, 1H), 2.65 (s, 3H), 3.43–3.53 (m, 1H), 3.74–3.82 
(m, 1H), 4.24 (dd, J = 8.5, 4.7 Hz, 1H), 6.30 (s, 1H), 7.30–7.47 
(m, 5H), 7.65–7.77 (m, 2H), 7.81 (dd, J = 11.6, 4.6 Hz, 1H), 8.57 (d, J = 7.9 Hz, 
1H). 13C NMR (CDCl3): 9.8, 24.5 (2C), 24.9, 25.9 (2C), 47.6, 53.5, 57.9, 118.5, 
122.3, 123.8, 124.1, 126.9 (2C), 127.8, 128.9 (2C), 130.1, 132.5, 141.6, 142.0, 
147.2, 151.0. LR-ESI-MS: C24H29N6 (m/z) [M + H]+ found 401.3 calcd 401.2; HR-
ESI-MS: C24H29N6 (m/z) [M + H]+ found 401.24466 calcd 401.24482. 
Synthesis of N1-(3-methyl[1,2,4]triazolo[3,4-α]phthalazin-6-yl)-2-
phenylethane-1,2-diamine (28). Procedure: To a solution of ketone 19 (10 mg, 
0.03 mmol) in 0.5 mL of a mixture CHCl3/MeOH (2:1) a solution of MeOH/NH3 
(0.5 ml) was added. Then, AcOH was added until the pH is 5, followed by adding 
NaBH3CN (2.25 mg, 0.036 mmol) and stirring to 50 °C for 18h. The reaction 
mixture was quenched with 1N NaOH, and the organic layer was extracted with 
CHCl3/ MeOH (10%) (3 × 50 mL). The organic extract was dried (MgSO4) and the 
solvent was evaporated to give the crude free base. Purification by FCC (CHCl3-
iPrOH 5%). 
N1-(3-Methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-2-
phenylethane-1,2-diamine (28). 
Yellow solid (52 %). IR: 3277, 3065, 2925, 2854, 2359, 2341, 
1515, 700. Mpt: 210-212 °C; 1H NMR (CDCl3): 2.69 (s, 3H), 
3.52 (ddd, J = 13.0, 8.7, 4.2 Hz, 1H), 3.87 (ddd, J = 13.2, 6.0, 4.8 
Hz, 1H), 4.38 (dd, J = 8.7, 4.7 Hz, 1H), 5.91 (br, 1H), 7.31–7.45 (m, 5H), 7.71 
(ddd, J = 12.3, 9.3, 4.4 Hz, 2H), 7.79–7.85 (m, 1H), 8.60 (d, J = 7.6 Hz, 1H). 13C 
NMR (CDCl3): 9.8, 48.9, 54.4, 118.4, 122.2, 123.9, 124.3, 126.1 (2C), 127.8, 128.9 
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(2C), 130.1, 132.6, 142.0, 143.8, 147.3, 151.0. LR-ESI-MS: C18H19N6 (m/z) [M + 
H]+ found 319.1 calcd 319.2. HR-ESI-MS: C18H19N6 (m/z) [M + H]+ found 
319.16652 calcd 319.16657. 
Synthesis of N-(2-((3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6 yl)amino)-1-
phenylethyl)acetamide (29). 
Procedure: Triethylamine (0.015 mL, 0.11 mmol) was added to a solution of 28 
(31.8 mg, 0.1 mmol) in CHCl3/MeOH (2:1, 0.5 mL), the mixture was cooled to 0 
°C, and acetyl chloride (7 μL, 0.104 mmol) was slowly added. The reaction 
mixture was stirred for 3h, warmed to room temperature and stirred overnight. The 
mixture was quenched with saturated sodium bicarbonate solution (20 mL). The 
phases were separated and the aqueous layer was washed with CHCl3/MeOH (2:1, 
20 mL). The combined organic layers were dried over magnesium sulfate and 
concentrated. The crude product was purified by washing with EtOAc and CHCl3.  
N-(2-{(3-Methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-
1-phenylethyl)acetamide (29). 
White solid (42 %). IR: 3270, 3065, 2925, 2853, 1625, 1517, 
701. Mpt: 216-218 °C. 1H-NMR (MeOD): 1.99 (s, 3H) 2.71 (s, 
3H), 3.75 (dd, J = 13.6, 8.6 Hz, 1H), 3.91 (dd, J = 13.6, 5.6 Hz, 
1H), 5.58 (dd, J = 8.6, 5.6 Hz, 1H), 7.27 (ddd, J = 7.3, 3.9, 1.2 Hz, 1H), 7.35 (dd, J 
= 10.4, 4.8 Hz, 2H), 7.42–7.46 (m, 2H), 7.82 (dt, J = 8.4, 3.7 Hz, 1H), 7.92 (dd, J = 
11.5, 4.4 Hz, 1H), 8.10 (d, J = 8.1 Hz, 1H), 8.43 (d, J = 7.4 Hz, 1H). 13C-NMR 
(MeOD): 9.5, 22.7, 48.3, 53.1, 120.4, 124.2, 124.3, 124.9, 128.0 (2C), 128.6, 126.6 
(2C), 132.2, 134.1, 141.7, 143.3, 148.6, 153.4, 173.2. LR-ESI-MS: C20H21N6O 
(m/z) [M + H]+ found 361.2 calcd 361.2, HR-ESI-MS: C20H21N6O (m/z) [M + H]+ 
found 361.17714 calcd 361.17714. 
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Synthesis of methyl (2-{(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-
1-phenylethyl)carbamate (30). Procedure: Into a well stirred solution of 28 (10.0 
mg, 0.03 mmol) in CHCl3/MeOH (2:1, 0.3 mL), cooled in a water-bath, was added 
dropwise a solution of methyl chloroformate (3 μL, 0.035mmol). The mixture was 
stirred for 1 h to 0 °C, warmed to room temperature, and stirred overnight. The 
mixture was concentrated. Purification by FCC (DCM/ MeOH: 98/2) yielded 29 
(62%) as a white solid. 
White solid (62 %). IR: 3270, 3065, 2929, 2858, 1628, 1517, 701. 
Mpt: 240-242 °C. 1H NMR (DMSO): 2.61 (s, 3H), 3.48 (s, 3H), 
3.60 (ddd, J = 13.2, 8.1, 4.9 Hz, 1H), 3.73 (dd, J = 12.4, 6.1 Hz, 
1H), 5.19 (dd, J = 13.8, 8.1 Hz, 1H), 7.22 (t, J = 7.3 Hz, 1H), 7.32 
(t, J = 7.6 Hz, 2H), 7.42 (d, J = 7.4 Hz, 2H), 7.75–7.80 (m, 2H), 
7.80–7.86 (m, 1H), 7.90–7.94 (m, 1H), 8.26 (d, J = 8.3 Hz, 1H), 8.38 (dd, J = 7.9, 
0.9 Hz, 1H). 13C NMR (DMSO): 9.4, 47.1, 51.3, 53.0, 118.1, 122.5, 123.4, 124.2, 
126.6 (2C), 127.0, 128.2 (2C), 130.2, 133.0, 141.1, 141.9, 146.1, 151.1, 156.4. LR-
ESI-MS: C20H21N6O2 (m/z) [M + H]+ found 377.2 calcd 377.2. HR-ESI-MS: 
C20H21N6O2 (m/z) [M + H]+ found 377.17214 calcd 377.17205. 
1-Methyl-3-(2-{(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-1-
phenylethyl)thiourea (31) 
Procedure: Into a well stirred solution of 29 (10.0 mg, 0.03 mmol) in 
CHCl3/MeOH (2:1, 0.3 mL), was added methyl isothiocyanate (10.9 mg, 0.15 
mmol). The mixture was stirred for 16 h to room temperature. The mixture was 
concentrated. Purification by washing with CHCl3 yielded 31 (79%) as a white 
solid. 
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White solid (79 %). IR: 3031, 2952, 1516, 1018, 797. Mpt: 262-
264 °C. 1H NMR (DMSO): 2.63 (s, 3H), 2.79 (d, J = 4.2 Hz, 3H), 
3.68–3.84 (m, 2H), 7.21 (t, J = 7.3 Hz, 1H), 7.32 (t, J = 7.6 Hz, 
2H), 7.41 (d, J = 7.3 Hz, 2H), 7.81 (t, J = 7.5 Hz, 1H), 7.70 (br, 
1H), 8.37 (d, J = 7.6 Hz, 1H), 7.88–7.95 (m, 2H), 8.29 (d, J = 8.1 
Hz, 1H). 13C NMR (DMSO):  9.5, 30.9, 46.9, 55.6, 118.2, 122.5, 
123.3, 124.3, 126.8 (2C), 126.9, 128.1 (2C), 130.2, 132.9, 141.1, 
141.6, 146.1, 151.1, 175.8. LR-ESI-MS: C20H22N7S (m/z) [M + H]+ found 392.2 
calcd 392.2. HR-ESI-MS: C20H22N7S (m/z) [M + H]+ found 392.16518 calcd 
392.16519. 
1-Ethyl-3-(2-{(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)amino}-1-
phenylethyl)urea (32). Procedure: Into a well stirred solution of 29 (10.0 mg, 
0.03 mmol) in CHCl3/MeOH (2:1, 0.3 mL), was added ethyl isocyanate (0.01 mL, 
0.15mmol). The mixture was stirred for 16 h to r.t. The mixture was concentrated. 
Purification by washing with CHCl3 yielded 32 (51%) as a beige solid. 
Beige solid (51 %). IR: 3035, 2958, 1519, 1018, 797. Mpt: 240-
242 °C. 1H NMR (MeOD): 1.02 (t, J = 7.2 Hz, 3H), 2.90 (s, 3H), 
3.09 (q, J = 7.2 Hz, 2H), 3.69–3.76 (m, 1H), 3.90 (dd, J = 13.7, 
4.6 Hz, 1H), 5.42 (dd, J = 8.9, 4.6 Hz, 1H), 7.28 (t, J = 7.3 Hz, 
1H), 7.37 (t, J = 7.5 Hz, 2H), 7.45 (d, J = 7.3 Hz, 2H), 8.00–8.08 
(m, 2H), 8.34 (d, J = 7.9 Hz, 1H), 8.46 (dd, J = 7.6, 1.0 Hz, 1H). 
13C NMR (MeOD): 9.2, 15.7, 35.8, 49.4, 53.3, 121.6, 121.7, 125.2, 125.5, 127.7 
(2C), 128.6, 129.7 (2C), 134.7, 134.9, 142.4, 142.5, 148.1, 155.1, 160.9. LR-ESI-
MS: C21H24N7O (m/z) [M + H]+ found 390.2 calcd 390.2. HR-ESI-MS: C20H22N7S 
(m/z) [M + H]+ found 390.20500 calcd 390.20368. 
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